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Abstract 
Bioactive peptides represent an important source of health promoting food. Therefore, 
the objective of this study was to identify the in vitro antioxidant and ACE inhibitory 
peptides derived from bovine serum albumin (BSA) and to characterise them after 
further purification. To achieve this objective, BSA was hydrolyzed with pepsin 
enzyme, fractionated by ultrafiltration using a 10 kDa molecular weight cut off 
membrane, and purified by gel filtration chromatography prior to characterisation. 
The total antioxidant activity was evaluated in a linoleic acid model system using the 
ferric thiocyanate (FTC) and thiobarbituric acid reactive species (TBARS) methods. 
The results indicated that gel filtration fraction number 18 exhibited the highest FTC 
antioxidant activity (65.4 %) compared to the (< 10 kDa) ultrafiltration fraction (44.8 
%) and BSA hydrolysate (34.9 %) using a concentration of 1mg peptide/ml. However, 
the peptide activities were lower than those of 0.01 % butylated hydroxyanisole (69.9 
%) and 0.01 % trolox (78.5 %) (P ≤ 0.05). Likewise, TBARS inhibition values were 
42.8, 54.8, 76.7 and 84.4 % for BSA hydrolysate, < 10 kDa, BHA and trolox, 
respectively. The antioxidant activity of the (Mw < 10 kDa) peptide was demonstrated 
by strong free radical scavenging using the 1, 1-diphenyl-2-picrylhydrazyl (DPPH•), 
hydroxyl (OH•) and superoxide anion (O2-•);  ferric (Fe3+) reducing and ferrous (Fe2+) 
metal ion chelating capacity and reducing power activity. A second gel filtration 
fraction number 22 exhibited the highest ACE inhibitory activity (79.5%) compared 
to the (10 kDa) ultrafiltration fraction (44.7%) and BSA hydrolysate (33.2 %) at a 
concentration of 10 mg/ml, with corresponding low IC50 values of 0.32, 0.56 and 0.75 
mg/ml respectively compared to captopril (88.5%, P ≤ 0.05). The peptide (GF 18) at 1 
mg/ml had no cytotoxic effect in epithelial caco-2 cells. Moreover, the presence of the 
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peptide showed high cell viability (99.7%) and reduced malondialdehyde formation 
(27.7 µg/ml) compared with cells treated with 3mM t-BHP alone, which showed low 
cell viability (54.6%) and high MDA (30.3 µg/ml) (P < 0.01). BSA peptides protected 
t-BHP treated cells from caspase-dependent apoptosis; inhibited intracellular ROS 
production and increased glutathione level and SOD activity. Similarly, the GF 22 
peptides (1 mg/ml) protected the endothelial EA.hy 926 against 3mM t-BHP damage 
and showed reduced mROS production by both lucigenin-enhanced 
chemiluminescence and the DHE fluorescence techniques. Additionally, the peptides 
reduced nitrite concentration and inhibited the activity of angiotensin converting 
enzyme in a dose dependent manner.  This study reports novel findings showing that 
BSA peptides have antioxidant and ACE inhibitory activities that could potentially be 
used as food supplements and pharmaceutical agents. 
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1  Literature review 
1.1 Proteins 
Proteins are the most structurally and functionally varied group of biomolecules found 
in all living cells. They participate in several cellular processes, including normal 
metabolic processes, transport of micromolecules (such as iron), replication of genetic 
material (DNA) and immunological recognition by antibodies. Proteins, along with 
lipids and carbohydrates, are important macronutrients and constitute a major 
component of living systems because of their vital role in various physiological 
functions (Mine and Shahidi, 2005; Davies, 2012). 
 
Proteins (also known as polypeptides) are large organic macromolecules consisting of 
one or more polypeptide chains; each polypeptide chain in turn consists of linear 
sequences of 20 small units called amino acids. These 20 amino acids that occur in all 
living organisms have a fundamental design and are composed of a central carbon 
atom connected to a carboxylic acid group (–COOH), an amino group (R-NH2), a 
hydrogen atom (-H) and a unique side chain (R) that determines the function and 
properties of the amino acid (Berg et al., 2002). Multiple amino acids are linked 
together to form a protein through condensation reactions involving the removal of 
one molecule of water, resulting in the formation of a peptide bond, as shown in 
Figure 1.1. 
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Figure 1.1 The condensation synthesis reaction of two amino acids depicting peptide bond 
formation through the removal of one molecule of water (Metzler, 2001). 
 
 
1.2 Protein structure 
Proteins have four levels of organisation: primary, secondary, tertiary and quaternary, 
which are described below and depicted in Figure 1.2 (Walsh, 2002). 
 
 
 
1.2.1   Primary structure  
The primary structure of a protein representing the lowest hierarchy of the protein 
structure refers to the linear sequence of amino acids covalently linked by peptide 
bonds, with the N-terminus (R-NH2) conventionally represented on the left and the C-
terminus (–COOH) conventionally represented on the right. Understanding the 
primary structure of proteins is very important for obtaining insights into various 
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genetic disorders resulting from abnormal amino acid sequences such as sickle cell 
anaemia (Figure 1.2) (Champe et al., 2005; Davies, 2012).   
 
1.2.2   Secondary structure 
Secondary protein structure refers to the specific arrangement of amino acid residues 
that are arranged close to each other in a linear sequence formed by the polypeptide 
backbone. The two most prevalent types of secondary structure in proteins are the α-
helix and β-pleated sheets. The α-helix is a spiral or twisted structure in which the 
polypeptide backbone follows a helical path. The α-helix is stabilised by hydrogen 
bonds between the amide nitrogen and carbonyl groups of amino acids constituting 
the polypeptide backbone (Hames et al., 2005). The second type of secondary 
structure, known as β-sheets or pleated sheets, is formed by the folding of a chain of 
amino acids over itself (Qiang et al., 2012). Two arrangements of adjacent β-sheets, 
parallel or antiparallel, are possible depending on whether the polypeptide chains are 
oriented in the same or opposite directions (Figure 1.2) (Belitz et al., 2009; Löwik et 
al., 2010). 
 
1.2.3 Tertiary structure 
The three-dimensional structure of proteins constitutes their tertiary structure and is 
formed by spatial association between various amino acids of the polypeptide chain 
and folding of the secondary structural elements. This structure is stabilised by 
multiple interactions, including hydrogen bonds (that link various amino acid 
residues), hydrophobic interactions (that link nonpolar side groups of amino acids), 
electrostatic interactions (between positively and negatively charged amino acid side 
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chains) and covalent disulphide bridges (formed between the sulphur atoms of two 
cysteine monomers) (Figure 1.2) (Belitz et al., 2009; Löwik et al., 2010). 
 
1.2.4 Quaternary structure 
The quaternary structure refers to the association of more than one protein molecule 
to form a multi-subunit protein. The most common example is the haemoglobin 
molecule that carries oxygen to all parts of the body; the haemoglobin molecule 
contains two α and two β subunits to form the tetramer α2β2 (Figure 1.2) (Belitz et al., 
2009; Davies, 2012). 
 
Figure 1.2  Levels of protein structure. A schematic depicting the primary, secondary, tertiary 
and quaternary protein structures (Russell, 2010). 
 
 
1.3  Bioactive peptides 
The role of proteins as active dietary components is increasingly acknowledged, and 
they are a rich source of biologically active peptides (Haque and Chand, 2008). Raw 
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food materials contain several naturally occurring proteins that exert their role either 
directly or following in vitro or in vivo enzymatic hydrolysis. 
  
Certain amino acid sequences (peptide sequences) in proteins exert potentially 
beneficial effects in human beings. Such peptide sequences remain inactive when 
present as part of the primary structure of the parent proteins; however, the action of 
appropriate enzymes such as proteases on the parent protein results in the release of 
the peptides into the digest, termed protein hydrolysate. Low but adequate quantities 
of the active intact peptides are present in the hydrolysate and could be employed for 
the management of chronic disease. In addition, several methods such as membrane 
ultrafiltration (UF) and column chromatography could be employed for generating 
fractions containing high concentrations of bioactive peptides (Aluko and Monu, 
2003; Howell and Kasase, 2010a; Mhd Sarbon et al., 2013). Pure peptides obtained 
from the hydrolysate could be employed for investigating structure–function 
relationships. 
 
Bioactive peptides derived from food proteins are defined as specific protein 
fragments composed of 3–40 amino acid residues per molecule (Memarpoor-Yazdi et 
al., 2013), which impact on biological functions, ultimately affecting the health of 
living beings (Kitts and Weiler, 2003; Möller et al., 2008). The activity of these 
peptides is dependent on their amino acid composition and sequence. The short chains 
of constituent amino acids remain in an inactive state as part of the precursor protein 
sequence and could be released through different mechanisms (Korhonen, 2009): in 
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vivo through the actions of digestive enzymes during gastrointestinal digestion or 
proteolytic enzymes derived from microorganisms or plants and in vitro through the 
action of microbial enzymes during food processing, such as milk fermentation and 
cheese production (Erdmann et al., 2008; Ktari et al., 2012; Kim et al., 2013). 
 
Bioactive peptides are resistant to hydrolysis; therefore, they are capable of 
functioning in the intestinal tract or directly within the blood stream following their 
absorption in the intestine and exert various physiological effects (Vermeirssen et al., 
2002a; Vermeirssen et al., 2002b). Therefore, scientific research aimed towards 
evaluating the in vivo bioavailability of bioactive peptides is gaining importance. 
 
Recent studies have established that bioactive peptides exhibit a number of biological 
activities in vivo depending on the characteristics of the protein and peptide, their 
amino acid sequences, the degree of hydrolysis and the type of hydrolysing enzyme 
(Li et al., 2013; Memarpoor-Yazdi et al., 2013). In addition, the biological impact of 
bioactive peptides attributable to their different properties has been investigated, 
including antimicrobial (Reddy et al., 2004; Rajanbabu and Chen, 2011), antioxidant 
(Sarmadi and Ismail, 2010), antithrombotic (Wang and Ng, 1999), antihypertensive 
(Erdmann et al., 2008) and immunomodulatory activities (Figure 1.3) (St Georgiev, 
1990; Gauthier et al., 2006). Moreover, these peptides have been applied in 
nutraceuticals for promoting human health and preventing chronic diseases. 
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Figure 1.3  Physiological functions of milk-derived bioactive peptides (Madureira et al., 
2010). 
 
To date, food-derived bioactive peptides are mainly obtained from bovine milk, cheese 
and dairy products as the greatest source. In addition, other animal and plant sources, 
including bovine blood, gelatine, chicken skin (Mhd Sarbon et al., 2013), egg, various 
fish species such as tuna, sardines, salmon and mackerel (Howell and Kasase, 2010a) 
as well as wheat, soy, rice, mushrooms, pumpkin and maize (Schrezenmeir et al., 2000) 
can be good sources of bioactive peptides and proteins. Further research is required for 
identifying new sources of bioactive peptides to maximise the utilisation of waste by-
products and improve global environmental conditions. 
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1.3.1  Production of bioactive peptides 
Enzymatic hydrolysis is the most common process for the production of bioactive 
peptides. The process of protein hydrolysis involves the cleavage of the peptide bond 
between two adjacent amino acids in a protein through the action of endopeptidases or 
gastrointestinal proteolytic enzymes such as trypsin, pepsin and chymotrypsin, resulting 
in the production of two peptides (Udenigwe and Aluko, 2012). In an in vivo scenario, 
the process of protein digestion begins in the stomach under acidic conditions with the 
action of the enzyme pepsin, which cleaves peptide bonds between aromatic amino acid 
residues (phenylalanine, tryptophan and tyrosine) to generate small peptides. In 
addition, the cleavage of the resultant peptides under alkaline conditions in the small 
intestine is performed by the action of trypsin, chymotrypsin and carboxypeptidase 
enzymes in the pancreas (Korhonen and Pihlanto, 2006). 
 
1.3.2  Purification of bioactive peptides 
The purification of peptides generated by enzymatic hydrolysis is the primary step for 
investigating their molecular and biological properties. Following the identification of 
peptides with potent biological activity, further purification is required. Several 
procedures involving the use of single or consecutive techniques have been employed, 
including UF (Alemán et al., 2011), gel-filtration (GF) chromatography (Li et al., 
2012a) and reverse-phase high-performance liquid chromatography (RP-HPLC) 
(Chen et al., 2012a). A brief procedure for the purification and identification of 
bioactive peptides from bovine serum albumin (BSA) is depicted in Figure 1.4. 
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Figure 1.4  Flowchart depicting steps involved in the purification and identification of 
bioactive peptides derived from BSA. 
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1.3.2.1   Ultrafiltration 
Ultrafiltration (UF) is a separation technique commonly employed on a laboratory and 
commercial scale for the fractionation, purification and concentration of proteins on 
the basis of their selective molecular weight (Ghosh, 2003; Martínez-Maqueda et al., 
2013). UF membranes are commercially obtained in a wide range of MW cutoffs 
(MWCOs; 1–500 kDa) (Zhao et al., 2009). Jun et al. purified a peptide from frame 
protein by fractionation using UF membranes of different MWCO (30, 10, 5, 3 and 1 
kDa) (Jun et al., 2004). In a study published in 2005, Hernandez-Ledesma et al. 
fractionated milk hydrolysates using UF with a 3-kDa MWCO membrane 
(Hernandez-Ledesma et al., 2005), while another group investigating small peptides 
employed a 1-kDa MWCO membrane for UF (Vilela et al., 2006). 
 
UF is commonly employed in the food industry for the rapid separation and 
concentration of food proteins because of its low cost and ease of operation 
(Raghavan and Kristinsson, 2008). A few common and useful applications of this 
technique for fractionation in the food industry include cheese production, 
fractionation and concentration of gelatine and removal of glucose from egg white 
(Pal, 2003). This method has also been widely employed in scientific research over 
the past few decades because of the large number and size range of peptides generated 
during the hydrolysis reaction, depending on the specific enzyme employed and the 
degree of hydrolysis. Basically, this method improves the activity of the peptides 
through the removal of enzymes and non-hydrolysed protein of high molecular mass. 
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1.3.2.2   Gel filtration chromatography 
Gel filtration (GF) chromatography, also referred to as size-exclusion 
chromatography, and is widely employed in the food industry for determining the 
composition of a particular food sample. The fractionation of food samples using this 
process is based on properties such as molecular size and shape (Lodish et al., 2000). 
 
The fractionation range is determined by employing resins of different pore sizes on 
the basis of polyacrylamide (Bio-Gel) or the carbohydrates dextran (Sephadex) or 
agarose (Sepharose). Sephadex columns are the most widely employed and are 
available in a wide range of pore sizes, including Sephadex G-15, G-25 and G-100 for 
MW of <1500, 1,000–5,000 and 5,000–10,000 Da, respectively (Sun et al., 2011; Li 
et al., 2012b). This technique involves loading of the protein sample onto the top of a 
column containing porous beads of 0.1 mm diameter. Proteins or peptides whose 
molecular size is greater than the pores in the swollen gel matrix are unable to enter 
the gel beads and therefore elute rapidly from the column. In contrast, molecules with 
a lower molecular size enter the matrix to varying degrees, move slowly through the 
column and elute gradually (Lodish et al., 2000; Ly and Wasinger, 2011). 
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1.3.2.3   Reverse phase high performance liquid chromatography 
Reverse phase high performance liquid chromatography (RP-HPLC) is a separation 
technique that is commonly used to isolate and purify peptides derived from chemical 
cleavage or enzymatic digestion of a purified protein. This technique exploits 
differences in the polarity of peptides, in turn governed by their amino acid 
composition, which determines their interactions with a hydrophobic stationary phase 
(Josic and Kovac, 2010; Ghassem et al., 2012a). This technique employs a nonpolar 
(hydrophobic) stationary phase (C18) consisting of spherical porous silica beads of 
particle size 3–5 µm modified with a covalently bonded phase. Nonpolar molecules 
strongly adhere to the nonpolar stationary phase, while polar molecules rapidly move 
through the beads and elute rapidly in the presence of an aqueous mobile phase 
(Kamysz et al., 2004; Josic and Kovac, 2010). The polar mobile phase is a mixture of 
water and a polar organic solvent such as acetonitrile; 0.1% TFA is typically added to 
acetonitrile to obtain well-shaped peaks and is frequently employed as a buffer for 
gradient elution (Guang and Phillips, 2009). 
 
1.3.3   Peptide sequencing 
1.3.3.1   Edman degradation 
Pehr Edman developed an automated method, termed Edman degradation, for 
determining the amino acid sequence of a peptide in 1950 (Edman, 1950). This 
technique involves the stepwise removal of amino acid residues from the N-terminus 
of the peptide without affecting peptide bonds between other amino acid residues. The 
uncharged N-terminal R-NH2 reacts with phenylisothiocyanate (C6H5-N=C=S) under 
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mildly alkaline conditions to form phenylthiocarbamoyl-peptide (PTC-peptide). This 
derivative is subsequently cleaved in the presence of an anhydrous acid to generate a 
thiazolinone intermediate, while the rest of the peptide chain is released. The 
thiazolinone intermediate is subsequently hydrolysed to yield a PTC derivative, which 
undergoes cyclisation, thereby generating a phenylthiohydantoin derivative (PTH-
amino acid). The PTH-amino acid derivative is then extracted into an organic solvent 
and identified using chromatography (HPLC) or electrophoresis (Kinter and Sherman, 
2005). This technique has been employed in several studies for detecting the amino 
acid sequence of purified peptides (Jung et al., 2006; Tsai et al., 2008). 
 
1.4   Milk proteins and peptides 
The previous two decades have witnessed substantial research on the importance of 
proteins in the human diet. Milk is a complex mixture of lipids, proteins, 
carbohydrates, vitamins and salts and contains approximately 87% water, 5% lactose, 
3% proteins, 4% lipids and 0.8% minerals (Haug et al., 2007c; Lindmark-Månsson et 
al., 2003). Milk proteins are produced and secreted by the mammary glands. Milk is a 
rich source of proteins as it contains all the essential amino acids required by humans. 
Approximately, 60% of the amino acids that comprise milk proteins are obtained by 
the cow from its diet. Variations in the milk protein content and amino acid 
composition are attributable to the difference in cow breed and genetic characteristics 
of individual animals (Tibulca and Jimborean, 2008). 
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From a nutritional point of view, the nutrient components of milk are multifunctional 
and encompass a wide-spectrum of energy sources, including essential fatty acids, 
amino acids and vitamins. Thus, milk is a first-rate source of these nutrients for 
infants; in addition, milk plays a role in combating diseases in infants because of the 
action of several constituent proteins such as lysozyme, peroxidase, lactoferrin (LF) 
and immunoglobulins (Igs) (Creamer and MacGibbon, 1996). 
 
Milk contains approximately 33 g/L of protein; the average protein content in milk is 
summarised in Table 1.1 (Ribadeau-Dumas and Grappin, 1989). Two major protein 
groups, typically defined by their chemical composition and physical properties, are 
found in milk: the insoluble casein micelles containing calcium phosphate that 
precipitates from raw milk at pH 4.6, as observed during cheese making, and the 
soluble whey proteins present in the remaining serum. Casein constitutes 
approximately 80% of the total protein content in milk, while serum or whey proteins 
constitute the rest (Creamer and MacGibbon, 1996). 
Table 1.1   Average protein content in milk (Ribadeau-Dumas and Grappin, 1989). 
 Cow milk protein       Amount (g/L) (%) of total protein  
 Total protein 33 100 
 Total caseins 26 79.5 
 αs1-Casein 10 30.6 
 αs2-Casein 2.6 8 
 β-Casein 9.3 28.4 
 Ќ-Casein 3.3 10.1 
 Total whey proteins 6.3 19.3 
 α-Lactoalbumin 1.2 3.7 
 β-Lactoglobulin 3.2 9.8 
 Bovine serum albumin 0.4 1.2 
 Immunoglobulins 0.7 2.1 
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1.4.1   Caseins 
Caseins are phosphoproteins with MW of 23 kDa and are classified into various types 
on the basis of the homology of their primary structure; these include α-s1-, α-s2-, β- 
and κ-caseins, which constitute 30%, 9%, 28% and 10%, respectively, of the total 
casein content in milk (Haug et al., 2007b). Each class of casein exhibits distinct 
amino acid composition, genetic variations, MW and functional properties (Wong et 
al., 1996; Kristjánsson et al., 2007) (Table 1.2). The amino acid composition or 
proline content of caseins allows a relatively random and open structure, while their 
high phosphate content allows association with calcium and the formation of casein 
micelles (Farrell Jr et al., 2004; Wong et al., 1996). 
 
1.4.2   Whey proteins 
The serum (whey) proteins constitute an important group of milk proteins with 
excellent nutritional and functional properties that exert a positive impact on the 
human body. The whey proteins are made up of approximately 50% β-lactoglobulin 
(β-Lg) and 20% α-lactalbumin (α-La) in addition to BSA, Ig, LF and several minor 
proteins and enzymes. Like the other major milk components, each type of whey 
protein has its own characteristic composition and variations (Table 1.2). Whey 
proteins lack phosphorus but contain a large amount of sulphur-containing amino 
acids that allow the formation of disulphide bonds. The presence of the covalent 
disulphide bonds and the noncovalent hydrophobic and electrostatic interactions 
within the proteins causes folding of the polypeptide chains, resulting in a compact 
spherical shape. Disruption of the bonds under different physical and chemical 
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conditions results in denaturation of the proteins such that the compact structure 
unfolds into a molten globule with exposed hydrophobic groups, lowering its 
solubility. Therefore, whey proteins play a vital role in determining the heat stability 
of milk concentrates and in the gelation of milk products (Morr, 1985; Michalski and 
Januel, 2006; Król and Zarajczyk, 2008; Darewicz et al., 2011). 
 
Table 1.2  Chemical and structural characteristics of milk proteins (Kinsella and Phillips, 
1989). 
 
  Property 
 Whey Caseins 
β-lg α-la BSA αs1- αs2- β- κ- 
Molecular Weight 18362 14194 65000 23612 25228 23980 19005 
Total amino acids residues 162 123 581 199 207 209 169 
A polar residues [%] 34.6 36 28 17 10 35 20 
Isoionic point 5.2 4.2 5.3 4.96 5.27 5.2 5.54 
No. proline residues 8 2 28 17 10 35 20 
No. lysine residues 15 12 59 14 24 11 9 
No. phosphoryl groups 0 0 0 8-9 10-13 5 1 
No. disulfide bonds 2 4 17 0 1 0 1 
No. thiol groups 1 0 1 0 0 0 0 
                                                      Secondary structure (%) 
α-helix 15 26 54 - - 9 23 
β-sheet 50 14 18 - - 25 31 
β-turns 18 - 20 - - - 24 
Unordered - 60 - - - 66 - 
Native conformation Globular Extended 
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1.4.3   Peptides from milk proteins 
Milk has excellent sources of nutrients that are essential for a balanced diet; it 
contributes to a range of biological activities that can impact upon digestion, metabolic 
responses, growth, development of specific organs and resistance to diseases. These 
activities can be attributed to the proteins and peptides present in milk. A few 
biological activities of milk proteins are latent and subject to proteolytic digestion. 
 
Milk contains a number of enzymes capable of acting on amino acids, carbohydrates, 
fat or vitamins, thereby changing the biological nature of milk. Proteinases are a group 
of enzymes found in milk and break down proteins into small fragments referred to as 
peptides. Certain biologically active peptides are derived from milk proteins through 
proteolytic digestion. Various types of proteinases are present in milk, including 
plasmin, acid milk proteinase and a proteinase derived from leukocytes (somatic cells) 
that enter milk during mastitis. Plasmin is derived from its inactive form plasminogen 
and is responsible for 90% of the proteolytic activity in cow’s milk. Plasminogen is 
converted into plasmin by the action of the enzyme plasminogen activator. Milk 
plasmin and plasminogen are typically associated with casein micelles and are 
dissociable from them upon changing temperature and pH conditions (Aslam and 
Hurley, 1998). 
Bovine and caprine milk proteins were recently identified as major sources of 
biologically active substances. Bovine milk contains approximately 32 g/L of 
proteins, of which caseins and whey proteins constitute 80% and 20%, respectively 
(Haug et al., 2007a) 
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1.4.3.1   Functional role of casein-derived bioactive peptides 
Casein-derived bioactive peptides are being extensively researched because caseins 
are insoluble proteins, they are precipitated from milk. The open and flexible structure 
of caseins has facilitated to derive a substantial number of peptides with different 
amino acid sequences through the digestion and hydrolysis of caseins (Silva and 
Malcata, 2005). 
 
Casein-derived peptides potentially have several effects in the human body. For 
producing functional food products with bioactive peptides, it is required that their 
bioavailability from natural sources is increased or novel food products are produced 
through the addition of isolated or enriched bioactive peptide fractions (Phelan et al., 
2009). 
 
Casein is a good source of peptides and protein fragments with several physiological 
functions and bioactive properties. The major role attributed to casein is mineral 
binding and carrying capacity, primarily for calcium and phosphorus. The four types 
of casein, α-s1, α-s2, β and , are responsible for transporting calcium and phosphorus 
through the formation of a coagulum and improving their digestibility in the stomach 
(Holt et al., 2013). 
 
In addition, the bioactive peptides derived from caseins have been shown to be 
beneficial to human health in multiple ways; these include the action on different 
systems such as cardiovascular, nervous, immune and digestive systems through their 
antioxidant (Zimecki and Kruzel, 2007), immunomodulatory (Politis and 
Chronopoulou, 2008), antihypertensive (Jauhiainen and Korpela, 2007) and 
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antithrombotic (Phelan et al., 2009) properties. A few biological functions of the 
peptides derived from milk caseins are shown in Table 1.3. 
 
Table 1.3  Biologically active peptides derived from bovine casein protein (Nagpal et al., 
2011). 
 
Precursor protein  Fragment  Peptide sequence Name  Function 
 
β-casein 60-70 
 
 
60-66 
 
60-64 
 
177-183 
 
139-202 
 
 
169-175 
 
63-68 
 
191-193 
1-25 
Tyr-Pro-Phe-Pro-
Gly-Pro-Ile-Pro-
Asn-Ser-Leu 
Tyr-Pro-Phe-Pro-
Gly-Pro-Ile 
Tyr-Pro-Phe-Pro-
Gly 
Ala-Val-Pro-Tyr-
Pro-Gln-Arg 
Tyr-Gln-Gln-Pro-
Val-Leu-Gly-Pro-
Val-Arg 
Lys-Val-Leu-Pro-
Val-Pro-Gln 
Pro-Gly-Pro-Ile-
Pro-Asn 
Leu-Leu-Tyr 
Arg-Glu-Leu-Glu-
Glu-Leu-Asn-Val-
Pro-Gly-Glu-Ile-
Val-Glu-Ser(P)-
Leu-Ser(P)-Ser(P)- 
Ser(P)-Glu-Glu-Ser-
Ile-Thr-Arg 
 
β-casomorphin-11 
 
 
β-casomorphin-7 
 
β-casomorphin-5 
 
β-casokinin-7 
 
β-casokinin-10 
 
 
 
 
 
 
 
Casein 
phosphopeptide 
 
 
 
 
 
Opioid agonist 
 
 
Opioid agonist, ACE- 
inhibition, immunomodulation 
Opioid agonist 
 
ACE-inhibition 
 
ACE- inhibition, 
immunomodulation 
 
ACE- inhibition 
 
Immunomodulation 
 
Immunomodulation 
Stimulation of mineral 
absorption  
 
 
αs1-casein 90-96 
 
90-95 
 
91-96 
 
23-34 
 
 
23-27 
 
104-109 
 
194-199 
Arg-Tyr-Leu-Gly-
Tyr-Leu-Glu 
Arg-Tyr-Leu-Gly-
Tyr-Leu-Glu 
Tyr-Leu-Gly-Tyr-
Leu-Glu 
Phe-Phe-Val-Ala-
Pro-Phe-Pro-Glu-
Val-Phe-Gly-Lys 
Phe-Phe-Val-Ala-
Pro 
Tyr-Lys-Val-Pro-
Gln-Leu 
Thr-Thr-Met-Pro-
Leu-Trp 
α-casein exorphin 
 
α-casein exorphin 
 
α-casein exorphin 
 
 
 
 
α-casokinin-5 
 
 
 
α-casokinin-7 
 
 
Opioid agonist 
 
Opioid agonist 
 
Opioid agonist 
 
ACE- inhibition 
 
 
ACE- inhibition 
 
 
 
ACE- inhibition, 
immunomodulation 
-casein 33-39 
 
25-34 
 
 
106-116 
Ser-Arg-Tyr-Pro-
Ser-Tyr-OH 
Tyr-Ile-Pro-Ile-Gln-
Tyr-Val-Leu-Ser-
Arg 
Lys-Lys-Asn-Gln-
Asp-Lys 
Casoxin 
 
Casoxin C 
 
 
Casoplatelin 
Opioid antagonist 
 
Opioid antagonist 
 
 
Antithrombotic 
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1.4.3.2   Functional role of whey-derived bioactive peptides 
Peptides have been derived from caseins and whey fraction of milk proteins. Whey 
was regarded to be an undesirable waste product generated during cheese-making and 
the production of other casein products. However, research over the past 25 years on 
the properties of milk whey has shown its nutritional and biological value, increasing 
its value in various industries (Smithers, 2008). Whey protein is presently thought to 
be an important nourishment with important nutritional and functional properties and 
is readily gaining acceptance as a functional food ingredient (Sinha et al., 2007). 
 
The presence of amino acids such as leucine, isoleucine and valine in whey proteins 
suggests the possible applications of peptides or hydrolysates with various biological 
and physiological properties essential to native proteins. Whey proteins such as α-La 
and β-Lg have been recently demonstrated to be good sources of bioactive peptides 
with several functional properties, including antihypertensive, opioid agonistic as well 
as antagonistic, immunomodulatory, antimicrobial, mineral-binding, antioxidant and 
hypocholesterolaemic properties (Smacchi and Gobbetti, 2000). 
 
Whey protein has a relatively high β-Lg content; β-Lg acts as an effective 
immunomodulator and emulsifier and helps in the simple resorption of vitamin A, 
vitamin D, calcium and fatty acids after binding to them by virtue of its hydrophobic 
regions (Cho et al., 1994; Beaulieu et al., 2006). In addition, β-Lg exhibits free-
radical scavenging activity (Hernández-Ledesma et al., 2007a). Similarly, α-La also 
performs several biological functions; it stimulates the phagocytic activity of 
macrophages by exerting an immunomodulatory effect (Jaziri et al., 1992). β-Lg and 
α-La have also been shown to exhibit tumour-suppressing properties (Parodi, 2007). 
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The various functions of Ig in milk include protection against microbial pathogens, 
activation of complement system, stimulation of phagocytosis, prevention of 
microbial adhesion and neutralisation of viruses and toxins (Bounous and Gold, 
1991). The antioxidant activity of serum albumin is reportedly effective in protecting 
lipids from phenolic-induced oxidative damage (Smith et al., 1992). Peptide 
sequences with specific bioactivities have been identified from numerous studies on 
whey milk proteins, including α-lactorphin, β-lactorphin, albutensin A and β-
lactotensin (Korhonen and Pihlanto, 2006), as shown in Table 1.4. 
 
Table 1.4   Biologically active peptides derived from bovine whey proteins (Shah, 2000). 
 
Precursor protein Fragment Peptide sequence Name  Function 
 
α-lactoalbumin 50-53 Tyr-Gly-Leu-Phe α-lactorphin Opioid agonist, ACE- 
inhibition 
 
β-lactoglobulin 102-105 
 
 
 
 
142-148 
 
 
146-149 
 
Tyr-Leu-Leu-Phe 
 
 
 
 
Ala-Leu-Pro-Met-His-
Ile-Arg 
 
His-Ile-Arg-Leu 
β-lactorphin 
 
 
 
 
 
 
 
β-lactotensin 
Non-opioid timulatory 
effect on ileum, ACE 
-inhibition  
 
ACE-inhibition 
 
 
Ileum contraction 
Bovine serum 
albumin  
399-404 
 
 
208-216 
Tyr-Gly-Phe-Gln-Asn-
Ala 
 
Ala-Leu-Lys-Ala-Trp-
Ser-Val-Ala-Arg 
Serorphin 
 
 
Albutensin A 
Opioid 
 
 
Ileum contraction, 
ACE-inhibition 
 
Lactoferrin 17-41 Lys-Cys-Arg-Arg-Trp-
Glu-Trp-Arg-Met-Lys-
Lys-Leu-Gly-Ala-Pro-
Ser-Ile- Pro-Ser-Ile-
Thr-Cys-Val-Arg-Arg-
Ala-Phe 
Lactoferricin Antimicrobial 
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1.5 Serum albumin 
Serum albumin, which has been extensively studied over several years (Carter and 
Ho, 1994b), is a highly abundant protein in the blood plasma, with an ideal 
concentration of 50 g/L. This soluble protein is present in the circulatory system of 
several organisms and performs various physiological functions, including 
maintenance of colloid osmotic pressure (COP) and the pH of blood (Figge et al., 
1991). It plays a vital role in the transport and deposition of a wide variety of 
endogenous and exogenous substances, including fatty acids, bile salts, amino acids, 
metals, steroid hormones, drugs and pharmaceuticals (Feng et al., 1998; Choi et al., 
2002; Sengupta and Sengupta, 2002). 
 
The structure, function and properties of serum albumin have been investigated to 
understand its interactions with other molecules and ligands (Sirotkin et al., 2009; 
Bolel et al., 2012; Datta et al., 2013). The following are examples of serum albumin 
encountered in mammalian species: human serum albumin (HSA), BSA, equine 
serum albumin and rat serum albumin. Among these, HSA and BSA are the 
predominantly studied serum proteins (Carter and Ho, 1994b). 
 
1.5.1 Bovine serum albumin  
BSA is among the most commonly studied proteins and the chief serum albumin 
protein derived from cows, including meat and dairy products. BSA is one of the main 
components of blood plasma, accounting for approximately 60% of its total protein 
content. The protein has high stability, water solubility and unusual binding capacity 
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(Moriyama et al., 1996). BSA is a globular protein with MW of 66 kDa and contains 
essential amino acids. BSA is capable of binding free fatty acids, lipids and flavour 
compounds, which results in altered thermal denaturation properties of the protein 
(Kinsella and Whitehead, 1989). 
 
1.5.1.1   Structure of bovine serum albumin 
The crystal structure of BSA revealed that the molecule is shaped like a heart and 
exhibits approximately 76% structural homology with HSA (Sułkowska et al., 2007; 
Bujacz, 2012). The primary sequences of both BSA and HSA were determined in the 
same year (Brown, 1975), a single polypeptide chain of BSA was found to contain 
583 amino acids, as opposed to 607 amino acids in HSA (Brown, 1975). The amino 
acid sequence proposed by Brown (1975) suggested that BSA contains three 
homologous but structurally separate domains (I, II and III), which are divided by 17 
disulphide bonds into nine loops (L1–L9). Each domain is composed of two 
subdomains (A and B), as depicted in Figure 1.5. Approximately 67% of the structure 
of BSA is composed of α-helices, while β-sheets are not present (Considine et al., 
2007). The C-terminal region of BSA is more condense than the N-terminal region, 
and the different domains exhibit changes in their hydrophobicity, net charge and 
ligand-binding properties (Morr and Ha, 1993). 
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Figure 1.5  A graphical representation of the structure of BSA, as determined from homology 
modelling, depicting domains and binding sites (Patra et al., 2012). 
 
 
1.5.1.2   Amino acid composition of BSA 
A low content of the vital amino acids, methionine and tryptophan, and a high content 
of cysteine and charged amino acids such as aspartic acid, glutamic acid, lysine and 
arginine help in the characterisation of serum albumins (Hirayama et al., 1990). As an 
abundant albumin, BSA in general contains a wide range of essential and non-
essential amino acids, as shown in Table 1.5; however, the content of glycine and 
isoleucine in BSA is lower than the average protein content (Peters, 1985). In 
addition, the content of specific amino acids such as aspartate, glutamine, alanine, 
leucine and lysine is high in both BSA and HSA (Reed et al., 1980). 
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Table 1.5   The amino acid composition of BSA (Brown, 1975; Reed et al., 1980; Hirayama 
et al., 1990). 
Alanine (48) Cysteine (35) Aspartate (41) Glutamic acid (56) 
Phenylalanine (30) Glycine (17) Histidine (16) Isoleucine (15) 
Lysine (60) Leucine (65) Methionine (5) Asparagine (14) 
Proline (28) Glutamine (21) Arginine (26) Serine (32) 
Threonine (34)  Valine (38) Tryptophan (3) Tyrosine (21) 
    Numbers in brackets refer to the amino acid residue content of BSA. 
 
BSA and HSA are two albumin proteins that mainly differ in the number and 
positioning of their tryptophan residues. The tryptophan residue located at position 
214 (Trp-214) of HSA is the only residue corresponding to residue Trp-212 of BSA; 
this residue is more solvent exposed and positioned in the second domain within a 
hydrophobic binding pocket (Peters, 1996). In addition, BSA has an additional 
tryptophan residue (Trp-134), which is located on the surface of the albumin in the 
first domain (Figure 1.6). BSA, which is a homologue of HSA, has been used as a 
model protein because of its medical importance, low cost, ready availability and 
uncommon ligand-binding properties (Weijers, 1977; Hamdani et al., 2009). 
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Figure 1.6  Three-dimensional shapes of HSA and BSA showing the position of the 
tryptophan residues (Hamdani et al., 2009). 
 
 
1.5.1.3   Functional properties of BSA 
1.5.1.3.1   Ligand binding 
The ability of albumin to bind various ligands is its most exceptional characteristic 
(Goodman, 1958; Jacobsen, 1969; Unger, 1972; Adams and Berman, 1980; Roda et 
al., 1982). Albumin helps in the transport of several substances; albumin has four 
binding sites that show varying degrees of specificity for different substances that 
allow the binding and transport of a considerable amount of compounds such as 
bilirubin, enzymes, amino acids, metal ions (Cu2+ and Zn2+), free fatty acids and 
drugs. The competitive binding of drugs such as warfarin and diazepam may occur at 
the same or different albumin sites, leading to conformational changes. In other 
words, albumin may be regarded a transporter for numerous exogenous and 
endogenous compounds in the blood (He and Carter, 1992; Peters, 1996). 
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1.5.1.3.2   Maintenance of colloid osmotic pressure (COP) 
Albumin plays an important role in the regulation of COP because of its abundance in 
blood plasma and accounts for 75%–80% of the osmotic pressure. It also helps the 
movement of fluid throughout the body and in and out of capillaries (Carter and Ho, 
1994a). 
 
1.5.1.3.3 Free-radical scavenging 
Albumin functions as a free-radical scavenger because of the presence of a free 
sulphydryl group that reacts with the thiol group in the protein and scavenges reactive 
nitrogen and oxygen species (Stamler et al., 1992). Albumin is likely to function as an 
important free-radical scavenger during sepsis as well (Carter and Ho, 1994a). 
 
 
1.6   Antioxidant peptides 
1.6.1   Lipids and lipid oxidation 
Lipids are a heterogeneous group of compounds present in living systems, typically 
characterised by limited solubility in water and solubility in nonpolar organic solvents 
such as hydrocarbons, chloroform, benzene, ethers and alcohols (Coultate, 2002). 
They form the structural components of cell membranes and energy reservoirs, serve 
as an essential precursor for the production of vitamins and hormones and help lipid 
solubilisation (Belitz et al., 2009). Lipids are formed of fatty acids as the main 
building blocks and are categorised as saturated fatty acids that do not contain double 
bonds and unsaturated fatty acids that contain them. Monounsaturated fatty acids are 
unsaturated fatty acids that contain a single double bond, and polyunsaturated fatty 
acids are fatty acids that contain more than one double bond. The number of double 
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bonds determines the oxidation potential of the fatty acid into lipid hydroperoxide. 
Polyunsaturated fatty acids are the most common fatty acids and are more susceptible 
to oxidation by oxygen or free radicals than saturated fatty acids because of the 
presence of multiple double bonds in the carbon chain. The double bonds adjacent to 
methylene (–CH2–) groups containing reactive hydrogen are more susceptible to 
attack by reactive species, resulting in lipid oxidation (Mylonas and Kouretas, 1998). 
 
For food storage and human health, the oxidation of lipid should be importantly 
considered because it is one of the key chemical changes that occur during processing, 
storage, shipment and final preparation of food products containing lipids. Lipid 
oxidation is mainly observed in food products containing polyunsaturated fatty acids. 
Oxygen free radicals or reactive oxygen species (ROS) often chiefly mediate the 
oxidation of lipid that occurs in food systems (Noguchi et al., 2002). 
 
1.6.2   Free radicals and ROS 
Free radicals are any chemical species that are capable of existing independently and 
containing one or more unpaired electrons. Free radicals are derived from the 
elements oxygen, nitrogen or sulphur, which generate ROS, reactive nitrogen species 
(RNS) or reactive sulphur species, respectively. The free radicals derived from 
oxygen are extremely important in several disease states. ROS are a comprehensive 
class of highly reactive molecules derived from oxygen metabolism. Several ROS 
types include the superoxide anion radical (O2−·), the hydroxyl free radical (OH·) 
which is an extremely powerful oxidising agent, hydrogen dioxide (HO2·), hydrogen 
peroxide (H2O2), hypochlorous acid (HOCl), singlet oxygen (1O2) and various lipid 
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peroxides (Lü et al., 2010). All these types of ROS exhibit strong capacity for 
reacting with membrane lipids, nucleic acids, proteins and enzymes, resulting in 
oxidative cellular damage (Chaillou and Nazareno, 2006). In addition, they comprise 
a major cause of health disorders such as cancer, arthritis, diabetes, inflammation, 
coronary heart disease and ageing (Di Bernardini et al., 2011a; Memarpoor-Yazdi et 
al., 2012). Human body produces free radicals and various ROS during normal 
essential metabolic processes. Their production is stimulated by external factors such 
as cigarette smoke, radiation, UV light, air pollutants and industrial chemicals. 
  
1.6.3   Oxidative stress 
The term ‘oxidative stress’ is employed for describing oxidative damage resulting 
from a disruption in the balance between free-radical production and antioxidant 
defences (Rock et al., 1996). Oxidative stress has been linked with the exposure to 
various environmental factors such as radiation, pollutants, cigarette smoke and toxic 
chemicals, which has also been implicated in the induction of several human diseases, 
including ageing (Rao et al., 2006). An increase in the oxidative stress is related to 
damage in numerous molecular species including lipids, proteins and nucleic acids 
(McCord, 2000). 
 
1.6.3.1   Oxidative damage to biomolecules 
1.6.3.1.1   Oxidative damage to DNA  
Free-radical-induced DNA damage could be explained as either chemical or structural 
in terms of the characteristic manner of numerous modifications, including deletions, 
alterations of the purine and pyrimidine bases, breaking of strand, cross-linking of 
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DNA-protein and rearrangements of chromosomes. DNA damage is related to the 
generation of the OH· via the Fenton reaction. This radical reacts with the purine and 
pyrimidine bases and the deoxyribose backbone leading to DNA oxidation. 
(Dizdaroglu et al., 2002; Valko et al., 2004). 
 
1.6.3.1.2   Oxidative damage to proteins 
Protein oxidation is predominantly mediated by ROS and reactive nitrogen species 
(RNS), which are also capable of generating other free radicals by reacting with 
transition metal ions. In an in vivo context, oxidative damage to proteins potentially 
alters the functioning of receptors, enzymes and transport proteins and could generate 
new antigens that interfere with immune responses. The oxidation of proteins could 
occur in three ways: oxidative alteration of a specific amino acid, free-radical-
mediated cleavage of peptides and protein cross-linking as a consequence of reacting 
with lipid peroxidation products (Lobo et al., 2010). 
 
1.6.3.1.3   Oxidative damage to lipids 
Oxidation of lipids is a free-radical-mediated process that results in various structural 
and functional changes. In addition, many lipid by-products are generated during lipid 
peroxidation. 
 
The presence of factors such as heat, enzymes, light, metals and microorganisms 
increases the susceptibility of lipids to the oxidative process. Lipids are susceptible to 
several processes such as autoxidation, photo-oxidation and enzymatic oxidation 
under different conditions, most of which include one or the other types of free 
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radicals or oxygen species. Of the abovementioned processes, autoxidation is 
discussed here in detail (Vercellotti et al., 1992; Shahidi, 2000). Autoxidation is 
defined as the spontaneous reaction of lipids with atmospheric oxygen, leading to 
complex chemical changes that result in the deterioration and off-flavour of food 
products (Gordon et al., 2001; Sikorski and Kolakowska, 2010). 
 
A chain reaction of free radicals is known to cause ROS-mediated lipid oxidation. The 
mechanism of free-radical chain reaction or autoxidation is conveniently divided into 
three distinct stages, namely initiation, propagation and termination, as illustrated in 
Figure 1.7 (Young and McEneny, 2001; Dalrymple et al., 2010). 
 
Initiation stage: The oxidisation of substrate molecules mediated free radical chain 
reaction is triggered by the initiators, resulting in hydrogen atom loss from the 
substrate molecule or unsaturated fatty acids (LH). This results in the formation of a 
lipid free radical (L•). In an unsaturated fatty acid (LH), the initiation step often 
occurs at a methylene group. 
(1) LH + OH• → L• + H2O 
 
Propagation stage: The generated free radical (L•) is highly unstable and reacts with 
oxygen to form a peroxyl radical (LOO•). In addition, this product reacts with another 
unsaturated lipid (LH) molecule by the abstraction of a hydrogen atom from it, 
resulting in lipid hydroperoxide (LOOH) and new lipid free radical (L•) formation. 
Thus, a cascade of reactions is commenced until the free radical is neutralised by 
other free radicals. 
(2a) L• + O2 → LOO• 
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(2b) LOO• + LH → LOOH + L• 
Termination stage: In the final stage, two free radicals combine to form a stable non-
radical product, thereby terminating the cascade reaction. 
 (3a) L• + L• → L-L 
(3b) LOO• + L• → LOOL 
 
 
 
 
 
Figure 1.7  Illustration of the mechanism of free-radical chain reaction representing the 
initiation, propagation and termination stages (Dalrymple et al., 2010). 
 
 
The mechanism described above is initiated in the presence of various physical or 
chemical factors, including temperature, ROS and photosensitisers such as 
chlorophyll, transition metal ions, heating or radiation. 
 
 34 
 
Hydroperoxide, the primary product of lipid autoxidation, is known to be unstable and 
susceptible to decomposition, which in turn generates aldehydes such as 
malondialdehyde, hydrocarbons, ketones, alcohols and epoxy compounds; these are 
known as secondary oxidation products. The estimation of these compounds, together 
with free radicals, constitutes the basis for measuring the oxidative deterioration of 
food lipids (Halvorsen and Blomhoff, 2011). 
 
1.6.4   Antioxidants 
Antioxidants are substances with the potential to delay or inhibit the oxidation of 
lipids or other oxidisable biomolecules when present at low concentrations (Halliwell, 
2007; Puchalska et al., 2014). Antioxidants possess a strong capacity for preventing 
the harmful action of free radicals by scavenging them and effectively detoxify 
organisms in multiple ways; these include inhibiting the formation of free lipid 
radicals, interrupting the initiation or propagation of autoxidation chain reactions 
(Young and Woodside, 2001), functioning as a reducing agent, converting 
hydroperoxide into stable or less-reactive compounds, converting prooxidant metals 
into stable products by functioning as a metal chelator and inhibiting prooxidative 
enzymes such as lipoxygenases (Pokorný, 2007; Kancheva, 2009; Puchalska et al., 
2014). 
 
Antioxidants have free radical scavenging capacity. They improve the shelf life of 
food and pharmaceutical products by delaying the process of lipid peroxidation, a 
chief cause of food and pharmaceutical product deterioration during processing and 
storage (Halliwell, 1996) 
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1.6.4.1   Mechanism of action of antioxidants 
There are two principal mechanisms underlying antioxidant activity (Rice–Evans and 
Diplock, 1993). The first mechanism relates to chain-breaking antioxidant activity in 
which the primary antioxidant (AH) donates an electron to the free radical (R•) 
present in the system. 
R• + AH → RH + A• 
The second mechanism includes complex formation between the lipid radical and the 
antioxidant radical (free-radical acceptor) and ROS initiators removal (secondary 
antioxidants) by quenching the chain-initiating catalyst. 
R• + A• → RA 
Different mechanisms are exerted by antioxidants on biological systems, including 
electron donation, metal-ion chelation or through co-antioxidants (Krinsky, 1992). 
 
1.6.4.2   Antioxidant defence systems 
The human body has a host of mechanisms for counteracting damage by free radicals 
and other ROS, which act on different oxidants and in different cellular 
compartments. The antioxidant defence system is categorised into two main groups: 
enzymatic antioxidants and non-enzymatic antioxidants. 
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1.6.4.2.1   Enzymatic antioxidants 
The first major line of defence against free radicals is the intracellular enzyme system 
composed of three major enzymes: superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx). These enzymes help in the reduction of the most 
harmful oxidants concentration in tissues. Several essential minerals are required for 
the formation and activity of these enzymes, including selenium, copper, manganese 
and zinc. 
 
1.6.4.2.1.1   Superoxide dismutases (SOD) 
Superoxide dismutases (SODs) are enzymes that occur in all aerobic cells and in 
extracellular fluids (Johnson and Giulivi, 2005). SODs catalyse the dismutation of 
superoxide anion into oxygen and hydrogen peroxide, as shown below (Rahman, 
2007): 
2 O2· + 2H → H2O2 + O2 
SODs are classified into three major types according to the metal-dependent redox-
active centre required for the dismutation reaction; they include Cu/Zn type (which 
binds both copper and zinc), Fe and Mn type (which binds either iron or manganese) 
and Ni type (which binds nickel). Humans, like all other mammals, contain the three 
types of SOD; Mn-SOD is found in the mitochondrial matrix and extracellular fluids, 
while Cu/Zn-SOD is localised in the cytoplasm (Cao et al., 2008). The higher plants 
contain two types of SOD, which are centralised in different cellular compartments; 
Mn-SOD is found in the matrix, while Fe-SOD is chiefly confined to the chloroplast 
(Corpas et al., 2006). SODs exhibit various functions, including maintaining the 
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concentration of superoxide radicals at low levels and defending against oxidative 
stress. 
1.6.4.2.1.2   Catalase (CAT) 
Catalase (CAT) is a common enzyme found in virtually all living organisms that are 
exposed to oxygen and is localised in the peroxisomes and cytosol. The major 
function of this enzyme is catalysing the decomposition of hydrogen peroxide into 
water and oxygen through a scavenging reaction (Chelikani et al., 2004). The enzyme 
typically occurs in all organs in animals but is particularly concentrated in the liver 
(Eisner and Aneshansley, 1999). 
2H2O2 → 2H2O + O2 
 
1.6.4.2.1.3   Glutathione peroxidases (GPx) 
Glutathione peroxidases (GPx) contains four selenium cofactors and catalyses the 
oxidation of GSH (reduced glutathione) to GSSG (oxidised glutathione) and one 
molecule of water at the expense of H2O2 (Rahman, 2007). 
H2O2 + 2GSH → GSSG + H2O 
Oxidised glutathione is harmful to cells as it reacts with proteins and oxidised thiol 
groups to form disulphide linkages and consequently promotes disulphide bond 
formation in proteins. This is countered in cells by the NADPH-mediated reduction of 
GSSG to GSH in the presence of the enzyme glutathione reductase; this enzyme is 
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localised in the cytosol and mitochondria and its distribution mirrors that of GPx 
(Willcox et al., 2004). 
GSSG + NADPH + H → 2GSH + NADP 
1.6.4.2.2   Non-enzymatic antioxidants 
The second line of defence against the harmful effects of free radicals is the presence 
of extracellular antioxidants, of which there are quite a few, including the vitamins A, 
C and E, enzyme cofactors (Q10), nitrogen compounds (uric acid) and peptides 
(glutathione). The water-soluble antioxidants (vitamin C and phenolic compounds), 
lipid-soluble antioxidants (vitamin E and carotenoids) and proteins (transferrin, LF 
and albumin) are capable of blocking the action of free radicals in the body by 
chelating transition metal ions (Bagchi and Puri, 1998; Becker et al., 2004). 
 
1.6.4.3   Sources of antioxidants 
1.6.4.3.1   Synthetic antioxidants 
Synthetic antioxidants have been developed for providing a system for measuring 
antioxidant activity, comparison with natural antioxidants and inclusion into food 
products. Certain synthetic antioxidants have been reported to chiefly consist of 
phenolic compounds and are usable in food products for suppressing free radical 
generation, preventing lipid oxidation and improving shelf life. Limited types of 
synthetic antioxidants are approved for use as food additives because of their harmful 
impact and side effects in human beings; these include butylated hydroxyanisole 
(BHA), butylated hydroxytoluene (BHT), propyl gallate (PG) and tert-
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butylhydroquinone (TBHQ) (Pihlanto, 2006; Shahidi and Zhong, 2010; Zhong et al., 
2011). A few synthetic antioxidants and their applications are listed in Table 1.6. 
 
Table 1.6   Illustration of chemical structures and applications of synthetic antioxidants 
(Carocho and Ferreira, 2013). 
 
Compound name Structure Application Reference 
 
BHA 
 
 
 
Food 
antioxidants 
 
(1975) Branen 
 
BHT  
 
 
 
Food 
antioxidants 
 
 .al et Botterweck
(2000) 
 
 
TBHQ 
 
 
 
Animal 
processed food 
antioxidants 
 
 Kadi-El and Gharavi
(2005) 
 
PG  
 
 
 
 
Food 
antioxidants 
 
(2003) al. et Soares 
BHA, butylated hydroxyl anisole; BHT, butylated hydroxyl toluene; PG, propyl 
gallate; TBHQ, tert-butylhydroquinone 
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The activity of phenolic antioxidants is dependent on resonance, which stabilises 
phenolic radicals and is determined by the substitutions at ortho and para positions of 
the aromatic ring and the size of the substituting groups, as shown by Shahidi et al. 
(1992). According to Hudson and Lewis (1983), the presence of carbonyl and–COOH 
groups in a wide range of phenolic compounds could result in the inhibition of 
oxidative rancidity through metal ion chelation. 
 
1.6.4.3.2   Natural antioxidants 
An increase in the demand for safe and naturally occurring antioxidants as alternatives 
to synthetic ones has been observed in recent years because of rising limitations on 
the use of synthetic antioxidants and their negative impact on human health (Gülçin, 
2012). 
 
Plant materials are rich sources of natural antioxidants because they include an 
aromatic ring as part of their molecular structure; these could be linked to a range of 
cyclic ring structures and contain one or more hydroxyl groups that provide unstable 
hydrogen and support the formation of free radicals (Shahidi, 1997). Natural 
antioxidants could function as reducing agents, as inhibitors of free-radical 
autoxidation chains and of singlet oxygen formation and as inactivators of prooxidant 
metals. 
 
Plant and food additives are good sources of natural antioxidants because they include 
vitamins (vitamins E and C and β-carotene), plant phenols (flavonoids and other 
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phenolic compounds) and peptides derived from proteins (Mukhopadhyay, 2007). 
Natural antioxidants from these sources provide oxidative stability to food products. 
 
1.6.5   Studies on antioxidant proteins and peptides 
Studies conducted to date suggest that dietary proteins are a source of physiologically 
active compounds, underscoring the importance of proteins in the diet. A marked 
antioxidant activity can be seen in proteins, peptides and protein hydrolysates that are 
derived from various plant and animal sources against the oxidation of lipids and fatty 
acids. The proteins, peptides and amino acids have been applied both in vitro and in 
vivo to block the harmful consequences of lipid oxidation. In recent years, several 
studies have identified the antioxidant properties of certain peptides derived from 
different protein sources; for example, peptides from goat milk (De Gobba et al., 
2014), chickpea protein hydrolysate (Torres-Fuentes et al., 2015) and proteins derived 
from sweet potato (Zhang et al., 2012a), duck egg white (Ren et al., 2014) and rice 
(Yan et al., 2015) have been shown to demonstrate antioxidant activity. In addition, 
aquatic products and by-products have also been identified as good sources of 
antioxidant peptides; for instance, peptides derived from mackerel (Wu et al., 2003), 
jumbo squid skin (Mendis et al., 2005) and hoki frame (Kim et al., 2007) proteins 
have been shown to exhibit significant antioxidant activities. 
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1.7 Angiotensin-I-converting enzyme (ACE) inhibitory 
peptides 
1.7.1 Role of ACE in cardiovascular system 
Hypertension or high blood pressure is a major and serious chronic health problem, 
particularly in developed countries, and it affects 15%–20% of adults worldwide; it 
has been found to be a main risk factor for the development of cardiovascular diseases 
such as arteriosclerosis, stroke, myocardial infarction and end-stage renal disease (Lin 
et al., 2012b). Given the prevalence and importance of hypertension, changes in life-
style, dietary approaches and pharmacological treatments are broadly employed for its 
treatment. Numerous inhibitors are typically employed in clinical practice, including 
vasodilators, calcium channel blockers, diuretics and angiotensin-II receptor blockers. 
These substances intervene in different interacting physiological systems that regulate 
blood pressure and fluid and electrolyte balance; the most common of these is the 
renin–angiotensin system (RAS) (FitzGerald et al., 2004). The metabolic pathways 
associated with the regulator of blood pressure have been reviewed by FitzGerald in 
2004. 
 
 
1.7.2  Renin angiotensin system 
The renin angiotensin system (RAS) is a classic endocrine system involved in the 
regulation of a long term of blood pressure and extracellular volume in the body; it is 
therefore an important medical target in the treatment of numerous diseases. The key 
role played by RAS in maintaining blood pressure homeostasis in mammals has been 
recognised because of its presence in various organs in humans, including the brain, 
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plasma, heart, kidney, and lungs as well as the circulatory system (Turner and 
Hooper, 2002). 
 
To date, food-derived antihypertensive peptides have attracted a lot of attention from 
the research community as well as consumers. A well-characterised mechanism 
underlying the blood pressure-lowering effect of food-derived peptides appears to 
involve the inhibition of ACE activity. 
 
The RAS cascade is initiated with the production of renin, a glycoprotein, by the 
juxtaglomerular (JG) cells of the afferent arteriole in the kidneys (Griendling et al., 
1993). In the JG cells, preprorenin is first converted to prorenin and then to active 
renin by the removal of a 34-amino acid peptide from the prorenin N-terminal, which 
is released into the circulation (Naruse et al., 1982). Several factors promote the 
release of renal renin, including volume-depleted states, high-salt content in the distal 
tubules, renal sympathetic nerve activity and reduced renal perfusion (Torretti, 1982). 
 
The released renin cleaves angiotensinogen, a liver protein, in the bloodstream. 
Angiotensinogen is a large globulin of high MW and a substrate for renin. The action 
of renin on angiotensinogen generates an inactive decapeptide angiotensin I. ACE 
catalyses the conversion of angiotensin I (Asp–Arg–Val–Tyr–Ile–His–Pro–Phe–His–
Leu), via the removal of the dipeptide (His–Leu) from the C-terminal, to the potent 
octapeptide vasopressor angiotensin II (Asp–Arg–Val–Tyr–Ile–His–Pro–Phe) as 
illustrated in Figure 1.8 (Heeneman et al., 2007; Ravinder Nagpal et al., 2011). 
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Figure 1.8  The renin–angiotensin system maintains the balance between angiotensin and 
bradykinin. Angiotensin-I-converting enzyme plays a vital role in the conversion of 
angiotensin I to angiotensin II and the deactivation of bradykinin (Madureira et al., 2010). 
 
 
The potent vasoconstrictor angiotensin II exerts an effect on several parts of the body, 
including vascular, neurological, renal and adrenal systems, by binding to receptors 
located throughout the body. The action of angiotensin II is mediated via two distinct 
receptors, the angiotensin type 1 (AT1) and type 2 (AT2) receptors, which mediate 
opposing effects of angiotensin II. The AT1 receptor mediates most 
pathophysiological effects of angiotensin II, including vasoconstriction (constriction 
of blood vessels), resulting in increased blood pressure; aldosterone production, 
resulting in sodium and water retention and stimulation of the sympathetic nervous 
system by thirst (Ushio-Fukai, 2009; Cat et al., 2011). The AT2 receptor shares 34% 
homology with the AT1 receptor at the amino acid level and is the principal receptor 
for angiotensin II in the foetus (Grady et al., 1991). Despite the decreased prevalence 
of the AT2 receptor in the adult vasculature, it is likely to be involved in mediating 
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vasodilation and anti-proliferative effects in the vascular smooth muscle (Horiuchi et 
al., 1999). 
 
1.7.3   Angiotensin-converting enzyme 
ACE (dicarboxypeptidase, EC 3.4.15.1) plays a major role in the regulation of blood 
pressure through its effects on RAS (Iroyukifujita et al., 2000). ACE is a 
multifunctional enzyme; in addition to its role in cleaving angiotensin I as part of 
RAS, it is a part of the kinin–kallikrein system and is involved in the metabolism of 
bradykinin, a strong vasodilator. Functionally, this enzyme promotes the production 
of angiotensin II and decreases vasodilation. ACE is widely found in several tissues, 
including vascular endothelial, neuroepithelial and epithelial cells (Carey and Siragy, 
2003). 
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Figure 1.9  Schematic depicting the somatic form of ACE (Johnston, 1994; Dzau et al., 
2001). 
 
The three-dimensional structure of ACE reveals an α-helical motif (Natesh et al., 
2003); the enzyme belongs to a class of zinc proteases whose activity is dependent on 
zinc and chloride. ACE has two isoforms, namely somatic ACE and germinal 
(testicular) ACE. The somatic form is the larger isoform of ACE, with MW of 150-
180 kDa, consisting 1306 amino acids. Somatic ACE is distributed in multiple cells 
and organs, including the brain, heart, kidney and the small intestine, and it is 
expressed as well in the neuronal cells, epithelial cells and plasma membrane of the 
vascular endothelium cells (in particular, the lung), while the testicular form, found in 
the sperm, is the smaller isoform of ACE, with approximately 90-110 kDa and 
consisting around 732 amino acids. Both ACE isoenzymes are encoded by the ACE 
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gene (Coates, 2003). The somatic form is of clinical interest because it is postulated to 
play an important role in the cardiovascular system as a controller of blood pressure. 
Somatic ACE consists of two homolog domains with a catalytic site in each domain, 
namely, the N- and C-terminal domains, both sites catalyse the cleavage of 
angiotensin I and bradykinin. The C-terminal domain seems to play a greater role in 
the regulation of blood pressure (Figure 1.8, 1.9 and 1.10) (Wei et al., 1992; Johnston, 
1994). 
 
 
 
Figure 1.10  X-ray crystallography analysis of native ACE (Natesh et al., 2003). 
 
 
1.7.4   ACE inhibitors 
1.7.4.1   Synthetic ACE inhibitors 
Exogenous ACE inhibitors were first discovered in snake venom (Ferreira et al., 
1970). Several studies have since attempted to synthesise ACE inhibitors such as 
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captopril, enalapril, fosinopril and Lisinopril, which are extensively employed in the 
treatment of hypertension (Table 1.7; Figure 1.11) (Ondetti et al., 1977). However, 
these synthetic ACE inhibitors are thought to cause certain undesirable side effects, 
including hypotension, cough, increased potassium levels, reduced renal function, 
taste disturbances and skin rashes (Atkinson and Robertson, 1979; Roy et al., 2010). 
Therefore, the identification and use of natural ACE inhibitors with minimal side 
effects in humans as an alternative approach to synthetic drugs are of enormous 
interest to the research community; an example is the ACE inhibitor peptides derived 
from food proteins (Actis-Goretta et al., 2006). 
 
Table 1.7   Classification of synthetic ACE inhibitors according to their molecular structure 
(Pandeya, 2004; Kumar et al., 2010) 
 
 
Drug class ACE inhibitors 
Sulfhydryl-containing agents Captopril and zofenopril 
Dicarboxylate-containing agents Enalapril, perindopril, ramipril, quinapril, 
isinopril and benzepril l 
Phosphonate-containing agents Fosinopril 
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                        Captopril                                                       Lisinopril 
 
                              
                          Enalapril                                                        Fosinopril  
Figure 1.11   Chemical structures of a few synthetic ACE inhibitors (Vercruysse et al., 2005). 
 
1.7.4.2   Natural ACE inhibitors 
Several ACE inhibitory peptides have been isolated through the enzyme digestion of 
various food proteins, including whey proteins (Hernández-Ledesma et al., 2002), fish 
(Curtis et al., 2002; Howell and Kasase, 2010a), porcine and chicken muscle 
(Nakashima et al., 2002), chicken skin (Mhd Sarbon et al., 2013), sardinella (Ben 
Khaled et al., 2012), sesame (Biswas et al., 2010) and egg (Nakashima et al., 2002). 
These natural ACE inhibitory peptides are considered to be safer and are relatively 
cheaper than the synthetic ones (Agyei and Danquah, 2011; Agyei and Danquah, 
2012). Antihypertensive peptides appear promising for incorporation into functional 
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food products and pharmaceutical drugs for potential use in the prevention and 
treatment of hypertension. 
 
The activity of ACE inhibitory peptides is highly influenced by binding to the C-
terminal tripeptide sequence of the substrate. ACE exhibits preference for 
hydrophobic amino acid residues at the C-terminal such as phenylalanine, tryptophan, 
tyrosine and proline. The presence of aromatic and aliphatic residues in the ultimate 
position of the substrate or competitive inhibitor has been demonstrated to increase 
the inhibitory activity of the peptide (Murray and FitzGerald, 2007). Because these 
peptides are composed of only a few amino acid residues, they possess the capacity to 
cross the gut epithelial barrier and enter the bloodstream, allowing their transport to 
other sites in the body and exert beneficial effects for the organism (Yust et al., 2003). 
 
Milk proteins are known precursors for a range of peptides that inhibit ACE 
(FitzGerald and Meisel, 1999). During the process of milk fermentation, the 
proteolytic activity of milk bacteria produces hypotensive peptides such as casokinins 
and lactokinins with a high amino acid content (Sipola et al., 2002). Casein-derived 
ACE inhibitory peptides are known as casokinins (Meisel, 1993), whereas whey-
derived inhibitors are known as lactokinins (FitzGerald and Meisel, 1999). Casokinins 
and lactokinins have been identified in fermented milk (Van der Zander et al., 2008; 
Moure et al., 2005) and milk protein hydrolysates obtained upon digestion with 
specific enzymes such as pepsin, trypsin and chymotrypsin (Abubakar et al., 1998; 
Hirota et al., 2007). 
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1.7.5   Methods for the determination of ACE inhibitory activity 
Numerous in vitro techniques have been developed to detect the ACE inhibitory 
activity of bioactive peptides; these include spectrophotometry (Cushman and 
Cheung, 1971), bioassays (Andersen, 1967), HPLC (Neels et al., 1982) and 
fluorogenic methods with internal quenching (Araaujo et al., 1999). The 
spectrophotometric method described by Cushman and Cheung (1971) is widely 
employed; this method is based on the hydrolysis of hippuryl–histidyl–leucine by 
ACE, which results in the release of hippuric acid (HA) and histidyl–leucine. The 
released HA is measured following extraction with ethyl acetate. This method 
involves several steps such as HA extraction with ethyl acetate, evaporation for the 
removal of ethyl acetate and redissolution in water, followed by the 
spectrophotometric estimation of HA at 228 nm (Wu et al., 2002). The method has 
therefore been modified for enhancing the accuracy and reliability of HA estimation 
(Kasase and Howell, 2009). 
 
1.8  Aim and objectives 
There is increasing interest in the therapeutic potential of food-derived bioactive 
peptides. This can be attributed to their biological activities that play a vital role in 
promoting human health and in preventing chronic diseases. The present study aims 
to investigate in vitro the ACE-inhibitory and antioxidant activities of peptides 
isolated from hydrolysates of BSA. The following are the main objectives of the 
study: 
1. To prepare protein hydrolysates from BSA using the digestive enzyme pepsin. 
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2. To isolate and identify antioxidant peptides from BSA protein hydrolysates and 
examine the mechanism of inhibition of oxidation. 
3. To study in vitro the antioxidant mechanisms of BSA-derived peptide fraction. 
4. To study in vitro the antioxidant behaviour of BSA-derived peptides on 
epithelial (Caco-2 cell line) and endothelial (EA.hy926 cell line) cells 
artificially exposed to pro-oxidant. 
5. To investigate in vitro the ROS scavenging activity of BSA-derived peptides in 
endothelial cells (EA.hy926 cell line). 
6. To investigate in vitro the inhibitory effect of BSA-derived peptides on ACE 
activity in endothelial cells (EA.hy926 cell line). 
7. To isolate and characterise peptides with ACE inhibitory activity from BSA 
hydrolysates and study the mechanism of ACE inhibition. 
8. To analyse the amino acid composition of purified antioxidant and ACE 
inhibitory peptides. 
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2 Antioxidant activities of peptides derived from 
bovine serum albumin (BSA) 
2.1   Introduction 
Oxidation is an important metabolic process in all living organisms that inevitably 
leads to the formation of free radicals and other reactive oxygen species (ROS) (Ahn 
et al., 2014). The free radicals thereby generated are extremely reactive and play a 
major role in multiple cellular processes such as signal transduction (Hancock et al., 
2001); however, a high concentration of free radicals is potentially damaging to living 
tissues and food products. The hydroxyl radical, considered the most reactive among 
ROS, has the ability to react with almost any compound that it comes in contact with 
in living cells. Free radical chain reactions have been shown to be associated with 
several diseases such as hypertension, diabetes mellitus, arthrosclerosis, cancer and 
coronary heart diseases and can initiate the peroxidation of membrane lipids (Sarmadi 
and Ismail, 2010; Memarpoor-Yazdi et al., 2012). 
 
Lipid peroxidation also occurs in food systems, particularly in those containing 
polyunsaturated fatty acids, and is a causative factor for the development of an 
undesirable flavour and taste, for decreased shelf life and for the formation of 
potentially toxic compounds in food products (Sampath Kumar et al., 2012). 
Antioxidants are employed for preserving food products by retarding the deterioration 
resulting from oxidation, scavenging free radicals and detoxification of organisms 
(Decker et al., 2005). Currently, synthetic antioxidants such as butylated 
hydroxyanisole (BHA), butylated hydroxytoluene (BHT), tert-butylhydroquinone and 
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propyl gallate have been widely employed in food products for preventing the 
deterioration caused by oxidation and improving shelf life (Zhong et al., 2011). Their 
use, however, is restricted in certain countries because of potential health issues 
(Branen, 1975). Therefore, an increasing number of studies have focused on the 
employment of nontoxic natural antioxidants as alternatives to the synthetic ones such 
as vitamin E, ascorbic acid, polyphenols and, recently, biopeptides derived from 
proteins (You et al., 2010). 
 
The antioxidant activities of bioactive peptides, which are generated upon the 
digestion of various proteins and exhibit low molecular weight and useful 
bioactivities, have attracted significant attention because of their ability to inhibit lipid 
peroxidation in the human body and food model systems (Memarpoor-Yazdi et al., 
2012). Recently, peptides obtained from animal and plant sources such as potato 
(Kudo et al., 2009), rice endosperm (Zhang et al., 2010), peanut (Chen et al., 2007), 
soy (Moure et al., 2005), corn gluten (Li et al., 2008), sunflower (Ren et al., 2010), 
milk (Hernández-Ledesma et al., 2007b), soybean (Gibbs et al., 2004) and eggs 
(Sakanaka et al., 2004) have been shown to exhibit antioxidant activity. 
 
The antioxidant activity of bioactive peptides is dependent on their amino acid 
composition, size, conformation and sequence, with bioactive peptides typically 
containing 2–20 amino acid residues (Chen et al., 1998a). Various parameters affect 
the bioactivity of these peptides, including the protein source, degree of hydrolysis, 
peptide structure and amino acid composition and the type of hydrolysing enzyme 
employed. Numerous peptides have been shown to exhibit multifunctional properties 
(Memarpoor-Yazdi et al., 2012); among these, antioxidant peptides have received 
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significant attention because of their important role in the retardation and treatment of 
various disorders such as arthrosclerosis, cancer, diabetes mellitus and heart diseases 
(Sakanaka et al., 2004; Chandrasekara and Shahidi, 2011a; Chandrasekara and 
Shahidi, 2011b). 
 
Various properties of proteins such as molecular weight, charge, hydrophobicity and 
amino acid composition could be exploited for the separation and purification of 
specific peptides from a mixture. This principle has been employed for designing 
several purification techniques that aid in understanding the molecular and biological 
properties of a specific peptide to recognise its biological function; these include 
ultrafiltration (UF), gel-filtration chromatography (GF) and high-performance liquid 
chromatography (HPLC) (Martínez-Maqueda et al., 2013). The antioxidant activity of 
protein hydrolysates and purified peptide fractions could be evaluated on the basis of 
inhibition of lipid oxidation in a linoleic acid model system through measurements of 
the concentrations of primary and secondary lipid oxidation products (Halvorsen and 
Blomhoff, 2011; Pawar et al., 2013). 
 
The aim of the present study was to identify the antioxidant peptides derived from 
BSA and characterise the most active peptide. Towards this end, BSA was hydrolysed 
with the digestive enzyme pepsin and the hydrolysate fractionated by UF. The UF 
peptide fractions were subsequently purified using gel-filtration chromatography 
techniques, and the antioxidant activities of the protein hydrolysate and purified 
peptides were evaluated using the linoleic acid model system. Amino acid 
composition was determined for the most potent antioxidant peptide. 
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2.2   Materials and methods 
2.2.1   Materials 
BSA, pepsin (from gastric mucosa, ≥2,500 units/mg protein), Sephadex G-25 resin, 
trifluoroacetic acid (TFA), linoleic acid (≥99%), ferrous chloride, 2-thiobarbaturic 
acid (TBA), sodium dodecyl sulphate (SDS), tetraethoxypropane (TEP), amino acid 
standards, triethylamine (TEA), phenylisothiocyanate (PITC), BHA, 6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), ammonium thiocyanate, 
trichloroacetic acid and ferric chloride were purchased from Sigma–Aldrich Co. 
(Dorset, UK). The reagents sodium phosphate, hydrochloric acid, absolute ethanol, 
sodium hydroxide, acetonitrile and sodium hydrogen carbonate were purchased from 
Fisher Scientific UK Ltd. (Loughborough, UK). UF membranes with 10-kDa-
molecular weight cut-off (MWCO) were procured from Vivaspin (Epsom, UK). All 
the other chemicals employed in the experiments were of analytical grade, with the 
exception of TFA and acetonitrile, which were of HPLC grade. 
 
2.2.2   Methods   
2.2.2.1   Preparation of bovine serum albumin hydrolysates 
BSA hydrolysates were generated using the method detailed in Roufik et al. (2006), 
with slight modifications. BSA (4 mg) was solubilised in 1 ml of Milli-Q water and 
homogenised in a blender (Omni mixer homogeniser, USA) for approximately 10 
min. The pH was adjusted to 2.0 using 0.1 M NaOH and/or 0.1 M HCl and incubated 
 58 
 
at 37°C. Pepsin solution was added to the mixture at an enzyme-to-substrate (E:S) 
ratio of 1:10 to enhance hydrolysis, followed by gentle stirring. The reaction was 
incubated for various time periods (2, 3, 4 and 6 h) and stopped by increasing the pH 
to 8.0 through the addition of 1 M NaOH. Samples were then collected and 
lyophilised for further studies. 
 
2.2.2.2   Isolation of bioactive peptides from BSA 
2.2.2.2.1   Ultrafiltration 
The lyophilised BSA powder was dissolved in Milli-Q water (1:10 w/v ratio) and 
fractionated by UF using a membrane with 10-kDa MWCO by centrifugation at 3,500 
g (Beckman, UK) for 30 min. The fraction with molecular weight < 10 kDa was 
freeze dried and stored at −80°C for use in antioxidative activity assays and for 
further purification (Jiang et al., 2014). 
 
2.2.2.2.2   Gel-filtration chromatography 
In total, 200 mg of the lyophilised peptide fraction (molecular weight < 10 kDa) of 
BSA hydrolysates that presented the highest antioxidant activity was dissolved in 5 ml 
of 50 mM sodium phosphate buffer (pH 7.0) and filtered through a 0.22-μm filter 
(Millipore). The peptides were purified by gel-filtration chromatography using a 
Sephadex G-25 column (2.0  90 cm; Sigma-Aldrich Co.) that was previously 
equilibrated with Milli-Q water; elution was performed with 50 mM sodium 
phosphate buffer (pH 7.0) at a constant flow rate of 1 ml/min within a duration of 10 
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h. Aliquots (5 ml) of the purified peptide fractions from different runs were pooled, 
and absorbance at 250 nm was separately monitored using the FPLC system and a 
spectrophotometer (Jiang et al., 2014). 
 
2.2.2.3   Lipid peroxidation inhibitory activity assay 
The antioxidant activity of BSA hydrolysates and the purified peptide fractions were 
determined in a linoleic acid model system according to the method described in Je et 
al. (2007), with slight modifications. 
 
2.2.2.3.1   Preparation of reaction mixture 
In brief, the freeze-dried samples (100 mg) were dissolved in a solution (25 ml) 
containing Milli-Q water (4.87 ml), 50 mM phosphate buffer (pH 7.0; 10 ml), linoleic 
acid (0.13 ml) and ethanol (99.5% (v/v) in water; solution volume made up to 25 ml) 
in glass tubes. The tubes were tightly sealed with silicone rubber caps and placed in 
an oven at 40°C for a period of 7 days. The analysis was performed in triplicate with 
positive [0.01% (w/v) BHT and 0.01% (w/v) trolox] and negative (Milli-Q water 
instead of samples) controls for comparison. 
 
2.2.2.3.2   Measurement of peroxide formation using ferric thiocyanate method 
The ferric thiocyanate (FTC) method was performed as described by He et al. (2013), 
with minor modifications. Aliquots (100 µl) of the assay mixtures described above 
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were withdrawn using a microsyringe at 24-h intervals and added to test tubes 
containing 75% (v/v) ethanol (4.7 ml), 30% (w/v) ammonium thiocyanate (100 µl) 
and 20 mM ferrous chloride solution (100 µl) in 3.5% hydrochloric acid. Three 
minutes after the addition of ferrous chloride to the reaction mixture, the amount of 
thiocyanate or the intensity of colour was measured by determining absorbance at 500 
nm using a spectrophotometer (UVIKON 860, Kontron Instrument, UK). The 
measurement was repeated every 24 h until the maximum absorbance was attained in 
the control; in this assay, the increase in absorbance corresponds to an increase in 
linoleic acid oxidation. All absorbance readings were performed in triplicate, and the 
percentage inhibition of peroxide formation in the linoleic acid system was 
mathematically calculated as follows: 
 
Inhibition (%) = (Absorbance of control on day maximum − Absorbance of sample on day maximum) × 100 
Absorbance of control on day maximum 
 
The standard curve for the FTC method was prepared using serially diluted ferrous 
chloride solution (0.1, 0.2, 0.4, 0.6, 0.8 and 1.0 mg/ml) taken in 10-ml screw-cap test 
tubes as standards. Aliquots (100 µl) of the prepared standards were withdrawn in 
triplicate and placed in separate test tubes containing absolute ethanol (5 ml) and 
hexane (200 µl). The mixture was subject to thorough vortexing, followed by the 
addition of 30% ammonium thiocyanate (100 µl) and vortexing for 3 min; this was 
followed by the spectrophotometric determination of absorbance at 500 nm against 
absolute ethanol as blank (Pearson, 1991). 
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2.2.2.3.3   Measurement of inhibition of lipid peroxidation using thiobarbituric 
acid reactive substances method 
The method employed by Aazza and Miguel (2011) was used for measuring the 
secondary products of lipid oxidation or the presence of free radicals subsequent to 
peroxide formation. At 24-h intervals, a 50-µl aliquot of the reaction mixture 
(described in Section 2.2.2.3.1) was added to a solution containing Milli-Q water (0.8 
ml), 8.1% (w/v) SDS (0.2 ml), 20% (w/v) acetic acid (pH 3.5; 1.5 ml) and 0.8% (w/v) 
2-thiobarbituric acid (TBA) solution (1.5 ml) in water. The mixture was placed in a 
water bath at 100°C for 60 min, cooled and centrifuged (Beckman, UK) at 4300 g 
for 10 min. The absorbance of the supernatant was measured at 532 nm using a 
spectrophotometer (UVIKON 860). The antioxidant activity of the sample was 
recorded on the basis of the absorbance determined on the final day using the FTC 
method. Data represent the average of triplicate experiments. The percentage 
inhibition of lipid oxidation was calculated according to the following equation: 
 
Inhibition (%) = (Absorbance of control on day maximum − Absorbance of sample on day maximum) × 100 
Absorbance of control on day maximum 
 
For obtaining the standard curve, tetraethoxypropane (TEP) solution was serially 
diluted to yield 1.25, 2.5, 5.0 and 10 µg/ml standard solutions of malondialdehyde 
(MDA). Each TEP dilution (1 ml) was added to a solution containing 25% (v/v) HCl 
(150 μl), 0.2% (w/v) BHA (100 μl) and 1% (w/v) TBA solution (100 μl) in 50 mM 
NaOH, followed by the addition of Milli-Q water (750 μl). The mixture was heated in 
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a water bath at 80°C for 30 min, cooled and centrifuged as above. The absorbance of 
the supernatant at 532 nm was measured as above and employed for calculating the 
amount of MDA in the sample, which was expressed as µg/ml of lipid (Tug et al., 
2005). 
 
2.2.2.3.4   Concentration-dependent lipid oxidation inhibitory activity of peptides 
Different concentrations (0.2, 0.4, 0.6, 0.8 and 1 mg/ml) of the purified gel-filtration 
peptide fraction were assayed in the linoleic acid model system to determine the 
correlation between lipid oxidation inhibitory activity and peptide concentration 
(Howell and Kasase, 2010b). In brief, different quantities of the lyophilised gel-
filtration peptide fraction (GF18) were separately dissolved in a solution containing 
50 mM phosphate buffer (pH 7.0), linoleic acid and ethanol (as detailed in Section 
2.2.2.3.2) to obtain 25-ml solutions containing the peptide at different final 
concentrations and mixed vigorously. The tubes were tightly sealed with silicone 
rubber caps and placed in an oven at 40°C for 72 h. Peroxide production was 
measured using the FTC assay. The analysis was performed in triplicate, and positive 
(0.01% BHT and 0.01% trolox) and negative (Milli-Q water instead of samples) 
controls were employed. 
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2.2.2.4   Analysis of amino acid composition 
2.2.2.4.1   Preparation of samples and standards 
The amino acid profile of BSA hydrolysate and the purified peptide fractions was 
determined as described by Bidlingmeyer et al. (1987), and the minor modifications 
detailed in Badii and Howell (2001) were incorporated. In this method, 20 mg of each 
sample was hydrolysed with 6 M HCl (10 ml) in screw-cap tubes (16 mm × 125 mm). 
Oxygen was then evacuated from the tubes using nitrogen gas pump before heating at 
110°C for 24 h. The hydrolysed samples were then subjected to various steps prior to 
characterisation using HPLC. 
 
2.2.2.4.2   Derivatisation of amino acids using PITC 
The amino acid standards and samples were derivatised according to the method 
detailed in ConzaLez-Castro et al. (1997), with slight modifications. Aliquots (20 µl) 
of each sample were placed in micro glass tubes and subjected to vacuum drying for 
approximately 15 min. This was followed by the addition of 20 µl of the drying agent 
[composed of TEA (100 µl), methanol (200 µl) and 1 M sodium acetate (200 µl)] and 
vacuum drying for 15 min. This was followed by the addition of 10 µl of the 
derivatisation reagent, which is composed of PITC (20 µl; stored in the absence of 
nitrogen at −20°C), HPLC-grade methanol (140 µl), TEA (20 µl) and milli-Q water 
(20 µl). The solution was maintained at room temperature for 20 min and again 
subjected to vacuum drying for approximately15 min. Finally, the dried mixture 
thereby obtained was reconstituted in 100 µl of eluent A [0.22 M sodium acetate 
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buffer containing 0.05% (v/v) TEA, pH adjusted to 6.4 with glacial acetic acid]. The 
samples and amino acid standards were analysed in duplicate by HPLC. 
 
2.2.2.4.3   HPLC equipment and conditions 
The RP-HPLC system (Ultimate 3000HPLC, Thermo Fisher Scientific Inc., 
Loughborough, UK) employed for amino acid analysis included a pump (Thermo 
Separation Products), autosampler (Spectra Physics AS1000), UV detector (Thermo 
Separation Products UV6000LP) and integration software (Chromeleon).   
 
The separation of samples and amino acid standards was performed using a C18 
reverse phase column (3.9  150 mm, 5-µm particle size; Nova–Pak, Waters 
Separations, Elstree, UK). The linear gradient solvent system that functioned as a 
mobile phase was prepared from two buffer solutions A and B; solution A consisted 
of 0.22 M sodium acetate buffer (pH 6.2) containing 0.05% (v/v) TEA and solution B 
of acetonitrile: Milli-Q water at a ratio of 60:40. The profile of the linear gradient 
solvent system is outlined in Table 2.1; a flow rate of 1 ml/min was employed, and the 
amino acids were detected at a wavelength of 254 nm. The amount of each amino acid 
was calculated with reference to the standard on the basis of peak area, while the 
amino acid composition was expressed as a percentage of the total amino acids in the 
samples. The samples and amino acid standards were run in duplicate. 
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Table 2.1   Gradient profile for the chromatographic isolation of amino acids. 
 
Time (min) Flow rate (ml/min) Solution A (%) Solution B (%) 
0 1.0 100 0 
10 1.0 54 46 
10.5 1.0 0.0 100.0 
11.5 1.0 0.0 100.0 
12 1.5 0.0 100.0 
12.5 1.5 100 0.0 
20.5 1.5 100 0.0 
20.5 1.0 100 0.0 
 
 
 2.2.3   Statistical analysis  
All experiments were independently repeated three times to ensure reproducibility, 
and all assays were run in triplicate. Data are displayed as mean ± standard deviation 
and analysed using statistical package for the social sciences (SPSS). One-way 
analysis of variance in conjunction with Dunnett’s multiple comparisons test was 
employed for determining the significance of differences between the mean values of 
control and test treatments; a P value of <0.05 (95% confidence interval) was 
considered to represent statistical significance. 
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2.3   Results and discussion 
2.3.1   Enzymatic hydrolysis of bovine serum albumin  
Bioactive peptides were derived from the parent protein BSA using various 
techniques such as enzymatic hydrolysis, fermentation and food processing 
(Udenigwe and Aluko, 2012; Kim et al., 2013). The enzymatic hydrolysis of proteins 
in food products is a mild process of great importance, which could be employed for 
improving various properties of the original food product without affecting its 
nutritional value and also improving its absorption in the intestine (Ducroo, 1982; 
Driou et al., 1985). 
The present study focused on the production of bioactive peptides from BSA using 
the digestive enzyme pepsin for protein hydrolysis. Digestion of BSA with pepsin 
produced good antioxidant peptide fractions.  Pepsin was a suitable enzyme for use in 
the present study, as it is reported that it yields a high percentage of peptides with 
exposed hydrophobic and aromatic amino acids as well as free amino acid residues 
capable of exhibiting antioxidant activity (Kageyama et al., 2010). Several 
characterised bioactive peptides have been generated using proteases, typically pepsin 
and trypsin. Pepsin displays optimal hydrolysis efficiency at a low pH of 
approximately 2 and a temperature range of 37°C–42°C (Driou et al., 1985). Under 
these conditions, pepsin usually cleaves at the carboxyl end of hydrophobic and 
preferably aromatic amino acid residues, including phenylalanine, tryptophan, 
tyrosine and leucine (Kageyama et al., 2010). In addition, the in vivo role of pepsin in 
the human gastrointestinal tract supports the possibility of association between its 
hydrolytic activities in vitro and in vivo (Whitaker, 1994). 
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The bioactive peptides generated from BSA hydrolysates were fractionated by UF 
using membranes with MWCO of < 10 kDa, followed by purification using gel-
filtration chromatography (Martínez-Maqueda et al., 2013). A percentage yield of 
19.8% and 37.2% was obtained for the crude BSA hydrolysate and peptide fraction of 
molecular weight < 10 kDa, respectively. The higher yield of peptide in the < 10 kDa 
fraction than in crude BSA hydrolysates indicated that the peptide was hydrolysed 
extensively. 
 
2.3.2 Antioxidant activity of BSA hydrolysates and their 
ultrafiltration fraction of < 10 kDa molecular weight in a linoleic acid 
model system 
Lipid oxidation is a complex process in biological systems that proceeds via radical-
mediated elimination of hydrogen atoms from the methylene group of polyunsaturated 
fatty acids, initiating a sequence of reactions that produce potentially toxic substances 
such as aldehydes and ketones (Niki, 2010; Winczura et al., 2012). Thus, the 
inhibition of lipid oxidation is an important parameter for evaluating the total 
antioxidant potential of food proteins and peptides. 
 
In the present study, the total antioxidant activity of crude BSA hydrolysates and their 
UF fraction of molecular weight < 10 kDa was estimated at a concentration of 1 
mg/ml in the linoleic acid model system using ferric thiocyanate (FTC) and 
thiobarbituric acid reactive substance (TBARS) methods and compared with that of 
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commercial antioxidant agents (0.01% trolox and 0.01% BHA). For both FTC and 
TBARS methods, measurements were performed every 24 h over a period of 7 days. 
 
In a pilot experiment, BSA hydrolysates obtained upon incubation with pepsin for 
different time periods (2, 3, 4 and 6 h; refer Section 2.2.2.1) were assayed in the 
linoleic acid model system over a period of 7 days and then subjected to the FTC 
assay to assess optimum conditions for the enzymatic activity of pepsin. Figure 2.1 
shows that the lipid peroxidation inhibition activity of BSA hydrolysates increased 
with increasing the time of incubation with pepsin, as also observed previously (Nasri 
et al., 2013). Hydrolysates generated following 6 h incubation with pepsin 
demonstrated the highest lipid peroxidation inhibitory activity (32.7%), followed by 
incubations for 4, 3 and 2 h (25.7%, 19.4% and 14.7% activity, respectively); 
statistically significant differences were obtained between the test samples (P ≤ 0.05). 
However, the inhibitory activity of BSA hydrolysates at all incubation periods 
examined was significantly lower than that of the positive controls BHA and trolox, 
the well-characterised antioxidants, which exhibited 67.1% and 79.8% activity, 
respectively (P ≤ 0.05). Thus, the highest lipid oxidation inhibitory activity was 
exhibited by BSA hydrolysates generated by incubation with pepsin for 6 h; this 
incubation time was therefore chosen for further studies because of high enzymatic 
hydrolytic activity. 
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Figure 2.1   Percentage inhibition of lipid oxidation by bovine serum albumin hydrolysates (1 
mg/ml) generated by incubation with pepsin for various time periods (2, 3, 4 and 6 h). The 
inhibitory activity was spectrophotometrically monitored at 500 nm by applying the ferric 
thiocyanate method subsequent to the linoleic acid model system. Butylated hydroxyanisole 
(0.01%) and trolox (0.01%) were employed as positive controls. The samples were assayed in 
triplicate (n = 3); results are presented as mean ± SD. 
 
As a next step, the inhibitory activities of BSA hydrolysate and its peptide fraction of 
molecular weight < 10 kDa were measured using the FTC method subsequent to the 
linoleic acid model system (Figure 2.2). The negative control (without antioxidants) 
showed rapid increase in absorbance on day 2 and peak absorbance, corresponding to 
maximum linoleic acid oxidation, on day 4; the absorbance showed gradual decline 
on day 7, corresponding to the instability and decomposition of hydrogen peroxide to 
yield secondary oxidation products (chiefly MDA), which led to the reduction in 
absorbance following long periods of incubation. Clearly, the significant decrease in 
absorbance is attributable to the formation of the intensive red colour associated with 
ferric thiocyanate complex (Chen et al., 2007). The BSA hydrolysate and its peptide 
fraction of molecular weight < 10 kDa exhibited significantly lower absorbance on 
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days 3 and 4 (compared with the negative control), indicating high antioxidant 
activity; in fact, the peptide fraction (molecular weight < 10 kDa) exhibited higher 
activity, corresponding to a lower absorbance (1.024) on day 4 than the BSA 
hydrolysate (1.203). None of the test samples displayed higher absorbance than the 
negative control (without antioxidants) over the 7 days of incubation in the linoleic 
acid model system, indicating the existence of antioxidant activity. Changes were not 
observed in lipid oxidation levels during the entire incubation period in the presence 
of the synthetic antioxidants BHA and trolox; these antioxidants exhibited higher 
antioxidant activities than BSA hydrolysate or its peptide fraction (molecular weight 
< 10 kDa; P ≤ 0.05), as shown in Figure 2.2. The results obtained in this study are in 
agreement with those of Zhu et al. (2011), which discuss the reduction in linoleic acid 
oxidation by peptides derived from wheat gluten. 
 
 
Figure 2.2  Antioxidative activities of bovine serum albumin hydrolysate and its peptide 
fraction of molecular weight < 10 kDa at a concentration of 1 mg/ml. The inhibitory activity 
was spectrophotometrically monitored at 500 nm by applying the ferric thiocyanate method 
subsequent to the linoleic acid model system. Milli-Q water instead of the sample was 
employed in the control. Butylated hydroxyanisole (0.01%) and trolox (0.01%) were 
employed as standards. The samples were assayed in triplicate (n = 3); results are presented as 
mean ± SD. 
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The results were then compared at day 4 as a general trend (Figure 2.3). All the test 
samples clearly presented a considerably higher percentage inhibition of lipid 
oxidation (P ≤ 0.05) on day 4, with 34.9%, 44.8%, 73.7% and 79.9% inhibition of 
linoleic acid oxidation by the BSA hydrolysate, its peptide fraction (molecular weight 
< 10 kDa), trolox and BHA, respectively. The lipid oxidation inhibitory activity of the 
peptide fraction (<10 kDa ) was higher than that of the BSA hydrolysate (P ≤ 0.05) 
but significantly lower than that of BHA and trolox, which are well-characterised 
antioxidants (P ≤ 0.05) (Cheung et al., 2012). 
 
 
Figure 2.3   Percentage inhibition of lipid oxidation on day 4 by the bovine serum albumin 
hydrolysate and its peptide fraction (molecular weight < 10 kDa) at a concentration of 1 
mg/ml. The inhibitory activity was spectrophotometrically monitored at 500 nm by applying 
the ferric thiocyanate method subsequent to the linoleic acid model system. Butylated 
hydroxyanisole (0.01%) and trolox (0.01%) were employed as standards. The samples were 
assayed in triplicate (n = 3); results are presented as mean ± SD. 
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exhibited the highest absorbance indicating rapid autoxidation in test samples 
following incubation for 7 days, given that the absorbance increased gradually and 
peaked at day 4, followed by a decline. Compared with the control, the absorbance 
from days 3 to 6 was significantly lower in the presence of samples, indicating lower 
lipid oxidation in the presence of the peptides. Differences were not observed between 
test samples and the negative control on day 1 (P ≥ 0.05). As assessed from the MDA 
concentration, the peptide fraction (molecular weight < 10 kDa) inhibited lipid 
oxidation with higher efficiency (8.023 µg/ml MDA) than the BSA hydrolysate 
(10.42 µg/ml MDA) but with lower efficiency than the synthetic antioxidants (P ≤ 
0.05). 
 
Figure 2.4  Antioxidative activities of bovine serum albumin hydrolysates and its peptide 
fraction of molecular weight < 10 kDa at a concentration of 1 mg/ml. The inhibitory activity 
was spectrophotometrically monitored at 532 nm by applying the thiobarbituric acid reactive 
substance method subsequent to the linoleic acid model system. Milli-Q water was included 
in the control instead of the sample. Butylated hydroxyanisole (0.01%) and trolox (0.01%) 
were employed as standards. The samples were assayed in triplicate (n = 3); results are 
presented as mean ± SD. 
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The antioxidant activities of samples were measured using the TBARS method on day 
4, given that the highest lipid oxidation activity was observed on this day; all samples 
significantly differed from the negative control on day 4 (P ≤ 0.05). The percentage 
inhibition of lipid oxidation exhibited by the BSA hydrolysate, peptide fraction 
(molecular weight < 10 kDa), BHA and trolox was observed to be 42.8%, 54.8%, 
76.7% and 84.4%, respectively. The peptide fraction (<10 kDa ) exhibited higher 
percentage inhibition of lipid oxidation than the BSA hydrolysate, as shown in Figure 
2.5 (Sabeena Farvin et al., 2014). 
 
 
Figure 2.5   Percentage inhibition of lipid oxidation by bovine serum albumin hydrolysate 
and its peptide fraction (molecular weight < 10 kDa) at 1 mg/ml concentration. The inhibitory 
activity was spectrophotometrically monitored at 532 nm by applying the thiobarbituric acid 
reactive substance method subsequent to the linoleic acid model system. Butylated 
hydroxyanisole (0.01%) and trolox (0.01%) were employed as standards. The samples were 
assayed in triplicate (n = 3); results are presented as mean ± SD. 
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Notably, the oxidation of linoleic acid was gradually inhibited by the addition of the 
fractionated BSA hydrolysate. The antioxidant activity determined using the TBARS 
assay was slightly higher than that determined using the FTC assay (Figure 2.6), 
suggesting that the BSA hydrolysate and its peptide fraction (molecular weight < 10 
kDa) displayed slightly higher efficiency in inhibiting the production of MDA than 
peroxide. Similar results pertaining to the antioxidant activity of 12 traditional Indian 
medicinal plants were reviewed by Farrukh et al. (2006); moreover, similar results 
pertaining to the potential antioxidant properties of pigmented rice were obtained by 
Lum and Chong (2012). 
 
Figure 2.6   Comparison of percentage inhibition of lipid oxidation on day 4 of incubation in 
the linoleic acid model system using ferric thiocyanate and thiobarbituric acid reactive 
substance methods. Butylated hydroxyanisole (0.01%) and trolox (0.01%) were employed as 
standards. The samples were assayed in triplicate (n = 3); results are presented as mean ± SD. 
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Interestingly, studies assessing the antioxidant activities of BSA have not been 
previously reported; however, a study by Roche et al. (2008) reported the antioxidant 
activities of human serum albumin (HSA). The antioxidant activities of HSA are 
likely to be similar to those of BSA, given that these two proteins exhibit 
approximately 76% structural homology. 
 
2.3.3   Gel-filtration chromatography 
The peptide fraction (molecular weight < 10 kDa) of BSA hydrolysate, which 
presented the highest antioxidant activity, was further purified by gel-filtration 
chromatography. The peptide fraction was dissolved in phosphate buffer (pH 7.0) and 
loaded onto Sephadex G-25 gel-filtration column (2.0  90 cm; Figure 2.7). Higher 
absorbance at the wavelength 250 nm was detected for 14 peptide fractions 
(numbered 13–26), as shown in Figure 2.8. Aliquots (5 ml) of each fraction from 10 
runs of gel filtration were pooled and freeze dried, and their antioxidant activity was 
evaluated using the FTC method to allow the selection of suitable peptide fractions 
for further purification. Fraction number 18 (GF18) exhibited the highest antioxidant 
activity (65.4%), as shown in Figure 2.9, which compared well with that of the 
synthetic antioxidants BHA and trolox (69.6% and 78.5%, respectively) (Figure 2.10). 
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Figure 2.7  Elution profile of the bovine serum albumin-derived ultrafiltration peptide 
fraction (molecular weight < 10 kDa) by gel-filtration chromatography using Sephadex G-25 
column with a flow rate of 1 ml/min. The separation of peptides was measured at 215 nm. 
 
 
Figure 2.8  Gel-filtration chromatography of the bovine serum albumin-derived ultrafiltration 
peptide fraction (molecular weight < 10 kDa) using Sephadex G-25 column with a flow rate 
of 1 ml/min. The separation of peptides was measured at 250 nm. 
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Figure 2.9  Antioxidative activities of gel-filtration fractions (1 mg/ml concentration). The 
inhibitory activity was spectrophotometrically monitored at 500 nm by applying the FTC 
method subsequent to 7 days of incubation in the linoleic acid model system. Butylated 
hydroxyanisole (0.01%) and trolox (0.01%) were employed as positive controls. The samples 
were assayed in triplicate (n = 3); results are presented as mean ± SD. 
 
 
Figure 2.10   Comparison of inhibition of lipid oxidation by gel-filtration fraction number 18 
(GF18; 1 mg/ml concentration) and the commercial antioxidants (0.01% butylated 
hydroxyanisole and 0.01% trolox). The inhibitory activity was spectrophotometrically 
monitored at 500 nm by applying the ferric thiocyanate method subsequent to the linoleic acid 
model system. The samples were assayed in triplicate (n = 3); results are presented as mean ± 
SD. 
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2.3.4   Inhibitory effects of the isolated peptide on peroxide formation 
The lipid oxidation inhibitory activity of the BSA-derived peptide fraction GF18 was 
assessed at various concentrations (0.2, 0.4, 0.6, 0.8 and 1 mg/ml) using the linoleic 
acid model system, followed by the FTC method. Increased inhibition of peroxide 
formation was observed with increasing peptide concentration (Figure 2.11), with 0.2, 
0.4, 0.6, 0.8 and 1 mg/ml GF18 concentrations resulting in 36.7%, 45.9%, 59.3%, 
66.8% and 70.4% inhibition of lipid oxidation, respectively. However, the well-
characterised synthetic antioxidants BHA and trolox, which were employed in the 
experiment as standards, presented higher lipid oxidation inhibitory activity than the 
BSA-derived peptide fraction (P ≤ 0.05). The differences between the test samples 
were found to be statistically significant (P ≤ 0.05). 
 
Figure 2.11  Lipid oxidation inhibitory activity of bovine serum albumin-derived peptide 
fraction GF18 at various concentrations (0.2, 0.4, 0.6, 0.8 and 1 mg/ml). The antioxidant 
activity was spectrophotometrically evaluated at 500 nm using the ferric thiocyanate method 
subsequent to incubation in the linoleic acid model system for 72 h. Butylated hydroxyanisole 
(0.01%) and trolox (0.01%) were employed as positive controls. The samples were assayed in 
triplicate (n = 3); results are presented as mean ± SD. 
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The lipid oxidation inhibitory activity of the BSA-derived peptide fraction GF18 was 
found to be dose-dependent, as shown in Figure 2.12, with strong positive linear 
correlation between peptide concentration and lipid oxidation inhibitory activity (R2 ≥ 
0.963). The effective peptide concentration capable of inhibiting 50% of lipid 
oxidation in the linoleic acid model system (IC50) was found to be 0.475 mg/ml. 
 
 
Figure 2.12 Dose-dependent inhibition of lipid oxidation by the bovine serum albumin-
derived peptide fraction GF18 at various concentrations (0.2, 0.4, 0.6, 0.8 and 1 mg/ml). The 
antioxidant activity was spectrophotometrically evaluated at 500 nm by the ferric thiocyanate 
method subsequent to incubation in the linoleic acid model system for 72 h. The samples 
were assayed in triplicate (n = 3); results are presented as mean ± SD. 
 
 
These results indicated that the peptide fraction GF18 contained antioxidant peptides 
that inhibited peroxide formation in the linoleic acid model system. The presence of 
specific amino acids in peptides, particularly hydrophobic amino acids such as 
phenylalanine, tryptophan and tyrosine, is likely to enhance their interaction with fatty 
acids (Li and Li, 2013). 
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2.3.5  Determination of amino acid composition of the BSA-derived 
peptide fraction 
The amino acid composition of a protein hydrolysate or peptide governs its 
antioxidant activities to a significant extent (Udenigwe and Aluko, 2011; Zhao et al., 
2012), with the functions of a particular peptide predominantly dependent on the 
presence of specific amino acid residues. Therefore, the amino acid composition of 
the BSA-derived peptide fraction GF18, which was obtained by gel-filtration 
chromatography and exhibited the highest antioxidant activity, was determined. 
 
The amino acid composition of the BSA-derived peptide fraction GF18 is presented in 
Table 2.2; variations are noticeable in the amino acid composition, which includes 
high proportion of the amino acids lysine, tryptophan, leucine, and alanine (16.8%, 
15.8%, 13.4% and 10.8%, respectively). 
 
The presence of hydrophobic amino acids such as phenylalanine, valine, leucine, 
alanine and tryptophan in the peptide fraction GF18 is likely to significantly 
contribute to its free-radical scavenging activity (Rajapakse et al., 2005; Udenigwe 
and Aluko, 2011). In addition, the hydrophobicity of peptides facilitates its 
antioxidant activity by enhancing solubility within lipids and providing better access 
to the free radicals generated during lipid oxidation (Sarmadi et al., 2011). The 
peptide fraction GF18 was found to contain limited proportion of threonine, arginine, 
proline, glycine, valine, glutamic acid, histidine, phenylalanine, serine and tyrosine 
(6.8%, 5.9%, 5.3%, 4.9%, 4.3% ,3.2%, 3.1%, 2.8%, 2.7% and 2.4%, respectively) and 
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extremely low levels of  methionine, isoleucine, cysteine and aspartic acid serine 
(1.9%, 1.3%, 1.1% and 0.6% respectively). 
 
Table 2.2   Amino acid composition of the BSA-derived peptide fraction GF18. Percentages 
are presented as mean ± SD of triplicate measurements. 
 
 
Amino acids Amount (%) 
Aspartic acid  0.6 ± 0.54 
Threonine 6.8 ± 0.47 
Serine 2.7 ± 0.54 
Glutamic acid  3.2 ± 0.6 
Proline 4.9 ± 0.23 
Glycine 5.3 ± 0.08 
Alanine 10.8 ± 0.24 
Cysteine 1.1 ± 0.39 
Valine 4.3 ± 0.07 
Methionine 1.9 ± 0.03 
Isoleucine 1.3 ± 0.27 
Leucine 13.4 ± 0.45 
Tyrosine 2.4 ± 0.12 
Phenylalanine 2.8± 0.15 
Histidine 3.1 ± 0.18 
Lysine 16.8 ± 0.23 
Arginine 5.9 ± 0.57 
Tryptophan 15.8 ± 0.19 
 
 82 
 
2.4  Conclusion 
The present study clearly demonstrates the antioxidant activity of peptides obtained 
from BSA hydrolysates that were generated using proteolytic digestion of BSA with 
the enzyme pepsin. The crude BSA hydrolysate and its peptide fractions (molecular 
weight < 10 kDa fraction generated by UF and GF18 gel-filtration fraction) exhibited 
good antioxidant activity and inhibited lipid oxidation in the linoleic acid model 
system. This antioxidant activity is attributable to the presence of specific amino acids 
in the peptide fraction, notably, the hydrophobic amino acids that facilitate hydrogen 
bonding or donate electrons to the free-radical species. The antioxidant activity of the 
BSA-derived peptide fraction GF18 was found to be dose-dependent, with an IC50 of 
0.475 mg/ml. The present results therefore support the production of natural 
antioxidant peptides from BSA by enzymatic hydrolysis for use as food additives and 
pharmaceutical agents. 
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CHAPTER THREE 
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3 Mechanism of antioxidant activity of the 
ultrafiltration peptide fraction (molecular weight < 10 
kDa) of bovine serum albumin hydrolysates 
 
3.1  Introduction 
Reactive oxygen species (ROS) encompasses a wide range of species, including the 
) and 2O2(OH·), hydrogen peroxide (H), hydroxyl radicals .·
−
2superoxide anion (O
), all of which are produced in the human body and in food 2O
1singlet oxygen (
systems (Perjés et al., 2012). Oxidative deterioration induced by free radicals is a 
significant economic consideration in the production and storage of lipid-containing 
food products because it causes an undesirable flavour and odour and decreases the 
functional and nutritional quality of food because of the production of secondary 
products, subsequent to processing and cooking (Frankel, 1980). Free radicals are also 
capable of oxidising and inducing damage to other biomolecules such as DNA, 
proteins and small cellular molecules (Pihlanto, 2006) and are therefore supposed to 
play a role in the incidence of various health disorders such as cardiovascular 
diseases, cancer, diabetes mellitus and neurological disorders as well as the process of 
ageing (Di Bernardini et al., 2011b; Memarpoor-Yazdi et al., 2012).                              
 
Thus, the inhibition of free-radical formation and lipid oxidation in biological and 
food systems is of paramount importance. The use of antioxidants aids the reduction 
of autoxidation in food products; moreover, antioxidants play a crucial role in human 
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health by protecting the structure and function of cells and mitochondria (Tinkel et 
al., 2012).                                                                                                                          
 
Chemical antioxidative agents have been widely employed for stabilising food 
products and inhibiting the generation of free radicals in living systems. The two most 
commonly employed antioxidants are butylated hydroxytoluene (BHT) and butylated 
hydroxyanisole (BHA). However, restrictions on the use of these synthetic 
antioxidants in food products have begun to be imposed because of their toxicity, 
carcinogenicity and possible risks to human health (Becker, 1993; Gülçin, 2012). 
Moreover, both BHT and BHA appear to play a role in tumour promotion 
(Botterweck et al., 2000). These factors have generated growing interest in 
antioxidant peptides obtained from natural sources, particularly peptides isolated from 
hydrolysed food proteins. Research on antioxidant peptides is gaining popularity 
because of their potential health benefits, low cost, easy absorption, low molecular 
weight, high activity and lack of side effects (Sarmadi and Ismail, 2010).                      
 
Proteolytic digestion of proteins using various types of enzymes such as pepsin, 
pancreatin, chymotrypsin, papain, alcalase and trypsin is an efficient approach for the 
generation of antioxidant peptides without affecting their nutritional and functional 
value (Sarmadi and Ismail, 2010). Several studies based on in vitro assays have 
demonstrated the antioxidant properties of peptides isolated from food proteins, 
including fish protein (Najafian and Babji, 2012), milk (Lin et al., 2012c), corn (Ren 
et al., 2010), soy protein (Park et al., 2010) and egg protein (Di Bernardini et al., 
2011b; Memarpoor-Yazdi et al., 2012). The antioxidant activities of these peptides 
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largely depend on the degree of hydrolysis, enzyme specificity and the nature of 
peptides released from the proteins (Sarmadi and Ismail, 2010).                                     
 
The presumed antioxidant peptides and free amino acid residues are thought to 
scavenge free radicals, chelate metal pro-oxidants and inhibit lipid peroxidation chain 
reactions (Sakanaka et al., 2004; Amarowicz, 2008). For example, the antioxidant 
activities of certain bioactive peptides involve the scavenging of ROS; these peptides 
are enriched in aromatic amino acid residues such as histidine, tryptophan and 
tyrosine as well as hydrophobic amino acid residues such as valine, leucine, 
methionine, proline and phenylalanine (Davalos et al., 2004; Amarowicz, 2008).          
 
Several bioactive peptides have been recently identified from hydrolysates of various 
proteins. For instance, a peptide exhibiting strong antioxidant activity has been 
isolated from hoki frame protein hydrolysates generated upon proteolytic digestion 
with the enzyme pepsin; the peptide, whose sequence was identified as Glu–Ser–Thr–
Val–Pro–Glu–Arg–Thr–His–Pro–Ala–Cys–Pro–Asp–Phe–Asn, presented higher lipid 
peroxidation inhibitory activity than the positive control α-tocopherol. In addition, 
this peptide derived from hoki frame protein efficiently quenched diverse sources of 
free radicals or ROS, including 1,1-diphenyl-2-picrylhydrazyl (DPPH), hydroxyl and 
peroxyl radicals and superoxide anions (Kim et al., 2007). Antioxidant peptides have 
also been purified from sweet potato protein hydrolysates generated with the enzyme 
alcalase; these peptides have been reported to contain a substantial proportion of 
hydrophobic amino acids that participate in antioxidant activity, namely histidine, 
methionine, cysteine, tyrosine and phenylalanine. The peptides exert protective effects 
against DNA damage by scavenging hydroxyl radicals and chelating ferrous (Fe2+) 
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ions (Zhang et al., 2012b). Other studies on Tilapia frame protein hydrolysate 
generated using trypsin revealed high hydroxyl-radical scavenging activity, 
attributable to peptides with sequences Asp–Cys–Gly–Tyr and Asn–Tyr–Asp–Glu–
Tyr (Fan et al., 2012).                                                                                                                                          
 
The present study aimed to elucidate the antioxidant activity of the bovine serum 
albumin (BSA)-derived peptide fraction (molecular weight < 10 kDa) obtained using 
ultrafiltration (UF). Five in vitro tests, namely DPPH radical scavenging activity, 
reducing power assay, superoxide anion radical scavenging activity, hydroxyl radical 
possible  employed for evaluatingelating activity, were ch-2+Fescavenging assay and 
mechanisms underlying the antioxidant activity.                                                              
 
3.2  Materials and methods 
3.2.1   Materials 
BSA, pepsin (from gastric mucosa, ≥2,500 units/mg protein), DPPH, ferrous chloride 
(FeCl2), 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine (ferrozine), BHA, H2O2, 
ethylenediaminetetraacetic acid (EDTA), pyrogallol, α-deoxyribose, ferrous sulfate, 
potassium ferricyanide, trichloroacetic acid (TCA) and thiobarbaturic acid (TBA) 
were obtained from Sigma–Aldrich Co. Ltd (Poole, UK). Other chemicals, including 
Tris–HCl and sodium phosphate, were purchased from Fisher Scientific UK Ltd. 
(Loughborough, UK). UF membranes with 10-kDa-molecular weight cut-off were 
purchased from Vivaspin (Epsom, UK). All other chemicals employed in the 
experiments were of analytical grade. 
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3.2.2   Methods 
3.2.2.1   Preparation of bovine serum albumin hydrolysates 
Enzymatic hydrolysis of BSA was achieved as detailed in Section 2.2.2.1. 
3.2.2.2   Ultrafiltration  
Ultrafiltration of BSA hydrolysates was achieved as detailed in Section 2.2.2.2.1.  
 
3.2.2.3   Characterisation of antioxidant activity 
Five distinct experiments were performed for characterising the antioxidant activity of 
the BSA-derived UF peptide fraction (molecular weight < 10 kDa) on the basis of its 
amino acid content, as follows. The first step involved the dissolution of all BSA 
peptide samples in Milli-Q water. 
 
3.2.2.3.1   Ferric reducing power assay 
The ability of the BSA-derived UF peptide fraction (< 10 kDa  molecular weight) to 
reduce ferric (Fe3+) to Fe2+ ions was measured according to the method detailed in 
Zhang et al. (2008), with slight modifications. In brief, an aliquot (2.5 ml) of the 
BSA-derived peptide fraction at various concentrations (0.5, 1.0, 5.0, 10, 15 and 20 
mg/ml) was added to 0.2 M phosphate buffer (pH 6.6; 2.5 ml) and 1% (w/v) 
potassium ferricyanide (2.5 ml). The mixtures were heated in a water bath at 50°C for 
30 min, followed by the addition of 10% (w/v) TCA (2.5 ml) and centrifugation at 
1650 g for 10 min. Subsequently, a 2.5-ml aliquot of each reaction was mixed with 
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milli-Q water (2.5 ml) and 0.1% (w/v) ferric chloride solution (0.5 ml). Following 
incubation for 10 min at room temperature, colour development in the assay mixture 
was monitored at a wavelength of 700 nm using a spectrophotometer (UVIKON 860, 
Kontron instrument, UK). For the reaction blank, Milli-Q water (2.5 ml) was 
employed instead of the sample. In this assay, higher absorbance indicates stronger 
reducing power. All absorbance readings were performed in triplicate. BHT (0.01%) 
and trolox (0.01%) were employed as positive controls. 
 
3.2.2.3.2   Fe2+-chelating activity 
The transition metal-chelating ability of the BSA-derived peptides was assessed using 
the modified method employed in Gulucin et al. (2011). Aliquots (0.5 ml) of various 
concentrations (0.5, 1.0, 5.0, 10, 15 and 20 mg/ml) of the UF peptide fraction 
(molecular weight < 10 kDa) of BSA were premixed with Milli-Q water (1.6 ml) 
followed by the addition of 2 mM FeCl2 solution (0.05 ml) and subjected to vigorous 
shaking. The mixture was allowed to stand for 30 s at room temperature. The reaction 
was stopped by the addition of 5 mM ferrozine solution (0.1 ml) followed by 
vortexing and allowed to stand again at room temperature for 10 min. The absorbance 
of the resulting Fe2+–ferrozine complex was measured at a wavelength of 562 nm 
using a spectrophotometer (UVIKON 860). EDTA (0.05% w/v) and Milli-Q water (1 
ml, instead of the sample) were employed as positive and negative controls, 
respectively. All absorbance readings were performed in triplicate (n = 3), and the 
Fe2+-chelating capacity of the peptide was calculated as a percentage according to the 
following formula: 
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𝐈𝐫𝐨𝐧 𝐜𝐡𝐞𝐥𝐚𝐭𝐢𝐧𝐠 𝐚𝐜𝐭𝐢𝐯𝐢𝐭𝐲 (%)  =
𝑨𝟎 − 𝑨𝟏 
𝑨𝟎 
 × 100, 
where A0 and A1 refer to the absorbance of the negative control and the peptide 
samples, respectively, in the presence of FeCl2. 
 
3.2.2.3.3   1, 1-diphenyl-2-picrylhydrazyl radical scavenging activity 
DPPH is a synthetic radical commonly employed for measuring the radical-
scavenging capacity of food proteins and peptides because of its better stability 
compared with natural radicals (Chandrasekara and Shahidi, 2011; Chandrasekara and 
Shahidi, 2011a; Chandrasekara and Shahidi, 2011b). The DPPH radical scavenging 
activity of the UF peptide fraction (molecular weight < 10 kDa) derived from BSA 
was assessed according to the modified method detailed in Memarpoor-Yazdi et al. 
(2012). In brief, 1 mM methanolic solution of DPPH (1 ml) was added to 1-ml 
aliquots of various concentrations (0.5, 1.0, 5.0, 10, 15 and 20 mg/ml) of the BSA-
derived peptide fraction (< 10 kDa). Following vigorous mixing, the reaction was left 
in the dark at room temperature for 60 min. The absorbance, reflecting the reduction 
of DPPH radical, was monitored at a wavelength of 517 nm using a UV 
spectrophotometer (UVIKON 860). The negative control contained methanol (1 ml) 
and Milli-Q water (1 ml). BHT (0.01%) and trolox (0.01%) were employed as 
positive controls. All absorbance readings were determined in triplicate. In this assay, 
a decrease in absorbance reflects increased DPPH radical scavenging activity. The 
antioxidant potential of the peptide was calculated from the percentage inhibition of 
DPPH radical using the following equation: 
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DPPH radical scavenging activity (%) = 
𝑨𝐜 − 𝑨𝐬
 𝑨𝐜 
 × 100, 
where Ac and As correspond to the absorbance of the control and samples, 
respectively. Serial dilutions of the BSA-derived peptide (< 10 kDa) were employed 
for evaluating the concentration causing 50% inhibition of DPPH radical (IC50) under 
the described conditions. 
 
3.2.2.3.4   Scavenging of superoxide anion radical (O2
−·) 
The superoxide anion radical-scavenging ability of the UF peptide fraction (< 10 kDa) 
derived from BSA was investigated using the pyrogallol autoxidation method 
described previously by Tang et al. (2010), with minor modifications. The reaction 
mixture included 1.8 ml of 50 mM Tris–HCl buffer (pH 8.2) and 1 ml of various 
concentrations (0.5, 1.0, 5.0, 10, 15 and 20 mg/ml) of the BSA-derived peptide 
fraction (< 10 kDa ). The mixture was incubated at 25°C for 10 min, followed by the 
addition of 0.1 ml of 10 mM pyrogallol solution (in 10 mM HCl). The reaction was 
initiated with the addition of pyrogallol, and the rate of pyrogallol autoxidation was 
measured every 30 s for 4 min at the wavelength 320 nm using a spectrophotometer 
(UVIKON 860). The control was similarly treated, except that it contained Tris–HCl 
instead of the sample. BHA (0.01%) and trolox (0.01%) were employed as positive 
controls. Data represent the average of triplicate experiments (n = 3). The superoxide 
anion scavenging activity was mathematically calculated using the following 
equation:                                                                                                                            
Superoxide anion scavenging activity (%) = 
𝑨𝟎 − 𝑨𝟏
 𝑨𝟎 
 × 100, 
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where A0 and A1 represent absorbance of the control and peptide, respectively. 
 
3.2.2.3.5   Hydroxyl radical-scavenging activity 
The hydroxyl radical scavenging activity of the BSA-derived UF peptide fraction  (< 
10 kDa) was determined as detailed in Batool et al. (2011), with a few modifications. 
This assay involves the generation of hydroxyl radicals through the Fenton reaction. 
The reaction mixture included 10 mM ferrous sulphate (0.1 ml), 10 mM EDTA (0.1 
ml), 10 mM α-deoxyribose (0.5 ml), 0.1 M sodium phosphate buffer (pH 7.4; 0.9 ml) 
and 0.2 ml of the peptide sample at different concentrations (0.5, 1.0, 5.0, 10, 15 and 
20 mg/ml). The mixture was subjected to thorough shaking in a test tube and the 
followed by  ,)0.2 ml( 2O2initiated by the addition of 10 mM Hwas reaction 
incubation in a water bath at 37°C for 1 h. Finally, 2.8% TCA (1 ml) was added to 
terminate the reaction. Subsequently, 1 ml of 1.0% (w/v) TBA (in 0.05 M NaOH) was 
added, and the mixture was incubated in a water bath at 100°C for 15 min. The 
mixture was then allowed to cool, and the absorbance of the solution was measured at 
532 nm using a spectrophotometer (UVIKON 860). For the negative control, Milli-Q 
water was used instead of the sample. BHA (0.01%) and trolox (0.01%) were 
employed as positive controls for comparison. All absorbance readings were 
performed in triplicate. The hydroxyl radical scavenging activity was measured 
according to the following equation:                                                                                 
Hydroxyl radical scavenging activity (%) = 
𝑨𝐜− 𝑨𝐬
 𝑨𝐜 
 × 100, 
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where Ac and As correspond to the absorbance of the negative control and samples, 
respectively. 
 
3.2.3   Statistical analysis 
All assays were performed in triplicate (n = 3). Data are expressed as mean ± standard 
deviation and analysed using statistical package for the social sciences (SPSS). One-
way analysis of variance in conjunction with Dunnett’s multiple comparison test was 
employed for determining the significance of differences between the mean values of 
control and test treatments. Differences were considered to be statistically significant 
at P < 0.05 (95% confidence interval). 
 
3.3  Results and discussion 
3.3.1   Ferric reducing power assay 
The ferric reducing power assay is often employed for assessing the ability of an 
antioxidant to donate a hydrogen or an electron atom to a free radical, thereby 
stabilising it; the reduced species subsequently obtains a proton from the test samples 
(Wang et al., 2008). Several studies have indicated that direct connection exists 
between the antioxidant activities and reducing power of specific antioxidant proteins 
and peptides (Samaranayaka and Li-Chan, 2011; Najafian and Babji, 2012). The 
reducing ability of the BSA-derived UF fraction (< 10 kDa ) was assessed by 
monitoring the reduction of Fe3+ to Fe2+ ions, as detailed in Zhang et al. (2008). The 
donation of an electron or hydrogen atom by antioxidants (reductants) in the assay 
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mixture results in the reduction of the Fe3+–ferricyanide complex to the more stable 
Fe2+ form; this results in the formation of an intense blue colour, which is 
spectrophotometrically measured at a wavelength of 700 nm. In this assay, the 
increase in absorbance reflects the increased reducing power of the antioxidant.     
          
ferricyanide –+3Feability to reduce the ossess the fractions have been shown to pBSA 
 )green shades of blue forms (coloured various 2+Feto (yellow colour) complex 
(Beyhan and Gedikli, 2010). In the present study, the absorbance of all reactions with 
varying peptide concentrations was lower than 0.2; this is attributable to the low 
concentration of the peptide in the assay mixture, as shown in Figure 3.1. Statistically 
significant differences were obtained using various concentrations of the BSA-derived 
peptide fraction (P ≤ 0.05).                                                                                               
  
 
Figure 3.1 Ferric reducing power assay employing various concentrations of the bovine 
serum albumin-derived ultrafiltration peptide fraction (< 10 kDa). The reducing power was 
spectrophotometrically monitored at 700 nm. All absorbance readings were performed in 
triplicate (n = 3). 
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The reducing power of the BSA-derived peptide fraction (< 10 kDa) was found to be 
dose-dependent (Figure 3.1), with increasing reducing power observed upon 
increasing peptide concentrations over the range of 0.5–20 mg/ml (P ≤ 0.05). The 
absorbance of the reaction containing 20 mg/ml of the peptide fraction was found to 
be 0.18, reflecting stronger antioxidant activity than other concentrations. Strong 
positive linear correlation was observed between the peptide concentration and 
reducing power (R2  0.9958). Ferric reducing activity was also reported by Vastag et 
al. (2011), where pumpkin oil cake protein hydrolysate obtained upon proteolytic 
digestion with alcalase and flavourzyme was investigated; low reducing activity 
(absorbance of < 0.1 at 700 nm) was observed in their system. In contrast, Zhu et al. 
(2006) reported higher reducing activity (absorbance > 0.4 at 700 nm) using wheat 
protein hydrolysates. 
 
 
Figure 3.2  Ferric reducing power assay employing bovine serum albumin-derived peptide 
fraction (10 mg/ml), with butylated hydroxyanisole (0.01%) and trolox (0.01%) as standards. 
The reducing activity was spectrophotometrically monitored at 700 nm. All readings were 
performed in triplicate (n = 3). Data are presented as mean ±SD. 
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Figure 3.2 shows that the reducing activity of the BSA-derived peptide fraction (< 10 
kDa) at 10 mg/ml concentration was significantly lower (absorbance of 0.1) than that 
of the synthetic antioxidants BHA and trolox (absorbance of 0.14 and 0.16, 
respectively), which were employed as standards (P ≤ 0.05). 
 
These results suggest that the BSA hydrolysate generated in the present study through 
proteolytic digestion with the enzyme pepsin contains peptides or amino acids capable 
of functioning as an electron donor and reacting with free radicals to form stable 
products, in agreement with several previous studies (Zhu et al., 2006; He et al., 
2013). Notably, differences in the specificity of the enzymes employed for hydrolysis 
of proteins could lead to the generation of peptides with varying proportions of the 
residue responsible for donating hydrogen or electrons. For instance, the hydrolysate 
of buckwheat protein generated with the digestive enzyme pepsin exhibited negative 
effects in the reducing power assay, while hydrolysis with a combination of 
pancreatin and pepsin led to the recovery of activity (Ma and Xiong, 2009). 
 
3.3.2   Ferrous ion-chelating activity 
Transition metal ions such as iron (Fe), copper (Cu), zinc (Zn) and manganese (Mn) 
play an important role in biological catalysis and are essential for the activity of 
several enzymes (Kleczkowski and Garncarz, 2012). At high concentrations, these 
metals function as pro-oxidative catalysts and are capable of catalysing the production 
of ROS such as hydroxyl radicals and superoxide anion (Fisher and Naughton, 2005), 
resulting in lipid peroxidation and cellular damage (Stohs and Bagchi, 1995). For 
(I) promote the reduction  (III) and copper of iron excessive concentrationsexample, 
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reaction. In Fenton  throughhighly reactive hydroxyl radicals  theto generate  2O2Hof 
lipid peroxidation chain reaction and the  is capable of stimulating 2+particular, Fe
affects the breakdown of hydroperoxide, leading to the generation of off–flavours. 
Therefore, the presence of antioxidant agents such as peptides facilitates the formation 
of stable metal–chelate complexes to inhibit lipid peroxidation and consequently 
prevent food rancidity (Amic et al., 2007).                                                                       
 
In the present study, the chelating activity of the BSA-derived peptide fraction (< 10 
kDa) was measured in the presence of ferrozine. This method involves the reaction of 
ferrozine with Fe2+ to form a purple–red complex (Fe2+–Fz3), which has significant 
absorption at a wavelength of 562 nm. The intensity of the (Fe2+–Fz3) complex 
decreases upon the addition of antioxidant agents with chelating activity, such as the 
BSA-derived peptide fraction (< 10 kDa). Thus, measurement of colour intensity 
enables the evaluation of the metal-chelating activity of a compound.    
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Figure 3.3  Ferrous ion-chelating activity of the bovine serum albumin-derived peptide 
fraction (< 10 kDa) at various concentrations. The activity was spectrophotometrically 
monitored at 563 nm. All readings were determined in triplicate (n = 3). Data are presented as 
mean ±SD. 
 
Figure 3.3 shows the Fe2+-chelating activity of the BSA-derived peptide fraction (< 10 
kDa) at various concentrations. The chelating activity of the peptide fraction increased 
with increasing concentrations of the peptide, attaining 60.3% at a peptide 
concentration of 20 mg/ml. Statistically significant differences were observed in the 
activity at various peptide concentrations (0.5–20 mg/ml; P ≤ 0.05), suggesting a 
dose-dependent Fe2+-chelating activity of the peptide fraction over the concentration 
range of 0.5–20 mg/ml. 
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Figure 3.4  Comparison of the ferrous ion-chelating activity of the bovine serum albumin-
derived peptide fraction (< 10 kDa; 10 mg/ml) with that of ethylenediaminetetraacetic acid 
(0.05%). The activity was spectrophotometrically monitored at 563 nm. All readings were 
determined in triplicate (n = 3). Data are presented as mean ±SD. 
 
Figure 3.4 shows the comparison of Fe2+-chelating activity of the BSA-derived 
peptide fraction (< 10 kDa; 10 mg/ml concentration) with that of EDTA (0.05%); the 
BSA-derived peptide fraction was observed to exhibit lower Fe2+-chelating activity 
(33.5%) than the synthetic chelator EDTA (64.7%), which was employed as a positive 
control. These results are consistent with those of a previous study (Chen and Luo, 
1998). 
 
The results of the present study are comparable with those of Lin et al. (2012a), where 
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activity at a concentration of 30 mg/ml. It has been shown that peptides with a high 
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chelating activity (Torres-Fuentes et al., 2011). The Fe2+-chelating activity observed 
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peptide, as described in Section 2.3.5. In addition, the chelation of pro-oxidant metal 
ions such as iron and copper by histidine-containing peptides leads to subsequent 
reduction in lipid peroxidation in both biological and food systems. Furthermore, it 
has been shown that a higher degree of hydrolysis and low molecular weight result in 
increased metal ion-chelating activity (Nalinanon et al., 2011). 
 
3.3.3   1, 1-diphenyl-2-picrylhydrazyl radical scavenging activity 
The production of free radicals is unavoidable in biological systems, and they are 
exogenously introduced; the damage induced by free radicals is known to cause 
various degenerative diseases (Singh and Singh, 2008). Therefore, measuring the 
capacity of an antioxidant to reduce the harmful effects of free radicals is of 
paramount importance. The DPPH radical scavenging assay is an in vitro technique 
developed for evaluating the free radical scavenging capacity of antioxidants in food 
(Beyhan and Gedikli, 2010). 
 
DPPH is among the few stable free radicals at room temperature and is characterised 
by dark purple colour, with maximum absorbance at 517 nm in methanolic or 
ethanolic solutions. The treatment of DPPH radical with a proton (H+) donor such as 
antioxidants results in quenching of the radical and change in colour of the DPPH 
solution from dark purple to pale yellow, accompanying the transfer of an electron 
from the antioxidant scavengers to the DPPH radical and the formation of a stable 
non-radical compound DPPH-H (Xie et al., 2008; Liu et al., 2010). 
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This method was therefore employed for measuring the free radical scavenging 
capacity of the BSA-derived peptide fraction (< 10 kDa). The extent of colour change 
correlates with the antioxidant activity of the peptide. Figure 3.5 shows that the DPPH 
radical scavenging activity increased with increasing peptide concentrations (P ≤ 
0.05), with 20 mg/ml concentration demonstrating the highest DPPH scavenging 
activity (55.9%). However, significant differences in scavenging activity were not 
observed between 0.5 and 1 mg/ml concentrations (15.6% and 16.1%, respectively; P 
≥ 0.05). 
 
 
Figure 3.5  1,1-Diphenyl-2-picrylhydrazyl radical scavenging activity of the bovine serum 
albumin-derived peptide fraction (< 10 kDa ) at different concentrations. The activity was 
spectrophotometrically monitored at 517 nm. All measurements were performed in triplicate 
(n = 3). Data are presented as mean ±SD. 
 
The scavenging activity of the BSA-derived peptide fraction (< 10 kDa) was found to 
be dose-dependent, as shown in Figure 3.6. The scavenging activity was evaluated on 
the basis of the concentration of the BSA-derived peptide fraction (< 10 kDa) that 
15.6 16.1
30.8
42.1
47.7
55.9
0
10
20
30
40
50
60
70
0.5 1 5 10 15 20
D
P
P
H
 r
ad
ic
al
 s
ca
ve
gi
n
g 
ac
ti
vi
ty
 (%
)
Concentrations (mg/ml)
 102 
 
resulted in the scavenging of 50% of the initial DPPH concentration (IC50). In this 
case, the IC50 of the BSA-derived peptide fraction (< 10 kDa) was calculated from 
linear regression analysis to be 15.2 mg/ml. Similarly, Sun et al. (2013) found the 
DPPH radical scavenging activity of egg white hydrolysates generated with the 
digestive enzyme pepsin to be dose-dependent. 
 
 
Figure 3.6  Dose dependence of the 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity 
of bovine serum albumin-derived peptide fraction (< 10 kDa). The activity was 
spectrophotometrically monitored at 517 nm. All measurements were performed in triplicate 
(n = 3). 
 
The DPPH scavenging activity of the BSA-derived peptide fraction (< 10 kDa) was 
compared with those of the synthetic antioxidant agents BHA (0.01%) and trolox 
(0.01%), which were employed as positive controls (Figure 3.7). The DPPH 
scavenging activity of the BSA-derived peptide (< 10 kDa) was found to be higher 
(42.5%) than that of BHA (33.7%). Statistically significant differences in the DPPH 
scavenging activity were observed between the antioxidant peptide and trolox (P ≤ 
0.05). 
y = 1.9499x + 18.916
R² = 0.9663
0
10
20
30
40
50
60
70
0 5 10 15 20
D
P
P
H
 r
ad
ic
al
 s
ca
ve
n
gi
n
g 
ac
ti
vi
ty
 
(%
)
Concentrations (mg/ml)
 103 
 
 
Figure 3.7  Comparison of the 1,1-diphenyl-2-picrylhydrazyl radical scavenging activity of 
the bovine serum albumin-derived peptide fraction (<10 kDa ; 10 mg/ml) with butylated 
hydroxyanisole (0.01%) and trolox (0.01%). The activity was spectrophotometrically 
monitored at 517 nm. All measurements were performed in triplicate (n = 3). Data are 
presented as mean ±SD. 
 
These results indicate that the BSA-derived peptide fraction (< 10 kDa) contains a 
higher proportion of amino acid groups capable of donating electrons to the DPPH 
radical than larger peptides. Several studies have reported the dependence of 
antioxidant activity of peptides on their molecular weight distribution (Peña‐Ramos 
et al., 2004) and the correlation of the high degree of hydrolysis and low molecular 
weight with DPPH radical scavenging activity (Raghavan and Kristinsson, 2008; 
Bougatef et al., 2009; Liu et al., 2010; Udenigwe and Aluko, 2011). In contrast, 
barley gluten hydrolysate fractions of molecular weight < 10 kDa exhibited DPPH 
radical scavenging activity of 61.9% at 10 mg/ml concentration, suggesting that 
peptides with higher molecular weight demonstrate much higher DPPH scavenging 
activity than peptides with lower molecular weight (Xia et al., 2012).                               
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3.3.4   Scavenging of superoxide anion radical 
The superoxide anion radical is an unstable and highly toxic free radical species 
inevitably generated in biological systems during the catalytic activity of several 
enzymes. The in vivo presence of this free radical is of concern because it acts as a 
potential precursor to other types of free radicals such as H2O2 and hydroxyl radicals. 
The superoxide anion radical and its derivatives enhance oxidative reactions capable 
of causing damage to cells and tissue components (Elias et al., 2008; Sun et al., 
2013). Studying the antioxidant scavenging of superoxide anion radicals is therefore 
of great importance (Covarrubias et al., 2008).                                                                
                                                                
The assay involves the generation of superoxide anion radicals by pyrogallol 
autoxidation in an alkaline solution; this results in the change in colour from 
colourless to yellow–brown within a few minutes, then to green and finally to yellow 
at the end of the autoxidation reaction. The autoxidation of pyrogallol 
is spectrophotometrically monitored every 30 s for 4 min at a wavelength of 320 
nm.                                                                                                                                     
 
The scavenging of superoxide anion radicals by the BSA-derived peptide fraction (< 
10 kDa) was investigated in the present study, as shown in Figure 3.8. The superoxide 
scavenging activity of the peptide fraction was found to increase with an increase in 
the sample concentration over the range of 0.5–20 mg/ml, corresponding to 25.5%–
89.7% activity (Moure et al., 2006); compared with the other concentrations, 
significantly higher antioxidant activity against superoxide anion radicals (89.7%) 
13.2 as calculated  was 50The IC concentration of 20 mg/ml.peptide was observed at a 
 105 
 
mg/ml from linear regression analysis of superoxide scavenging activity and various 
concentrations of the BSA-derived peptide fraction (< 10 kDa); the activity was also 
found to be dose-dependent. These results are similar to those obtained with flaxseed 
protein (Udenigwe et al., 2009), where stronger superoxide anion radical scavenging 
                                larger size.a were observed for peptides of  50activity and lower IC 
     
 
 
Figure 3.8 Scavenging of superoxide anion radicals by the bovine serum albumin-derived 
peptide fraction (< 10 kDa) over the concentration range of 0.5–20 mg/ml and IC50 
determination. The activity was spectrophotometrically monitored at 320 nm. Data represent 
the average of triplicate experiments (n = 3). 
 
The scavenging activity of the BSA-derived peptide fraction (< 10 kDa) at 10 mg/ml 
concentration was compared with that of the synthetic antioxidant agents BHA 
(0.01%) and trolox (0.01%), which were employed as positive controls. Figure 3.9 
shows that the scavenging activity of the peptide at the above mentioned 
concentration was significantly higher (52.5%) than that of the synthetic antioxidants 
BHA and trolox (20.9% and 35.2%, respectively; P ≤ 0.05). These results clearly 
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inhibit superoxide-induced damage to vital cellular components (Sannigrahi et al., 
2010). 
 
 
Figure 3.9  Comparison of the scavenging of superoxide anion radicals by the bovine serum 
albumin-derived peptide fraction (<10 kDa; 10 mg/ml) and the synthetic antioxidants 
butylated hydroxyanisole (0.01%) and trolox (0.01%). The activity was 
spectrophotometrically monitored at 320 nm. Data represent the average of triplicate 
experiments (n = 3). Data are presented as mean ±SD. 
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The assay system involves the generation of hydroxyl radicals by EDTA and H2O2 for 
evaluating the hydroxyl radical scavenging activity of the BSA-derived peptide 
fraction (< 10 kDa); the pink colour generated is spectrophotometrically monitored at 
532 nm. The hydroxyl radical scavenging activity exhibited by different 
concentrations of the BSA-derived peptide fraction (< 10 kDa) is shown in Figure 
3.10; the scavenging activity was observed to increase from 8.5% to 65.8% with an 
increase in peptide concentrations, with the highest scavenging activity observed at 20 
mg/ml peptide concentration (65.8%). Statistically significant differences were 
observed in the scavenging activity between reactions with various peptide 
concentrations (P ≤ 0.05). These results indicate that the BSA-derived peptide 
exhibits dose-dependent hydroxyl radical scavenging activity because of the presence 
of amino acids that function as hydrogen donors, thereby stabilising the hydroxyl 
radical (Jung et al., 1995). 
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Figure 3.10   Hydroxyl radical scavenging activity of bovine serum albumin-derived peptide 
fraction (< 10 kDa) over a range of concentrations (0.5–20 mg/ml). The activity was 
spectrophotometrically monitored at 532 nm. All absorbance readings were measured in 
triplicate (n = 3). Data are presented as mean ±SD. 
 
 
The hydroxyl radical scavenging activity of the BSA-derived peptide fraction (<10 
kDa) at 10 mg/ml concentration was compared with those of the synthetic 
antioxidants BHA (0.01%) and trolox (0.01%), which were employed as positive 
controls. Figure 3.11 shows that the hydroxyl radical scavenging activity of the BSA-
derived peptide was slightly lower (38.6%) than that of BHA (52.9%) and trolox 
(66.2%; P ≤ 0.05). These results are similar to those obtained with peptides 
(molecular weight < 10 kDa) derived from corn gluten meal, which exhibited lower 
hydroxyl radical scavenging activity at 5 mg/ml concentration than ascorbic acid 
(Zhuang et al., 2013). Numerous studies have reported the hydroxyl radical 
scavenging activity of hydrolysates from various protein sources (Pihlanto, 2006; 
Zhuang and Sun, 2011). 
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Figure 3.11  Comparison of the hydroxyl radical scavenging activity of bovine serum 
albumin-derived peptide fraction (< 10 kDa; 10 mg/ml) with the synthetic antioxidants 
butylated hydroxyanisole (0.01%) and trolox (0.01%). The activity was 
spectrophotometrically measured at 532 nm. Data represent the average of triplicate 
experiments (n = 3); results are presented as mean ±SD. 
 
 
3.4   Conclusion 
The results of the present study confirm that the BSA-derived peptide fraction (< 10 
kDa) exhibits strong free radical scavenging, metal-ion chelating and reducing 
activities in a peptide dose-dependent manner. In addition, the in vitro antioxidant 
activity of the peptide fraction (< 10 kDa) was comparable with that of the synthetic 
antioxidants BHA and trolox. The antioxidant activities of peptides are associated 
with the presence of specific amino acids capable of functioning as an electron or 
hydrogen donor. The radical scavenging activity of the BSA-derived peptide is 
attributable to the presence of several hydrophobic amino acids such as tyrosine, 
methionine, histidine, lysine, glycine and tryptophan. Moreover, the histidine residue 
in the primary sequence of peptides plays a critical role in their antioxidant activity. 
The antioxidant activities associated with hydrophobic peptides are attributable to 
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their increased ability to donate protons to electron-deficient radicals. Therefore, the 
high antioxidant activity of the BSA-derived peptide fraction (< 10 kDa) is 
attributable to its large molecular size and the presence of hydrophobic amino acids 
within its sequence. 
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4 Angiotensin-I-converting enzyme inhibitory 
peptides derived from bovine serum albumin 
 
4.1   Introduction 
 
Nutritional science has now progressed to encompass ‘nutrition for optimal health’ 
and is known to contribute to disease prevention in the form of nutritional 
supplements. An example is the use of bioactive peptides in a wide range of natural 
and modified foods (Korhonen and Pihlanto, 2003). Angiotensin-I-converting enzyme 
(ACE) inhibitory peptides are bioactive peptides with potent in vivo antihypertensive 
properties. Hypertension is associated with an extremely high risk of disorders such as 
cardiovascular disease, coronary heart disease, stroke, arteriosclerosis, myocardial 
infarction and kidney dysfunction (Zhang et al., 2006; Lin et al., 2012c). In fact, 
approximately 20% of the adult population worldwide is affected by high blood 
pressure (Alper et al., 2001; Chow et al., 2013). The occurrence of hypertension 
increases with age, affecting approximately 65% of individuals of the age group of 
65–74 years (Duprez et al., 2002). Therefore, the use of ACE inhibitory peptides 
derived from food products for maintaining the population health by lowering high 
blood pressure is of enormous interest (Cian et al., 2014). 
 
The causes of hypertension are varied and not well characterised; however, the role of 
the renin–angiotensin system in controlling the fluid balance and blood pressure 
homeostasis of organisms is well known (Eriksson et al., 2002; Riordan, 2003). In 
fact, dipeptidyl carboxypeptidase (ACE or kinase II, EC 3.4.15.1), an enzyme 
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belonging to the class of zinc metalloproteases, is known to effectively regulate blood 
pressure as part of the renin–angiotensin system; the activation of this enzyme is 
dependent on zinc and chloride ions (Eriksson et al., 2002; Skrbic and Igic, 2009; 
Guang et al., 2012). 
 
ACE plays a crucial role in the cardiovascular system by regulating hypertension 
through cleavage of the dipeptide (His–Leu) from the C-terminus of angiotensin I 
(Asp–Arg–Val–Tyr–Ile–His–Pro–Phe–His–Leu), which generates a vasopressor 
octapeptide, angiotension II (Asp–Arg–Val–Tyr–Ile–His–Pro–Phe); ACE also 
inactivates bradykinin, a component of the kallikrein–kinen system (Natesh et al., 
2003; Wijesekara and Kim, 2010). Therefore, inhibiting the action of ACE is essential 
for preventing hypertension and associated disease (Bougatef et al., 2009). Nowadays, 
specific synthetic ACE inhibitors are employed for treating essential hypertension, 
congestive heart failure and myocardial infarction in humans; these include captopril, 
enalapril, fosinopril, moexipril, alacepril and lisinopril (Ondetti et al., 1977). The 
drawback associated with the use of these inhibitors is that they are known to  cause  
strong side effects such as coughing, angioedema, skin rashes and taste disturbance 
(Antonios and MacGregor, 1995; Coleman and Cox, 2011). 
 
As an alternative to pharmacological treatment, a nutritional approach could be 
employed for achieving moderate reduction in blood pressure. Natural ACE inhibitory 
peptides derived from different food proteins have been shown to exhibit good in vivo 
activity as antihypertensive agents (Hata et al., 1996a); however, the ACE inhibitory 
peptides are less active than the synthetic ACE inhibitors but are considered safer by 
consumers (Qu et al., 2010). 
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Recent studies on the isolation of ACE inhibitory peptides from hydrolysates of 
different food proteins such as milk (López-Fandiño et al., 2006), egg (Yu et al., 
2012), sea fish (Lee et al., 2010), fresh-water fish (Ghassem et al., 2011; Chen et al., 
2012a), peanuts (Jimsheena and Gowda, 2010), soybean (Wu and Ding, 2001), 
rapeseed (Marczak et al., 2003) and flaxseed (Udenigwe and Aluko, 2012) have 
attracted significant attention; these peptides have been shown to inhibit ACE activity 
both in vitro and in vivo. 
 
The current study designed to investigate ACE inhibitory peptides derived from 
bovine serum albumin (BSA) hydrolysates obtained upon digestion with the enzyme 
pepsin and to characterise peptides with potent ACE inhibitory activity. The 
techniques employed for peptide identification as well as amino acid analysis of the 
potent peptides are also reviewed. 
 
4.2   Materials and methods 
4.2.1   Materials 
BSA, pepsin (from gastric mucosa, ≥2,500 units/mg protein), hippuryl-L-histidyl-L-
leucine (Hip–His–Leu) substrate, ACE (4 U/mg) from rabbit lung, 
phenylisothiocyanate, Sephadex G-25 resin, triethylamine, captopril and amino acid 
standard solution were obtained from Sigma-Aldrich Co. Ltd. (Poole, Dorset, UK). 
An ultrafiltration membrane with 10-kDa molecular weight cut-off (MWCO) was 
procured from Vivaspin (Epsom, UK). Acetonitrile and trifluoroacetic acid (TFA), 
both of high-performance liquid chromatography (HPLC) grade, were supplied by 
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Fisher Scientific Holding UK Ltd. (Loughborough, UK). The remaining chemicals 
and reagents employed in experiments were of analytical grade. 
 
4.2.2   Methods 
4.2.2.1   Preparation of bovine serum albumin hydrolysates 
Enzymatic hydrolysis of BSA with the enzyme pepsin was performed as detailed in 
Section 2.2.2.1. 
4.2.2.2   Isolation and purification of ACE inhibitory peptides 
4.2.2.2.1   Ultrafiltration 
Ultrafiltration of the BSA hydrolysate was performed as detailed in Section 2.2.2.2.1. 
4.2.2.2.2   Gel-filtration (GF) chromatography 
GF chromatography of the BSA hydrolysate was performed as detailed in Section 
2.2.2.2.2.  
   
4.2.2.3   In vitro assay for ACE inhibitory activity 
The assay for ACE inhibitory activity was performed as detailed in Wu et al. (2002), 
and the modification detailed in Gupta et al. (2013) was incorporated. The assay 
involves the hydrolysis of Hip–His–Leu by the enzyme ACE, resulting in the release 
of hippuric acid (HA) and His–Leu. Prior to the assay, the BSA-derived peptide 
samples (10 mg) as well as captopril (1 µM) were dissolved in 100 mM borate buffer 
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(1 ml) of pH 8.3 containing 300 mM NaCl. Solutions of ACE and Hip–His–Leu were 
also prepared in the same buffer. 
 
The assay was initiated by transferring each peptide fraction sample (10 µl) to a test 
tube and adding 2.17 mM Hip–His–Leu (50 µl), followed by incubation in a water 
bath at 37°C for 10 min. This was followed by the addition of 10 μl ACE (2 mU) and 
incubation for 30 min at 37°C with continuous agitation. The reaction was 
subsequently terminated by the addition of 1 M HCl (85 µl). The analysis was 
performed in triplicate, with positive (Captopril) and negative (containing borate 
buffer instead of peptide) controls. 
HA generated by the catalytic activity of ACE was measured using RP-HPLC. 
Aliquots (10 µl) of each reaction mixture were injected into a nonpolar C18 column 
(3.0 mm  150 mm, 5 µm) and separated using two solutions, solution A [0.05% (v/v) 
TFA in ultrapure water] and solution B [acetonitrile in 0.05% (v/v) TFA], at a flow 
rate of 1 ml/min. The peaks corresponding to the separated HA and Hip–His–Leu 
were spectrophotometrically detected at a wavelength of 228 nm. The degree of ACE 
inhibition was calculated using the following equation: 
% ACE inhibitory activity = [(Acontrol − Asample)/Acontrol] × 100, 
where Acontrol and Asample correspond to the absorbance of negative control and sample, 
respectively. 
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4.2.2.4   Determination of inhibitory concentration of crude BSA and 
purified BSA-derived peptides 
The inhibitory concentration (IC50) is defined as the concentration of crude BSA or 
purified BSA-derived peptides capable of decreasing ACE activity by 50% under the 
assay conditions. Dose dependence of ACE inhibition was determined using five 
concentrations (0.2, 0.4, 0.6, 0.8 and 1 mg/ml) of the peptide fraction. IC50 was 
determined by plotting percentage inhibition of ACE activity against the various 
peptide concentrations. The experimental conditions were similar to those of the ACE 
inhibitory assay detailed in Section 4.2.2.3. 
 
4.2.2.5 Analysis of amino acid composition of ACE inhibitory peptide 
The amino acid composition of ACE inhibitory peptide was analysed as described in 
Section 2.2.2.4. 
 
4.2.2.6   Inhibitory kinetics of the BSA-derived peptide fractions 
The kinetics of inhibition of ACE activity by the BSA-derived ACE inhibitory peptide 
was determined as detailed in Rao et al. (2012); the experimental conditions were 
similar to those of the ACE inhibitory assay detailed in Section 4.2.2.3. Two different 
concentrations (4 and 10 mg/ml) of the inhibitory peptide were separately added to 
each assay mixture containing 2 mU ACE, and ACE inhibitory activity determined at 
various concentrations of the substrate Hip–His–Leu (0.5, 1.0, 1.5 and 2.17 mM) at 
varying reaction times (0–40 min). Lineweaver–Burk plots were employed for 
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identifying the type of ACE inhibition (competitive or non-competitive inhibition) in 
the presence of the inhibitory peptide. 
 
4.2.3   Statistical analysis 
All assays were performed in triplicate (n = 3). Data have been expressed as mean ± 
standard deviation and analysed using Statistical Package for the Social Sciences 
(SPSS) statistical package. One-way analysis of variance in conjunction with 
Dunnett’s multiple comparison test was employed for determining the significance of 
differences between the mean values of control and test treatments. Differences were 
considered to be statistically significant at P < 0.05 (95% confidence interval). 
 
4.3   Results and discussion 
4.3.1   Enzymatic hydrolysis of BSA and ultrafiltration for enriching 
ACE inhibitory activity 
Enzymatic hydrolysis of a native protein molecule is the most prevalent way of 
generating bioactive peptides. Numerous studies have verified the release of 
antihypertensive and/or ACE inhibitory peptides from food proteins by hydrolysis 
with various digestive enzymes (Pihlanto-Leppälä et al., 2000; Vermeirssen et al., 
2004a; Roufik et al., 2006; Lourenço da Costa et al., 2007). In the present study, the 
gastric degradation of BSA resulting in the release of ACE inhibitory peptides was 
investigated by hydrolysing BSA using commercially obtained pepsin, a digestive 
enzyme normally produced in the gastrointestinal system of humans. The selection of 
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a specific enzyme is based on its substrate specificity; pepsin is an endopeptidase that 
occurs in human gastric juice and catalyses the hydrolysis of proteins to peptides by 
preferentially cleaving peptide bonds at the N- and C-terminal of phenylalanine, 
tyrosine and leucine (Jung et al., 2006). 
The ACE inhibitory activity of BSA hydrolysate generated by proteolytic digestion 
with pepsin was found to be 30.2% with a low IC50 of 0.75 mg/ml, as shown in Figure 
4.1. These results are consistent with those reported by Makinen et al. (2011), where 
the ACE inhibitory activity of rapeseed hydrolysates generated using pepsin was 
estimated to be 76.1% with an IC50 of 0.06 mg/ml; similarly, the IC50 in the case of 
whey hydrolysate was found to be 0.048 mg/ml (Vermeirssen et al., 2004b). These 
results indicate that the in vitro hydrolytic activity of pepsin effectively generates 
bioactive peptides with high ACE inhibitory activity (Lee et al., 2010). 
The results of the present study support the efficacy of pepsin in generating bioactive 
peptides during the degradation of food proteins (Iroyukifujita et al., 2000; Miguel et 
al., 2004a; Zambrowicz et al., 2013). Contreras et al. (2009) showed that casein 
hydrolysate generated using pepsin exhibited ACE inhibitory activity. Similarly, 
Miguel et al. (2009) reported that the hydrolysate of bovine casein protein generated 
using pepsin exhibited potent ACE inhibitory activity with an IC50 of 0.053 mg/ml. 
These reports suggest that further purification of the crude BSA hydrolysate could 
generate ACE inhibitory peptides with potent activity, given that BSA hydrolysates 
contain a mixture of several peptides and other components. 
The first step toward the purification of the active peptide was the fractionation of the 
BSA hydrolysate by ultrafiltration using membrane of 10-kDa MWCO. In fact, 
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ultrafiltration has been employed in various studies as the first step in the purification 
of ACE inhibitory peptides (Raghavan and Kristinsson, 2009; Mahmoodani et al., 
2012; Li et al., 2012b). A percentage yield of 17.5% and 37.2% was obtained for the 
crude BSA hydrolysate and peptide fraction of molecular weight < 10 kDa, 
respectively. The higher yield of peptide in the < 10 kDa fraction than in crude BSA 
hydrolysates correlated with higher ACE inhibitory activity (Figure. 4.1). 
 
Figure 4.1  Angiotensin-I-converting enzyme inhibitory activity (%) of bovine serum 
albumin hydrolysates and its peptide fraction of molecular weight < 10 kDa at a concentration 
of 10 mg/ml. The activity was measured by high-performance liquid chromatography. 
Captopril (1µM) was employed as the positive control. All measurements were performed in 
triplicate (n = 3); results are presented as mean ± SD. 
 
As shown in Figure 4.1, the BSA peptide fraction of molecular weight < 10 kDa 
presented significant ACE inhibitory activity (44.7%) at a concentration of 10 mg/ml 
with a corresponding IC50 of 0.56 mg/ml. Compared with the crude BSA hydrolysate, 
the peptide fraction of molecular weight < 10 kDa exhibited high ACE inhibitory 
activity and lower IC50, as also observed previously in several studies (Hai‐Lun et 
al., 2006; Vercruysse et al., 2010; Lau, 2013). However, the positive control 
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captopril, a strong ACE inhibitor, exhibited the highest ACE inhibitory activity 
(88.5%) and a lower IC50 of 0.022 µM among the test samples (P ≤ 0.001), as also 
observed previously (Fujita and Yoshikawa, 1999). Similarly, Li et al. (2012) 
reported that the IC50 of the ACE inhibitory peptide fraction obtained from loach fish 
meat was lower than that of the un-purified hydrolysates (0.231 and 0.631 mg/ml, 
respectively). In addition, the use of ultrafiltration has been reported to enhance the 
ACE inhibitory activity of peptides (Urista et al., 2011). 
 
The ACE inhibitory activities of peptide fractions (molecular weight < 10 kDa) 
obtained from various food proteins have been examined. Raghavan and Kristinsson 
(2009) observed that the peptide fraction (<10 kDa) obtained from tilapia protein 
hydrolysates exhibited 20% ACE inhibitory activity; the ACE inhibitory activity of 
the peptide fraction (molecular weight < 10 kDa) derived from the peptic hydrolysate 
of the water-soluble protein from Phascolosoma esculenta was found to be 65% (Du 
et al., 2013). Similarly, a study conducted on whey protein hydrolysates by Pan et al. 
(2012) reported that the peptide fraction of molecular weight < 10 kDa exhibited 
51.5% ACE inhibitory activity. In the present study, the peptide fraction (<10 kDa) 
was further purified for the enrichment of ACE inhibitory activity. 
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4.3.2   Gel filtration chromatography 
The BSA-derived peptide fraction (< 10 kDa) exhibiting the highest ACE inhibitory 
activity was further purified by GF chromatography. The ultrafiltration peptide 
fraction (< 10 kDa) was dissolved in phosphate buffer (pH 7.0) and loaded onto 
Sephadex G-25 GF column (2.0 cm  90 cm) (Refer chapter 2; Fig. 2.7). Fourteen 
peptide fractions separated on the basis of their molecular size (fraction nos. 13–26) 
exhibited higher absorbance at a wavelength of 250 nm, as shown in Figure 2.8 
(chapter 2). Aliquots (5 ml) of each fraction from 10 runs of GF chromatography were 
pooled, freeze dried and evaluated for ACE inhibitory activity using HPLC. All the 
GF peptide fractions exhibited ACE inhibitory activity (Figure 4.2), with the highest 
activity (79.5%) and lowest IC50 (0.32 mg/ml) exhibited by GF fraction no. 22 (GF22; 
Figure 4.2). The percentage inhibition of ACE activity exhibited by GF22 was slightly 
lower than that exhibited by the synthetic ACE inhibitor captopril at 1µM 
concentration (79.5% and 88.5%, respectively; P ≤ 0.05), as shown in Figure 4.3. 
Table 4.1 summarises the ACE inhibitory activity and half-maximal IC50 of the BSA 
hydrolysate, the peptide fractions obtained upon ultrafiltration (< 10 kDa) and GF 
chromatography (GF22) and captopril. 
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Figure 4.2  Angiotensin-I-converting enzyme (ACE) inhibitory activity of the gel-filtration 
fractions (10 mg/ml) obtained from the BSA-derived peptide (< 10 kDa). Gel-filtration 
fraction 22 exhibited the highest ACE inhibitory activity, as measured by high-performance 
liquid chromatography. Captopril (1µM) was employed as the positive control. All 
measurements were performed in triplicate (n = 3); results are presented as mean ± SD. 
 
    
 
Figure 4.3  Comparison of angiotensin-I-converting enzyme (ACE) inhibitory activity of 
gel-filtration fraction 22 (10 mg/ml) and the synthetic ACE inhibitor captopril (1µM). All 
measurements were performed in triplicate (n = 3); results are presented as mean ± SD. 
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Fourteen fractions obtained upon GF chromatography of the ultrafiltration peptide 
fraction (molecular weight < 10 kDa) exhibiting ACE inhibitory activity contained 
peptides smaller than <10 kDa and exhibited stronger ACE inhibitory activity than the 
ultrafiltration peptide fraction (<10 kDa). Several studies have shown that this 
purification step generates peptides with lower IC50 than the native hydrolysates or 
fractionated peptides obtained upon ultrafiltration (Mullally et al., 1997; Fujita et al., 
2001; Miguel et al., 2004b; Quirós et al., 2007). For example, Sun et al. (2011) 
showed the enrichment of peptides exhibiting ACE inhibitory activity upon GF 
chromatography of freshwater clam hydrolysates using Sephadex G-25 column, 
corresponding to the decrease in the IC50 from 0.65 to 0.059 mg/ml. In the present 
study, the GF22 fraction was selected for further analysis. 
 
Table 4.1 Angiotensin-I-converting enzyme inhibitory activity and half-maximal 
inhibitory concentration of the BSA hydrolysate, peptide fractions obtained upon 
ultrafiltration (<10 kDa) and gel-filtration chromatography (10 mg/ml) and captopril (1µM). 
Sample ACE Inhibition (%) IC50 (mg/ml) 
Hydrolysate 30.2 0.75 
Ultrafiltration (Mw <10 kDa) 44.7 0.56 
Gel filtration (GF22) 79.5 0.32 
Captopril  88.5 0.022 
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4.3.3  Amino acid composition of the purified ACE inhibitory peptide 
The amino acid composition of the ACE inhibitory peptide is a key factor governing 
its inhibitory activity. In the present study, the amino acid composition of the peptide 
fraction GF22, which was obtained following GF chromatography and exhibited the 
highest antioxidant activity, was determined. 
 
The amino acid profile of the BSA-derived peptide fraction GF22 is summarised in 
Table 4.2. Variations are noticeable in the amino acid composition, which includes a 
high proportion of tryptophan, lysine, leucine and alanine (18.4%, 17.4%, 13.7% and 
11.1%, respectively). The presence of hydrophobic amino acids (aromatic or branched 
chain such as phenylalanine, tryptophan or tyrosine) within the GF22 peptide fraction 
is likely to significantly contribute to the ACE inhibitory activity of the peptide. 
 
We et al. (2008) proposed the existence of hydrophobic amino acids or proline 
residues in the majority of naturally occurring ACE inhibitory peptide fractions; 
however, the GF peptide fraction GF22 obtained in the present study had a lower 
proline content. This concurs with the results reported in Wu et al. (2008), where the 
ACE inhibitory peptides derived upon GF chromatography of canola meal protein 
hydrolysates contained a high proportion of hydrophobic amino acids but a lower 
proline content. The amino acid composition obtained in the present study also agrees 
with those of ACE inhibitory peptides derived from Haruan (Channa striatus) 
myofibrillar protein hydrolysate (Ghassem et al., 2011). 
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As shown in Table 4.2, the BSA-derived peptide fraction GF22 contained quantities 
of valine, arginine, threonine, glycine, proline,  phenylalanine, serine, glutamic acid 
and tyrosine residues (7.6%, 6.5%, 6.5%, 5.8%, 4.3%, 4.1%, 2.6%, 2.5% and 2.3%, 
respectively) and limiting quantities of  isoleucine, methionine, cysteine, aspartate and 
histidine residues. 
 
The three-dimensional structure of ACE reveals that its somatic isoform is composed 
of two active sites termed the N- and C-domains. ACE inhibitors could act on both 
active sites; however, the C-domain active site appears to play a more important role 
in regulating blood pressure (Wei et al., 1992; Johnston, 1994). In addition, bioactive 
peptides with hydrophobic and aromatic amino acids in the C-domain contribute to 
binding with angiotensin II receptors, thereby blocking the activity of ACE (Ryan et 
al., 2011). The binding of related substrates to ACE is known to be influenced by the 
C-terminal of the substrate, suggesting that ACE inhibitory peptides with hydrophobic 
and aromatic amino acids at these positions could effectively inhibit ACE (Murray 
and FitzGerald, 2007; Liu et al., 2012). This in turn suggests that the range of 
hydrophobic amino acids observed in the potent GF peptide fractions of BSA 
hydrolysate in the present study could facilitate access to the C-domain active site of 
ACE and possibly function in lowering the blood pressure. 
 
The purified peptide obtained in the present study was also found to contain glycine, 
alanine, valine and proline residues, which could increase the hydrophobicity of the 
peptide and thereby enhance ACE inhibitory activity. The presence of the 
aforementioned amino acids in bioactive peptides derived from food protein 
hydrolysates has been previously shown to increase the ACE inhibitory activities of 
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specific peptides (Miguel and Aleixandre, 2006; Zambrowicz et al., 2013) such as the 
peptides derived from milk (VPP) (Hata et al., 1996b), buckwheat (GPP) ((Ma et al., 
2006) and soybean protein (ALP)((Lo and Li-Chan, 2005). 
 
Table 4.2 Amino acid composition of the BSA-derived gel-filtration peptide fraction GF22. 
Percentages are presented as mean ± SD of triplicate measurements. 
 
  Amino acids Amount (%) 
Aspartic acid  0.23±0.04 
Threonine 6.5±0.09 
Serine 2.6±0.13 
Glutamic acid  2.3±0.8 
Proline 4.3±0.03 
Glycine 5.8±0.2 
Alanine 11.1±0.04 
Cysteine 0.54±0.09 
Valine 7.6±0.05 
Methionine 0.71±0.23 
Isoleucine 0.77±0.21 
Leucine 13.04±0.05 
Tyrosine 2.5±0.02 
Phenylalanine 4.1±0.05 
Histidine 0.1±0.08 
Lysine 17.4±0.22 
Arginine 6.5±0.18 
Tryptophan 18.4±0.06 
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4.3.4   Inhibitory kinetics of the peptide fraction GF22 
The ACE inhibitory activity of the BSA-derived GF peptide fraction GF22 was 
examined using the Lineweaver–Burk plot to elucidate the mechanism underlying the 
binding of the inhibitor peptide and the inhibition of enzymatic activity. The 
inhibition of enzymatic activity by the peptide could be of two types: competitive or 
non-competitive inhibition. The competitive inhibitors reversibly bind to the active 
site and compete with the substrate for active site binding (Jao et al., 2012). In 
contrast, non-competitive inhibitors reversibly bind at a site distinct from the active 
site and thereby change the structure of the enzyme, leading to a decrease in its 
catalytic activity. 
 
In the present study, the kinetics of ACE inhibition was examined at two different 
concentrations (4 and 10 mg/ml) of the peptide, as shown in Figure 4.4. The rate of 
ACE activity was found to be significantly higher in the control (uninhibited ACE in 
the absence of peptide) as opposed to the test samples (in the presence of peptide), 
suggesting that the ACE-inhibitory peptide derived from BSA decreases the rate of 
ACE activity, which catalyses the release of HA from the Hip–His–Leu substrate. 
 
The Michaelis–Menten constant (Km) and maximum velocity (Vmax) were analysed 
using the Lineweaver–Burk plot, and slopes were determined (Fig. 4.4). The linear 
plots corresponding to the control (Hip–His–Leu substrate only in the absence of 
peptide) and two concentrations of the peptide (4 and 10 mg/ml) intersect the Y-axis at 
a common point, indicating that the increase in the concentration of the ACE inhibitor 
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increased the Km at constant reaction velocity. The Km values in the negative control 
(Hip–His–Leu substrate in the absence of peptide) and two peptide concentrations (4 
and 10 mg/ml) were 0.61, 0.66 and 0.69 mM, respectively, while the corresponding 
Vmax values were 0.46, 1.7 and 2.5 mM/min, respectively. 
 
These results confirm that the BSA-derived GF peptide fraction GF22 is a competitive 
inhibitor of ACE, which gains access to and competes with the Hip–His–Leu 
substrate for binding to the active site of ACE. Several bioactive peptides derived 
from hydrolysates of various food proteins were reported to be competitive inhibitors 
of ACE, including the peptides obtained from soy protein (Wu and Ding, 2002), rice 
protein hydrolysate (Chen et al., 2013) and hen egg white protein (Rao et al., 2012). 
In contrast, certain ACE inhibitors derived from food proteins were non-competitive 
inhibitors, including the peptides from tuna frame protein hydrolysate (Lee et al., 
2010), lysozyme hydrolysates (Asoodeh et al., 2012) and cuttlefish (Balti et al., 
2010). Variations in the amino acid composition of isolated peptides are known to 
play a major role in their inhibitory kinetics. 
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Figure 4.4  Lineweaver–Burk plot depicting angiotensin-I-converting enzyme activity 
inhibition at various substrate concentrations by the bovine serum albumin-derived inhibitory 
peptides (4 and 10 mg/ml). 
 
4.4  Conclusion 
Several therapeutic approaches have been employed for the treatment of hypertension, 
including the use of medicines containing synthetic ACE inhibitors, which are known 
to cause undesirable side effects. Naturally-occurring peptides capable of inhibiting 
ACE activity have been isolated from hydrolysates of several food proteins (Ariyoshi, 
1993). In the case of BSA, these peptides are inactive in the native protein but are 
released upon enzymatic hydrolysis. In the present study, BSA hydrolysis was 
performed for 6 h using the protease pepsin, which allows investigation of the gastric 
degradation of the BSA-derived ACE inhibitory peptide. BSA hydrolysates were 
found to exhibit ACE inhibitory activity of 30.2% and a low IC50 of 0.75 mg/ml. 
Following separation and enrichment by ultrafiltration, the peptide fraction of 
molecular weight < 10 kDa exhibited significantly increased ACE inhibitory activity 
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(44.7%) at a concentration of 10 mg/ml and a corresponding IC50 of 0.56 mg/ml. 
Further purification of the ultrafiltration peptide fraction (< 10 kDa) using GF 
chromatography yielded 14 fractions possessing ACE inhibitory activity; of these, 
GF22 was exhibited the highest ACE inhibitory activity (79.5%) and a low IC50 (0.32 
mg/ml). The amino acid profile of GF22 showed a variety of amino acids including a 
high proportion of tryptophan, lysine, leucine and tryptophan residues, and limited 
amounts of histidine, isoleucine, methionine and cysteine residues. The ACE 
inhibitory activity of the peptide derived from BSA hydrolysate is likely attributable 
to the presence of hydrophobic amino acids. In addition, the ACE inhibitory peptide 
in GF22 is a competitive inhibitor of ACE and therefore competes with the substrate 
Hip–His–Leu for active site binding. In conclusion, the present study shows that BSA 
is a potential source of ACE inhibitory peptides and may be employed as a component 
of functional foods and neutraceuticals. 
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5 Antioxidant activity of the bovine serum 
albumin-derived peptide against tert-butyl 
hydroperoxide-induced oxidative stress in the human 
intestinal Caco-2 cell line 
 
5.1   Introduction 
The partial reduction of oxygen to various reactive oxygen species (ROS) such as 
superoxide ion biradical (O2−·), hydroxyl radical (OH.) and oxidants such as hydrogen 
peroxide (H2O2) accompanies various metabolic processes (Jaiswal, 2004; Perjés et 
al., 2012). These highly reactive species presumably play a role in various cellular 
processes such as cell proliferation, cell cycle, cell death and signal transduction 
(Owuor and Kong, 2002). However, upon excessive ROS accumulation in cells such 
that their endogenous antioxidant capacity is overwhelmed, the redox homeostasis of 
cells is altered and a state of oxidative stress ensues (Cimen, 2008). Compromised 
cellular antioxidant system or extreme production of ROS results in oxidative damage 
to several cellular components, particularly membrane proteins, lipids (Alghazeer et 
al., 2008), enzymes and DNA (Lee et al., 2007); this culminates in cell death and 
enhances the progression of numerous serious diseases such as chronic inflammation, 
cardiovascular complications, cancer and Alzheimer’s disease (Valko et al., 2004; 
Yongvanit et al., 2012; Carocho and Ferreira, 2013). 
 
Various mechanisms are employed by humans to protect against exogenous or 
endogenous sources of ROS, including the endogenous antioxidant system comprising 
catalase (Martins and English, 2014), glutathione reductase, glutathione peroxidase 
 134 
 
and superoxide dismutase, which play a crucial role in reducing and scavenging ROS 
in cells and in countering cellular oxidative stress (Nordberg and Arnér, 2001; Berger, 
2005; de Moraes Mourão et al., 2009). 
However, the endogenous antioxidant system could prove insufficient to effectively 
deal with ROS production induced by several exogenous factors such as heavy 
metals, UV irradiation, pollution and ionising radiation to maintain low ROS 
concentration (Gill and Tuteja, 2010). Under such circumstances, exogenous non-
enzymatic antioxidants such as vitamin C (ascorbic acid), vitamin E (α-tocopherols) 
and glutathione (GSH) play an important role in maintaining redox homeostasis 
(Pietta, 2000; Rahman, 2007). 
 
Surprisingly, several natural antioxidants found in food products have displayed 
potential preventive/therapeutic properties against oxidative stress in cultured cells 
(Carocho and Ferreira, 2013). Of these, protein hydrolysates and bioactive peptides 
derived from food proteins have increasingly attracted attention because of 
considerable in vitro evidence of their antioxidant properties (Power et al., 2013). 
Protein hydrolysates have also been reported to contain a wide range of amino acid 
residues and short chain peptides with antioxidant properties upon introduction into 
live cells (Li et al., 2010; Ngo and Kim, 2013). Various cell lines cultured in vitro 
have exhibited greater viability and longevity in media containing protein 
hydrolysates, which is attributable to the potent antioxidant activity of the peptides 
(Hartshorn et al., 2010). Furthermore, protein hydrolysates of dairy products are 
regularly employed in microbiological growth media and as complements in cell or 
tissue culture media to enhance culture performance (Hartshorn et al., 2010); this is 
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attributable to the existence of free amino acids and oligopeptides containing side 
chains with antioxidant and ROS-scavenging activities. 
 
Significant importance is being paid in recent times to research on oxidative stress 
and antioxidants. In addition to standard chemical assays for antioxidant activity, a 
review of the biological effects of antioxidants in food products is also essential and 
could be accomplished by employing a valid in vitro cell model that mimics the in 
vivo target site of oxidative stress and utilises easy techniques to determine the 
bioactivity of various antioxidants (Samaranayaka et al., 2010). Human 
adenocarcinoma-derived Caco-2 cells could be potentially employed as a valid cell 
culture model for rapid screening of several bioactive peptides (Hidalgo et al., 1989). 
 
Several methods are available for the in vitro estimation of intestinal absorption in 
humans, although the Caco-2 cell line is the most commonly employed. This cell line 
was derived from colon adenocarcinoma and forms a monolayer of epithelial cells 
under in vitro culture conditions that exhibit numerous morphological and functional 
features of intestinal absorptive cells (Hidalgo et al., 1989). Several studies have 
reported the existence of transporters typical of the small intestine in cultures of Caco-
2 cells (Maubon et al., 2007); this cell line is therefore considered an ideal in vitro 
model for estimating and elucidating the mechanism of intestinal absorption and 
metabolism (Hilgers et al., 1990). 
 
 136 
 
The present study aimed to assess the protective effects of the bovine serum albumin 
(BSA)-derived gel-filtration (GF) peptide fraction GF18 (see Chapter 2) against tert-
butyl hydroperoxide (t-BHP)-induced oxidative damage in cultures of the Caco-2 
epithelial cell line. The morphological alterations in cultured cells treated with the 
peptide fraction in the presence and absence of t-BHP were observed by phase-
contrast microscopy, and measurement of intracellular ROS was accomplished using 
flow cytometry. The activities of caspase 3/7 were assessed using a luminometer, and 
malondialdehyde (MDA) levels were evaluated using the thiobarbituric acid reactive 
substance (TBARS) method. The GSH content in the presence and absence of t-BHP 
was also evaluated. Measurement of the endogenous antioxidant enzyme activities of 
BSA peptide in Caco-2 cells under oxidative stress was assessed.   
 
5.2   Materials and methods 
5.2.1   Materials 
BSA, pepsin (from gastric mucosa, ≥2,500 units/mg protein), 3-[4,5-dimethylthiazol-
2-yl]-2,5 diphenyl tetrazolium bromide (MTT) dye, 6-hydroxy-2, 5,7,8-
tetramethylchromane-2-carboxylic acid (Trolox), ascorbic acid, dimethyl sulfoxide 
(DMSO), penicillin/streptomycin antibiotic solution (50 U/ml), trypan blue, cell lysis 
buffer, thiobarbituric acid (TBA), trichloroacetic acid (TCA), 1,1,3,3-
tetraethoxypropane (TEP), tert-butyl hydroperoxide (t-BHP) was procured from 
Sigma–Aldrich Co. Ltd. (Poole, Dorset, UK). The human colorectal carcinoma (Caco-
2) cell line was kindly supplied by the nutrition group (Faculty of Health and Medical 
Sciences, University of Surrey, UK). Dulbecco’s Modified Eagle’s Medium 
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(DMEM), nonessential amino acids (NEAAs), purified trypsin-
ethylenediaminetetraacetic acid solution, 5-(and-6)-chloromethyl-2 ′ , 7 ′ -         
dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA) and heat-
inactivated foetal bovine serum (FBS) were obtained from Invitrogen (Paisley, UK). 
Phosphate-buffered saline (PBS) was purchased from Fisher Scientific Holding UK 
Ltd. (Loughborough, UK). Caspase-Glo® 3/7 Reagent (DEVD-aminoluciferin 
substrate) and ultrafiltration membrane with 10-kDa molecular weight cut-off were 
purchased from Promega (Southampton, UK) and Vivaspin (Epsom, UK), 
respectively. The OxiSelect™ superoxide dismutase activity assay kit (colorimetric), 
OxiSelect™ catalase activity assay kit (colorimetric) and OxiSelect™ Total 
Glutathione (GSSG/GSH) Assay Kit were purchased commercially from Cell Biolabs, 
Inc (Cambridge Bioscience Ltd., Cambridge, UK). Cell lysis buffer was obtained 
from Abcam (Cambridge, UK).  Other chemicals and reagents employed in 
experiments were of analytical grade. 
 
5.2.2   Methods 
5.2.2.1   Preparation of bovine serum albumin hydrolysates 
Enzymatic hydrolysis of BSA was performed as detailed in Section 2.2.2.2.1. 
5.2.2.2   Isolation and purification of BSA-derived peptides 
5.2.2.2.1   Ultrafiltration 
Ultrafiltration of BSA hydrolysates was performed as detailed in Section 2.2.2.2.1. 
 138 
 
5.2.2.2.2   Gel filtration chromatography 
Gel filtration chromatography of the BSA-derived peptide fraction (< 10 kDa) was 
performed as detailed in Section 2.2.2.2.2. 
  
5.2.2.3   Antioxidant activity of the BSA-derived peptide in Caco-2 
cells 
5.2.2.3.1   Cell culture conditions 
Caco-2 cells preserved in liquid nitrogen were thawed at 37C in a water bath and 
centrifuged at 500 g for 3 min, followed by re-suspension in cell culture media and 
plating; cells were used between passages 21 and 22. The cells were transferred to a 
75-cm2 flask and cultured in DMEM supplemented with 10% heat-inactivated FBS, 
5% NEAAs, 5% L-glutamine and 5% penicillin/streptomycin antibiotic solution. The 
cells were cultured in an incubator at 37C under atmospheric conditions of 95% air 
and 5% CO2. Culture media were replaced with fresh media every 2 days. Once the 
cells reached 80% confluence, media were aspirated and cells were washed with PBS 
(3 ml) and detached by the addition of trypsin (2 ml) and incubation at 37C for 10 
min. Fresh DMEM (5 ml) was added to inhibit trypsin, followed by centrifugation at 
1500 ×g for 3 min for the removal of trypsin. Trypsin-free Caco-2 cells were re-
suspended in fresh DMEM (10 ml) and subsequently employed for passaging, 
counting and freezing. 
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5.2.2.3.2   Cell viability 
Cell viability was assessed by the MTT colorimetric assay, as described in Roehm et 
al. (1991), by incorporating slight modifications to the method detailed in 
(Wiriyaphan et al., 2015). The in vitro MTT assay is based on the reduction of the 
tetrazolium ring of MTT (yellow colour) by the enzyme mitochondrial dehydrogenase 
in living cells to yield a purple insoluble product formazan; this product is solubilised 
with DMSO and spectrophotometrically measured at a wavelength of 492 nm using a 
multiwell scanning spectrophotometer [enzyme-linked immunosorbent assay (ELISA) 
plate reader]. In this assay, higher absorbance reflects greater viability of cells. The 
percentage of viable cells with respect to the control was measured using the 
following equation: 
Viability of cells (%) = (mean absorbance of treated cells/mean absorbance of control 
cells) × 100 
The assay was initiated by seeding Caco-2 cells at 80% confluence onto a 96-well 
culture plate at a density of 2 × 104 cells (200 µl per well) and allowing the cells to 
adhere overnight. Following incubation for 24 h at 37C, the cells were washed with 
PBS and MTT solution (10 mg/ml in PBS; 20 µl) was added, followed by 
reincubation at 37C for 2 h. The culture media in each well was aspirated, and 
DMSO (200 µl) was added. The plate was incubated under constant agitation for 5 
min at room temperature, and the intensity of purple colour was measured at 492 nm. 
Untreated cells (DMEM) were employed as negative control in each experiment, 
while 0.01% trolox and 0.01% ascorbic acid (in DMEM) were employed as positive 
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controls. Triplicate samples were employed for each experimental condition, and the 
experiment was independently repeated three times to ensure reproducibility. 
 
5.2.2.3.3   Viability of Caco-2 cells treated with BSA-derived peptide 
Caco-2 cells were seeded at a density of 2 × 104 cells (200 µl per well) in a 96-well 
culture plate, as described in Section 5.2.2.3.1. Following 24 h of incubation at 37C, 
the culture medium was aspirated and replaced with fresh DMEM (200 µl) 
supplemented with various concentrations of the BSA-derived peptide fraction GF18 
(using a stock solution of 1 mg/ml) and incubated for 24 h. The MTT assay for 
viability was subsequently performed, as detailed in Section 5.2.2.3.2 (Wiriyaphan et 
al., 2015). 
 
5.2.2.3.4   Viability of Caco-2 cells treated with tert-butyl hydroperoxide  
An extensively employed synthetic oxidising agent, t-BHP, was utilised for inducing 
oxidative stress in cell/tissue culture (Sardão et al., 2007; Tiwari and Kakkar, 2009). 
Prior to the actual experiment, a pilot experiment was performed to determine the 
effective concentration of t-BHP capable of causing lethality in at least 50% of the 
live cells. For the assay, Caco-2 cells were seeded at a density of 2 × 104 cells (200 µl 
per well) in a 96-well culture plate and incubated at 37C for 24 h. The cells were 
then treated with DMEM (200 µl) containing various concentrations of t-BHP [0.1, 
0.3, 0.5, 1, 3, 5 and 10 mM; a stock solution of 70% (w/v)], t-BHP was employed to 
induce oxidative stress, followed by an additional incubation for 2.5 h. The viability 
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of the t-BHP-treated cells was subsequently determined by the MTT assay, as 
described in Section 5.2.2.3.2 (Wiriyaphan et al., 2012). 
 
5.2.2.3.5  Protective effects of the BSA-derived peptide fraction GF18 against 
tert-butyl hydroperoxide-induced oxidative stress 
Caco-2 cells were seeded at a density of 2 × 104 cells (200 µl per well) onto a 96-well 
culture plate and incubated at 37C for 24 h. The culture medium was aspirated and 
replaced with fresh DMEM (200 µl) containing the BSA-derived peptide fraction 
(0.008 mg/ml) and incubated for 24 h at 37C. The culture medium was aspirated, and 
oxidative stress was induced by treatment with 3 mM t-BHP (200 µl per well) for 2.5 
h. Subsequently, the viability of cells was determined by the MTT assay, as detailed 
in Section 5.2.2.3.2 (Wiriyaphan et al., 2015). 
 
5.2.2.4   Morphological alterations in Caco-2 cells 
Caco-2 cells at 80% confluence were seeded in 25-cm2 cell culture flasks at a density 
of 1 × 106 per flask and allowed to adhere overnight. Following 24-h incubation at 
37C, the culture medium was aspirated and cells were washed with PBS (2 ml). 
Fresh DMEM containing the BSA-derived peptide fraction GF18 (0.008 mg/ml; stock 
solution of 1 mg/ml) was added and incubated for 24 h. The culture medium was 
subsequently aspirated and cells were rinsed with PBS (2 ml), followed by treatment 
with 3 mM t-BHP for 2.5 h. The cells were then examined using a phase-contrast 
microscope (Zeiss Telaval microscope) fitted with a camera (Nikon, Japan). 
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5.2.2.5   Measurement of lipid peroxidation in Caco-2 cells 
The formation of MDA, a secondary product of membrane lipid oxidation, was 
measured as described by Buege and Aust (1978), and modified by Prosperini et al. 
(2013). In brief, Caco-2 cells were seeded at a density of 1 × 106 cells in 25-cm2 cell 
culture flasks and incubated at 37 C until 80% confluence was achieved. The cells 
were then incubated with the BSA-derived peptide fraction GF18 at a selected dose of 
0.008 mg/ml for 24 h, following which the culture medium was aspirated. The cells 
were washed with PBS (3 ml) and subsequently treated with 3 mM t-BHP for 2 h at 
37C. The cells were then harvested by adding 20% TCA (3 ml), treated with 0.7% 
TBA (2 ml) and finally boiled in a water bath at a maximum temperature (100C) for 
1 h. The samples were then cooled at room temperature and centrifuged at 1500 g 
for 10 min. The formation of the MDA–TBA adduct, visualised as an intense pink 
colour, and was measured at a wavelength of 532 nm using a spectrophotometer (UV 
Mini 1240 Shimadzu Europa, Milton Keynes, UK). To evaluate the concentration of 
MDA in the test samples, a standard curve of 1,1,3,3-TEP was prepared from a stock 
solution of 200 µg/ml, as detailed in Section 2.2.2.3.3. The analysis was performed 
with positive (0.01% trolox) and negative (DMEM) controls. Three independent 
experiments were performed to ensure reproducibility. 
 
5.2.2.6   Caspase-Glo 3/7 assay 
Caspase-Glo 3/7 assay (Promega) was employed for evaluating the activity of caspase 
3/7 in Caco-2 cells per the manufacturer’s instructions. In brief, Caco-2 cells were 
seeded at a density of 2  104 cells (200 µl per well) in a white-bottomed 96-well 
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plate and incubated for 24 h at 37C. The cells were treated with the BSA-derived 
peptide (100 µl, 0.008 mg/ml) prepared in fresh DMEM from a stock solution of 1 
mg/ml and further incubated for 24 h. Subsequently, the cells were treated with 3 mM 
t-BHP (100 µl) for 2.5 h at 37C, followed by the addition of caspase 3/7 reagent (100 
µl) and incubation of the white-bottomed plate in the dark for 30 min at room 
temperature. The luminescence of the cell, which is proportional to the caspase 
activity, was determined using a GloMax®96-luminometer (Promega). A negative 
control (DMEM) was employed for the experiment. The experiment was 
independently repeated three times to ensure reproducibility. 
 
5.2.2.7   Determination of intracellular ROS  
The intracellular production of ROS in Caco-2 cells was assessed by flow cytometry 
using the non-fluorescent dye CM-H2DCFDA. This nonpolar dye penetrates cells and 
is enzymatically cleaved by intracellular esterases to yield the polar DCFH, which in 
turn is oxidised to the fluorescent dye DCF in the presence of ROS. Thus, the 
fluorescence intensity of DCF is effectively employed as a probe for the formation of 
oxidative species in the Caco-2 cell line (Cilla et al., 2008). The assay was initiated by 
seeding Caco-2 cells (1 × 106 cells) in 25-cm2 cell culture flasks and incubation at 
37C until 80% confluence was achieved. The cells were then treated with the BSA-
derived peptide at a selected dose of 0.008 mg/ml (prepared from a stock solution of 1 
mg/ml) for 24 h, followed by washing with PBS (2 ml). This was followed by 
treatment with 3 mM t-BHP for 2.5 h at 37C. The media from each flask was 
collected in 15-ml centrifuge tubes, and the adherent cells were washed with PBS (1 
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ml). The cells were subsequently detached by trypsinisation involving incubation with 
trypsin (2 ml) for 5 min at 37C, followed by the addition of the corresponding media 
(that were previously collected) and centrifugation for 3 min at 150 ×g. The media 
were then aspirated from each tube, and cells were suspended in PBS (1 ml), followed 
by the addition of CM-H2DCFDA (5 µl, prepared in DMSO). Finally, the cells were 
gently transferred to flow cytometry tubes and incubated for 30 min at 37C. 
Following the incubation, the cells were maintained in dark on ice until examination 
to reduce the photooxidation of CM-H2DCFDA in the presence of light. Fluorescence 
intensity was estimated by flow cytometry using excitation and emission wavelengths 
of 490 and 520 nm, respectively, using the BD FACSCanto flow cytometer (BD 
Biosciences, California, USA). Analysis was performed with positive (0.01% trolox) 
and negative (DMEM) controls. Three independent experiments were performed, and 
the results are presented as mean ± standard deviation (SD) (García-Nebot et al., 
2014). 
 
5.2.2.8  Measurement of the total glutathione content and endogenous 
antioxidant enzyme activity of bovine serum albumin peptide in 
Caco-2 cells under oxidative stress  
5.2.2.8.1   Preparation of Caco-2 cell lysates  
Caco-2 cells were plated in 25 cm2 cell culture flasks at a density of 1 × 106 cells/flask 
and incubated at 37C until they reached 80% confluence. The cells were then treated 
with 0.008 mg/ml bovine serum albumin peptide and incubated overnight. After 24 h, 
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the cells were rinsed with 2 ml of PBS. Subsequently, 3 mM of t-BHP was added to 
the treated flask, and the flask was incubated at 37C for additional 2.5 h. Next, media 
from each flask was aspirated and placed into a 15 ml centrifuge tube. The remaining 
attached cells were washed with 1 ml of PBS. To detach the adherent cells, 2 ml of 
trypsin was added, and the flasks were incubated for another 5 min at 37C. After this 
step, cells were returned to the media collected in the 15 ml centrifuge tubes and 
centrifuged for 3 min at 150 × g. The supernatant from each tube was removed and 
cells were lysed with 300 µl of lysis buffer. If lysed cells were to be used 
straightaway, they were kept on ice. Alternatively, if lysed cells were to be used in 
further studies, they were frozen at −80ºC for up to one month. A similar procedure 
was used to prepare the cell lysates treated with 0.01% ascorbic acid and 0.01% 
trolox.  
 
5.2.2.8.2   Measurement of total glutathione (GSSG/GSH) concentration  
The OxiSelect total glutathione assay kit (colorimetric method) was used to determine 
the activity of reduced and oxidized glutathione concentration in Caco-2 cells, 
according to manufacturer’s instructions. Briefly, 100 µl of the prepared cell lysate or 
glutathione standard was added to separate wells of a 96-well microtiter plate. Next, 
25 µl of 1X glutathione reductase and 25 µl of 1X NADPH solution were added to 
each well and thoroughly mixed. At this point, a microtiter plate reader was prepared 
for the kinetic assay and set to a wavelength of 405 nm. Finally, 50 µl of 1X 
chromogen was added to the test wells and mixed. The absorbance was immediately 
recorded at 2-min intervals for a total of 10 min. Glutathione concentration in the test 
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sample was calculated using a glutathione standard curve, which was provided with 
the kit. The glutathione activity assay was carried out in triplicates (n = 3). 
 
5.2.2.8.3   Measurement of catalase (CAT) activity 
The OxiSelect CAT activity assay kit (colorimetric method) was used to determine 
the activity of CAT in Caco-2 cells, according to the manufacturer’s instructions. 
Briefly, 20 µl of the prepared cell lysate or the diluted CAT standard were added to 
separate wells of a 96-well microtiter plate. Subsequently, 50 μl of 12 mM H2O2 
working solution was added to each well and the solution was mixed thoroughly and 
incubated for approximately 1 min. Next, 50 μl of CAT quencher was added to each 
well to stop the CAT reaction. A 5 μl aliquot of the reaction was transferred to a fresh 
well in the microtiter plate, to which 250 μl of prepared chromogenic working 
solution was added. The plate was incubated for approximately 1 h with vigorous 
mixing at room temperature. The absorbance of the resulting quinone imine dye was 
measured at wavelength of 520 nm using a UV/visible spectrophotometer. The CAT 
activity assay was performed in triplicates (n = 3). CAT concentration in the test 
sample was calculated by preparing a CAT standard curve, which was supplied with 
the kit. CAT activity was expressed as activity units (AU) per mg of protein. 
  
5.2.2.8.4   Measurement of superoxide dismutase (SOD) activity 
The OxiSelect SOD activity assay kit (colorimetric method) was used to determine 
SOD activity in Caco-2 cells, according to the manufacturer’s instructions. A total of 
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90 μl (i.e. 70 μl of the prepared cell lysate or 70 μl of distilled water for the blank with 
5 μl xanthine solution, 5 μl chromogen solution and 10 μl of 10X SOD assay buffer) 
was added to separate wells of a 96-well microtiter plate. Then, 10 µl of the pre-
diluted 1X xanthine oxidase solution was added to each well, before being thoroughly 
mixed and incubated at 37ºC for 1 h. The activity of SOD was determined by 
measuring the developed colour of formazan dye at 450 nm using the absorbance 
microtiter plate reader (Behring Co, Marburg, Germany). The SOD activity assay was 
performed in triplicates (n = 3). The SOD activity was assessed as the percentage 
inhibition rate and calculated according to the following equation: 
SOD activity (inhibition %) = (Ablank−Asample)/(Ablank) × 100 
where Ablank and Asample are the absorbance values of the blank and test samples at 450 
nm, respectively.  
 
5.2.3   Statistical analysis 
All assays were performed in triplicate, and each experiment was independently 
repeated three times to ensure reproducibility. Data are presented as mean ± SD and 
analysed using statistical package for the social sciences (SPSS). One-way analysis of 
variance in conjunction with Dunnett’s multiple comparison test was employed for 
determining the significance of differences between the mean values of control and 
test treatments. Differences were considered to be statistically significant at P < 0.05 
(95% confidence interval). 
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5.3   Results and discussion 
5.3.1   Viability of Caco-2 cells treated with the BSA-derived peptide 
The direct effects of the BSA-derived peptide fraction GF18 on the viability of Caco-
2 cells were determined by the MTT assay, a colorimetric method involving 
spectrophotometric quantitation, as described by Lee et al. (2013). This assay is a 
sensitive measurement of the metabolic status of cells, particularly the mitochondria 
that serve as early indicators of changes in cellular redox activity (Circu and Aw, 
2010). 
 
Figure 5.1 shows cell viability at different concentrations (0.002–0.8 mg/ml) of the 
BSA-derived peptide. The treatment of Caco-2 cells (20,000 cells/well) with the 
BSA-derived peptide fraction GF18 for 24 h resulted in excellent cell viability 
(≥80%), indicating that the range of peptide concentration employed (0.002–0.8 
mg/ml) did not cause cellular damage or exert cytotoxic effects during the 24-h 
incubation period. In addition, statistically significant differences in viability were 
observed between the control (untreated cells) and the test sample treated with 0.008 
mg/ml peptide (99.7% cell viability; P < 0.05). Slight reduction in cell viability was 
observed upon treatment with higher concentrations of the peptide (0.08–0.4 mg/ml), 
indicating that the increase in peptide concentrations could result in reduced cell 
viability. Therefore, the peptide concentration of 0.008 mg/ml was selected for further 
studies on antioxidant activity because of the high viability of Caco-2 cells and lack of 
cytotoxicity associated with this concentration. 
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Figure 5.1  Viability of Caco-2 cells treated with various concentrations of the BSA-derived 
peptide. Cell viability was assessed using the 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tetrazolium bromide assay, and untreated cells (Dulbecco’s Modified Eagle’s Medium) were 
employed as the negative control. All assays were performed in triplicate (n = 3), and the 
experiment was independently repeated three times to ensure reproducibility. The different 
columns represent means with significant differences (P < 0.05). Data are presented as mean 
± SD. 
 
The effects of treatment with the BSA-derived peptide (at a concentration of 0.008 
mg/ml) and the synthetic antioxidant agents ascorbic acid (0.01%) and trolox (0.01%) 
on the viability of Caco-2 cells were compared, as shown in Figure 5.2; similar cell 
viability was observed upon treatments with the peptide and the two synthetic 
antioxidants ascorbic acid and trolox (99.7%, 95.2% and 92.8% viability, 
respectively; P ≥ 0.05). This result strongly supports previous observations that the 
bioactive peptide derived from dairy proteins exhibits good cellular antioxidant 
activity comparable with that of the positive controls (antioxidants) at the 
concentrations selected (Serafini et al., 2002; Vinson et al., 2002). 
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Figure 5.2  Viability of Caco-2 cells treated with the BSA-derived peptide fraction GF18 at a 
concentration of 0.008 mg/ml. Untreated cells (Dulbecco’s Modified Eagle’s Medium) were 
employed as the negative control. Trolox (0.01%) and ascorbic acid (0.01%) were employed 
as positive controls. The different columns represent means with significant differences (P < 
0.05). Data are presented as mean ± SD of triplicate measurements (n = 3). 
 
5.3.2   Viability of tert-butyl hydroperoxide-treated Caco-2 cells  
The organic hydroperoxide analogue t-BHP is widely employed for studying the 
effects of free radicals in in vitro cell systems and triggers several cellular responses, 
including cell death, lipid peroxidation (Baker and He, 1991), DNA damage and 
decrease in the GSH content (García-Alonso et al., 2006; Rosa et al., 2007). The 
presence of transition metals promotes the decomposition of t-BHP and generation of 
tert-butoxyl or tert-butyl peroxyl radicals through Fenton reaction, which in turn 
results in oxidative stress in the cell lines and tissue cultures (Kennedy et al., 1992; 
Tripathi et al., 2009; Chapple et al., 2013). In fact, t-BHP has recently been 
characterised as a good tool for studying oxidative stress in various types of cells 
(García-Nebot et al., 2014; Kim et al., 2015). 
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Figure 5.3 shows the viability of Caco-2 cells treated with various concentrations of t-
BHP relative to the negative control (untreated cells). 
 
 
Figure 5.3  Viability of Caco-2 cells treated with various concentrations of tert-butyl 
hydroperoxide for 2.5 h. Untreated cells were employed as the negative control. The different 
columns represent means with significant differences (P < 0.05). Data are expressed as mean 
± SD of triplicate measurements (n = 3). 
 
The treatment of Caco-2 cells for 2.5 h with increasing concentrations of t-BHP (0.1, 
0.3, 0.5, 1, 3, 5 and 10 mM) decreased the viability of the cells in a dose-dependent 
manner (Fig. 5.3). Statistically significant differences in cell viability were observed 
upon treatment with t-BHP relative to the untreated cells (P ≤ 0.05) as well as 
between treatments with various concentrations of t-BHP (P < 0.001). The cell 
viability resulting from treatments with 0.1, 0.3, 0.5, 1, 3, 5 and 10 mM t-BHP was 
found to be 77.5%, 70.8%, 64.3%, 60.3%, 54.6%, 34.7% and 12.2%, respectively. 
Therefore, 54% cell viability (corresponding to ~50% cell death) was observed upon 
treatment of cells with 3 mM t-BHP; this concentration of t-BHP was therefore 
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selected for subsequent experiments on oxidation and measurements of the protective 
effect of the BSA-derived peptide fraction GF18 in Caco-2 cells. 
 
5.3.3   Protective effect of BSA peptide fraction on t-BHP 
The protective effects exerted by the BSA-derived peptide fraction GF18 on the 
viability of the Caco-2 cells treated with t-BHP were assessed by the MTT assay. As 
depicted in Figure 5.4, increased cell viability was observed upon treatment of Caco-2 
cells with the peptide (0.008 mg/ml; 97.3% viability). As expected, compared with the 
treatment with t-BHP alone (54.6%), preincubation of cells with the peptide conferred 
significant protection against the cytotoxicity generated by treatment with 3 mM t-
BHP for 2.5 h, as evidenced by enhanced viability (77.9%) at the selected 
concentration and in a time-dependent manner. Statistical analysis using ANOVA 
revealed significant differences between the various test treatments (P ≤ 0.01). 
 
Several studies on Caco-2 cells had reported a marked decreased in cell viability after 
subjecting cells with an inducing agents such as H2O2 or t-BHP for 2 hours (Laparra 
et al., 2008; Garcia-Nebot et al., 2011; Garcia Nebot et al., 2013). 
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Figure 5.4  Protective effects of the bovine serum albumin-derived peptide fraction GF18 
(0.008 mg/ml) against oxidative stress induced by tert-butyl hydroperoxide (3 mM) in the 
Caco-2 cell line. Untreated cells were employed as the negative control. The different 
columns represent means with significant differences (P < 0.05). Data are presented as mean 
± SD of triplicate measurements (n = 3). 
 
It is noteworthy, the ability of BSA peptide to reduce the toxic effect of t-BHP may be 
attributed to the presence of histidine-containing peptide and the hydrophobic amino 
acids (valine, isoleucine, leucine and phenyl alanine) which has an ability to scavenge 
hydroxyl radical and metal chelating. It was reported by Kim et al. (2007), a purified 
peptide from a hoki frame protein, prepared by pepsin enzyme showed a protective 
effect against the toxic agent t-BHP on embryonic lung fibroblasts (MRC-5) cells by 
scavenging lipid-derived radicals. The data in the present study indicated that peptide 
possessed both antioxidant and ROS scavenging activity hence, protecting Caco-2 
cells from oxidative stress. 
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5.3.4   Morphological alterations in Caco-2 cells 
Analysis of the morphological characteristics of Caco-2 cells treated with the BSA-
derived peptide (0.008 mg/ml), trolox (0.01%) and ascorbic acid (0.01%) revealed 
normal morphology and healthy-looking cells, similar to the negative control 
(untreated cells), as shown in Figure 5.5 (panels B–D and A, respectively). Treatment 
with 3 mM t-BHP for 2.5 h resulted in marked morphological alterations indicative of 
cell death because of the cytotoxic effects of t-BHP (Fig. 5.5F); however, 
pretreatment with the BSA-derived peptide fraction GF18 exerted protective effects 
48 h post-treatment with 3 mM t-BHP (Fig. 5.5E). 
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       (A) Control (untreated cells)                                              (B) Peptide (0.008 mg/ml)                              
                           
       (C) Trolox (0.01%)                                                              (D) Ascorbic acid (0.01%)  
 
                          
       (E) Peptide (0.008 mg/ml) and t-BHP (3mM)                     (F) t-BHP (3mM) 
 
Figure 5.5  Morphological changes in Caco-2 cells induced by treatments with tert-butyl 
hydroperoxide (3 mM) and the bovine serum albumin-derived peptide fraction (0.008 
mg/ml). Cells were observed using a phase-contrast microscope (Zeiss Telaval microscope) 
fitted with a camera (Nikon, Japan). 
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5.3.5  Measurement of lipid peroxidation in Caco-2 cells 
Lipids are prone to oxidation because of the presence of reactive double bonds in 
polyunsaturated fatty acids (Porter et al., 1995). Two of the well-investigated 
biomarkers of lipid peroxidation are isoprostanes and MDA; these are produced as a 
result of ROS-induced lipid peroxidation, leading to extensive cellular oxidative stress 
and cell damage (Gomez-Monterrey et al., 2010; Ho et al., 2013). In the present 
study, the membrane-permeable oxidant t-BHP was employed for inducing oxidative 
stress in Caco-2 cells, and the formation of the secondary product MDA was detected. 
The toxic compound t-BHP is easily metabolised to generate free radicals such as 
peroxyl (ROO·) and alkoxyl (RO) radicals, which in turn initiate membrane lipid 
peroxidation that subsequently generates TBARS (Barr and Mason, 1995). 
 
 
Figure 5.6  Effect of the bovine serum albumin-derived peptide (0.008 mg/ml) on the 
secondary product of lipid peroxidation (malondialdehyde) in Caco-2 cells treated with tert-
butyl hydroperoxide (3 mM). Untreated cells were employed as the negative control. The 
different columns represent means with significant differences (P < 0.05). Data are presented 
as mean ± SD of triplicate measurements (n = 3). 
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Figure 5.6 shows that TBARS formation increased in Caco-2 cells upon treatment 
with 3 mM t-BHP, resulting in the production of approximately 30.3 µg/ml of MDA 
as opposed to untreated cells (17.9 µg/ml), with the differences being statistically 
significant (P < 0.001). The presence of the BSA-derived peptide at the selected 
concentration (0.008 mg/ml) in Caco-2 cells resulted in the production of 20.4 µg/ml 
MDA, which is significantly lower than that in t-BHP-treated cells (P < 0.01). When 
Caco-2 cells pretreated with peptide (0.008 mg/ml) were treated with 3 mM t-BHP, 
the peptide was observed to exert a strong protective effect against t-BHP-induced 
oxidative stress and markedly decreased MDA formation (27.7 µg/ml) in comparison 
with cells treated with only t-BHP (P ≤ 0.05). 
 
These results indicate that the BSA-derived peptide fraction possessed the capacity to 
increase the resistance of Caco-2 cells to t-BHP-induced oxidative stress and 
scavenge lipid-derived free radicals that oxidise polyunsaturated fatty acids in the cell 
membrane (Chapple et al., 2013). In addition, the side chains of the constituent amino 
acid residues in the antioxidant BSA-derived peptide are likely to function as 
hydrogen donors, with the ability to quench/decrease the load of oxidising free 
radicals (Udenigwe and Aluko, 2011; Wiriyaphan et al., 2012). 
 
5.3.6   Caspase-Glo 3/7 assay 
Two types of cell death, termed necrosis and apoptosis, occur in mammalian cells. 
Necrosis refers to an uncontrolled cell death program categorised by the swelling of 
cells, ATP depletion and disruption of the cell membrane resulting in damage to 
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cellular components and a reduction in the intracellular GSH content (Girotti, 2001; 
Elmore, 2007). In contrast, apoptosis, also termed programmed cell death, occurs in 
multicellular organisms through the activation of caspases, thereby resulting in the 
removal of damaged cells. Apoptosis is mediated by a series of biochemical events 
that result in multiple morphological alterations such as cell shrinking, blebbing, 
nuclear fragmentation and chromatin condensation (Elmore, 2007). The apoptosis 
program is an important biological feature for the elimination of unnecessary or 
infected cells. 
                                                          
 
Figure 5.7   Measurement of caspase 3/7 activities in Caco-2 cells. Caco-2 cells were treated 
with 3 mM tert-butyl hydroperoxide in the presence or absence of the bovine serum albumin-
derived peptide fraction (0.008 mg/ml). Untreated cells were employed as the negative 
control. Luminescence was determined using a GloMax®96 luminometer. The different 
columns represent means with significant differences (P < 0.05). Data are presented as mean 
± SD of triplicate measurements (n = 3). 
 
In the present study, the Caspase-Glo 3/7 assay kit was employed for estimating the 
activities of caspases 3/7 and thereby apoptosis in Caco-2 cells. High activities of 
caspases 3 and 7 were detected in Caco-2 cells treated with 3 mM t-BHP (88.9% 
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activity); however, the treatment of cells with 3 mM t-BHP in the presence of prior 
treatment with the BSA-derived peptide resulted in lower levels of caspase activation 
(25.4%; P < 0.001). Treatment with the peptide alone resulted in markedly lower 
activation of caspases 3 and 7 (17.7%), as shown in Figure 5.7. 
 
These results suggest that the antioxidant activity of the BSA-derived peptide fraction 
allows reduction in cellular apoptosis by decreasing the activation of caspases 3 and 7 
in response to t-BHP-induced free-radical chain reaction. These results are similar to 
those observed by Giovannelli et al. (2000), where the antioxidant activity of phenolic 
compounds was found to exert protective effects against H2O2-induced oxidative 
damage. 
 
5.3.7   Determination of intracellular reactive oxygen species levels 
In living organisms, a moderate increase in ROS encourages cell proliferation and 
differentiation; however, extreme levels of ROS could lead to oxidative damage to 
cells and macronutrients and prove toxic to cancer cells, inducing apoptosis (Boonstra 
and Post, 2004; Li et al., 2007; McLean et al., 2008). Mitochondria are the source of 
ROS and play an important role in the regulation of apoptotic signalling. In fact, ROS 
play a major role in apoptosis by regulating the action of several enzymes implicated 
in the cell death pathway (Wu, 2006). 
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Figure 5.8   Effect of the bovine serum albumin-derived peptide fraction on the generation of 
reactive oxygen species (ROS). Caco-2 cells were treated with 3 mM tert-butyl 
hydroperoxide in the presence or absence of the peptide fraction, followed by determination 
of the intracellular ROS content by flow cytometry using the nonfluorescent dye 5-(and-6)-
chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate acetyl ester. Untreated cells were 
employed as the negative control. The different columns represent means with significant 
differences (P ≤ 0.05). Data are presented as mean ± SD of triplicate measurements (n = 3). 
 
In the present study, the generation of ROS was assessed by flow cytometry using the 
non-fluorescent dye CM-H2DCFDA to confirm the reduction in t-BHP-induced 
oxidative stress in Caco-2 cells by the BSA-derived peptide fraction. Figure 5.8 shows 
the rapid increase in intracellular ROS levels upon treatment of Caco-2 cells with 3 
mM t-BHP (approximately 80.5% ROS production) compared with the negative 
control (untreated cells; 55.8%; P < 0.01). However, a statistically significant 
decrease in ROS generation was observed upon treatment of Caco-2 cells with the 
BSA-derived peptide, both in the presence and absence of t-BHP (33.7% and 40.3%, 
respectively), compared with t-BHP-treated cells (P < 0.001). 
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These observations suggest that the rapid increase in ROS production and the 
oxidative damage triggered by the action of t-BHP is likely associated with its higher 
stability in aqueous solution (Alía et al., 2005). In addition, the present study 
underscores the protective effects of the BSA-derived peptide against oxidative 
damage in colon cancer cells and its ability to reduce ROS production; this activity is 
likely related to its action as an ROS scavenger (García-Nebot et al., 2011; García-
Nebot et al., 2014; Kim et al., 2014a). 
 
5.3.8  Measurement of the total glutathione content and the endogenous 
antioxidant enzyme activity of bovine serum albumin peptide in Caco-2 cells 
under oxidative stress  
The human body possesses several cellular endogenous antioxidant defence systems 
to protect itself from the harmful effects of oxidative stress. These systems involve 
several complex antioxidant enzymes, including CAT, glutathione peroxidase, 
glutathione reductase and SOD, which act synergistically to protect the cells against 
free radicals by terminating chain reaction (de Moraes Mourão et al., 2009). In the 
present study, an attempt has been made to determine the total glutathione content and 
the endogenous antioxidant enzyme activity of bovine serum albumin peptide after 
pre-treatment with the dose selected by MTT assay (0.008 mg/ml), with or without 
the addition of 3 mM of t-BHP in Caco-2 cells for 2 h. 
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5.3.8.1  Measurement of total glutathione (GSSG/GSH) 
Glutathione is a tripeptide thiol produced in the cytosol via two reactions involving 
glutamic acid, cysteine and glycine. Glutathione functions as an antioxidant by 
preventing cell deterioration because of free radicals (Forman et al., 2009). Inside 
cells, glutathione exists in two states: reduced (GSH) and oxidized (GSSG). Because 
of the presence of glutathione reductase, approximately 90% of glutathione in healthy 
cells is in the form of GSH, whereas only 10% is in the form of GSSG.  
 
Glutathione has several biological functions, including the detoxification of 
endogenous compounds. For example, glutathione peroxidase helps to degrade 
harmful hydrogen peroxide into water and GSSH. Moreover, glutathione reductase 
catalyses the conversion of stable GSSG to GSH (Miester, 1988).  
 
In this study, the total concentration of glutathione in Caco-2 cells significantly 
increased in cells pre-treated with 0.008 mg/ml of the BSA peptide by approximately 
0.15 µM. Treatment with 3 mM of t-BHP alone significantly decreased the total 
glutathione level in Caco-2 cells by 0.06 µM; however, in the presence of the BSA 
peptide there was a slight increase by 0.09 µM (P < 0.01). 
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Figure 5.9  The total glutathione content in Caco-2 cells pretreated with 0.008 mg/ml BSA 
peptide for 24 h followed by the addition of 3mM of t-BHP for 2 h. Untreated cells were 
employed as the negative control. The different columns represent means with significant 
differences (P ≤ 0.05). Data are presented as mean ± SD of triplicate measurements (n = 3). 
 
The above results indicate that the BSA peptide is useful for measuring the total 
glutathione content and protects Caco-2 cells against t-BHP induced oxidative 
damage (Tiawari and Kakkar, 2009). Several studies have reported that peptides from 
food proteins can increase GSH levels in Caco-2 cell lines (Ahrene et al., 2008; 
Sullivan et al., 2011; Yaning Shi et al., 2014). Cellular growth and differentiation as 
well as cell signalling and apoptosis are all influenced by changes in the glutathione 
concentrations in the cell (Yang et al., 2006). Therefore, cellular metabolism can 
adversely be affected if the GSH concentration is decreased because of t-BHP or 
H2O2
. GSH protects cells against oxidative damage by quenching hydroxyl radicals 
and singlet oxygen species. Furthermore, it provides reducing equivalents to the 
enzymes of the cellular antioxidant system (Alonso et al., 2006). Therefore, 
maintenance of the intracellular glutathione levels by the BSA peptide suggests that 
this peptide may play a protective role and possess antioxidant activity. 
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Figure 5.10  Comparison of glutathione content between cells pretreated with BSA peptide 
(0.008mg/ml), ascorbic acid (0.01%) and trolox (0.01%). Untreated cells were employed as 
the negative control. The different columns represent means with significant differences (P ≤ 
0.05). Data are presented as mean ± SD of triplicate measurements (n = 3). 
 
Figure 5.10 demonstrates the total glutathione content in cells that were pretreated 
with the BSA peptide compared to treatment with ascorbic acid and trolox, which are 
well-known antioxidants. The total glutathione level in cells pretreated with the BSA 
peptide was slightly lower (0.15 µM) than those pretreated with ascorbic acid (0.17 
µM) and trolox (0.19 µM). Although all samples possess good cellular glutathione 
content, ANOVA tests showed that the level of GSH in Caco-2 cells was significantly 
lower in the test samples (BSA peptide, ascorbic acid and trolox) compared to the 
negative control (P ≤ 0.05). 
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5.3.8.2   Measurement of CAT activity 
CAT (EC 1.11.1.6, H2O2 oxidoreductase) is one of the most important endogenous 
antioxidant enzymes and is more abundant in aerobic cells. The major function of 
CAT is to catalyse the decomposition of hydrogen peroxide to water and oxygen 
through a scavenging reaction (Chelikani et al., 2004; De Moraes Mourao et al., 
2009). This study evaluated CAT activity (AU/mg protein) in Caco-2 cells in the 
presence and absence of 3 mM of t-BHP (Figure 5.11). 
 
 
Figure 5.11   Effect of 0.008 mg/ml BSA peptide on CAT activity in cells treated with 3 mM 
t-BHP of Caco-2. Untreated cells were employed as the negative control. The different 
columns represent means with significant differences (P ≤ 0.05). Data are presented as mean 
± SD of triplicate measurements (n = 3). 
 
There was no significant difference in CAT activity in Caco-2 cells under oxidative 
stress induced by t-BHP compared to untreated cells (P > 0.05). CAT activity in 
untreated cells was 9.9 U/mg protein; furthermore, when cells were treated with 
peptide alone, the CAT activity was 7.6 U/mg protein, and when cells were treated 
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with and without t-BHP, CAT activity was 10.4 and 9.1 U/mg protein, respectively 
(Figure 5.11). 
 
Figure 5.12   CAT activity of Caco-2 cells treated with BSA-derived peptide fraction GF18 at 
a concentration of 0.008 mg/ml. Untreated cells (Dulbecco’s Modified Eagle’s Medium) were 
employed as the negative control. Trolox (0.01%) and ascorbic acid (0.01%) were employed 
as positive controls. Data are presented as mean ± SD of triplicate measurements (n = 3). 
 
CAT activity of Caco-2 cells, which were treated with BSA peptide at 0.008 mg/ml, 
was compared to Caco-2 cells treated with artificial antioxidant agents such as 
ascorbic acid and trolox at a concentration of 0.01% for both as depicted in figure 
5.12. The results presented in the figure showed a statistical similarity in CAT activity 
between BSA peptide and the two synthetic antioxidant agents (ascorbic acid and 
trolox) (P ≥ 0.05).   
 
CAT is induced by low concentrations of endogenous or exogenous t-BHP or H2O2 
(Masaki et al., 1998). Therefore, the concentration of t-BHP (i.e. 3 mM) used in this 
study may have been too low to induce CAT. This may explain why no significant 
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differences were observed between cells treated with or without t-BHP. In addition, 
our study showed that the BSA peptide had no effect on CAT activity, which is in 
agreement with several previous results of peptides obtained from food proteins 
(Sullivan et al., 2012; Yaning Shi et al., 2014, Carla Souse et al., 2015). 
 
5.3.8.3   Measurement of SOD activity 
SOD (EC 1.15.1.1, superoxide oxidoreductase) is an endogenous cellular antioxidant 
enzyme located in aerobic cells (Johnson and Giulivi, 2005). SOD catalyses the 
dismutation reaction of the superoxide anion radical into oxygen and hydrogen 
peroxide (Rahman, 2007). Therefore, SOD is crucial for antioxidant defence as it 
protects aerobic cells from the harmful effects of the superoxide radical, and from 
further formation of reactive oxygen species (ROS) (Patil et al., 2010; Ungvari et al., 
2011). 
 
In the current study, SOD activity was highest in Caco-2 cells treated with the BSA 
peptide alone compared to untreated cells (i.e. 66.4% of the SOD activity in control 
cells; P < 0.05; Figure 5.13). After the cells were placed under oxidative stress with 3 
mM t-BHP, the SOD activity was markedly reduced to 50.6%, observed in the control 
cells (P < 0.01) (Figure 5.13). However, the lowest SOD activity was observed when 
Caco-2 cells were treated with 3 mM of t-BHP alone (42.2% of the SOD activity in 
control cells; P < 0.05) (Figure 5.13). 
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Figure 5.13  Effect of the bovine serum albumin-derived peptide fraction on SOD activity. 
Caco-2 cells were treated with 3 mM tert-butyl hydroperoxide in the presence or absence of 
the peptide fraction. Untreated cells were employed as the negative control. The different 
columns represent means with significant differences (P ≤ 0.05). Data are presented as mean 
± SD of triplicate measurements (n = 3). 
 
The above result supports the fact that the BSA peptide (GF18), which acts as an 
antioxidant, helps to protect Caco-2 cells against t-BHP induced toxicity by enhancing 
SOD activity (Sullivan et al., 2011; Sullivan et al., 2012; Carla Souse et al., 2015). 
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Figure 5.14  SOD activity of Caco-2 cells treated with BSA-derived peptide fraction GF18 at 
a concentration of 0.008 mg/ml. Untreated cells (Dulbecco’s Modified Eagle’s Medium) were 
employed as the negative control. Trolox (0.01%) and ascorbic acid (0.01%) were employed 
as positive controls. Data are presented as mean ± SD of triplicate measurements (n = 3). 
 
 
The SOD activity of Caco-2 cells treated with BSA peptide (0.008 mg/ml) was 
compared to Caco-2 cells treated with 0.01% ascorbic acid and 0.01% trolox (Figure 
5.14). BSA peptide, ascorbic acid and trolox showed SOD activity of 66.4%, 58.3% 
and 60%, respectively, compared to the control cells (P < 0.05). Therefore, BSA 
peptide appears to possess better cellular antioxidant and ROS scavenging activity 
than the well-known antioxidant agents (ascorbic acid and trolox). 
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5.4   Conclusion 
The present study demonstrates that the BSA-derived peptide fraction GF18 obtained 
following hydrolysis of BSA with pepsin exhibits good antioxidant activity and exerts 
a protective effect against t-BHP-induced oxidative stress in Caco-2 cells by 
increasing cell viability; this activity is dependent on the concentration of the peptide 
as well as incubation time of the reaction and is similar to that of the synthetic 
antioxidants trolox and ascorbic acid. In addition, compared with cells subjected to 
oxidative stress, the protective effect of the peptide resulted in markedly decreased 
formation of MDA. Moreover, significantly lower activation of caspases 3 and 7 was 
observed in Caco-2 cells treated with t-BHP in the presence of prior treatment with 
the BSA-derived peptide, suggesting that the peptide protected cells from caspase-
dependent apoptosis. The BSA-derived peptide therefore exhibits antioxidant effects 
against t-BHP-induced oxidative stress in Caco-2 cells by inhibiting intracellular ROS 
production. Regarding the glutathione level, peptide possessed good cellular 
glutathione level and protecting Caco-2 cells against t-BHP induced oxidative 
damage. In terms of the antioxidant activates, BSA peptide protected cells against t-
BHP induced reduction in SOD activity. BSA peptide did not observe a significant 
effect on catalase activity. Moreover, the antioxidant activity of the peptide is 
attributable to the presence of specific amino acid residues capable of functioning as 
an electron or hydrogen donor. The radical-scavenging activity of the peptide is 
associated with the presence of several constituent hydrophobic amino acids such as 
tyrosine, methionine, histidine, lysine, glycine and tryptophan. Taken together, these 
results highlight the potential benefits of producing natural antioxidant peptides from 
BSA for use as food additives and pharmaceutical agents. 
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6   Effects of the bovine serum albumin-derived peptides on 
the inhibition of angiotensin-I-converting enzyme and 
reactive oxygen species in the endothelial cancer cell line 
EA.hy926 
 
6.1   Introduction 
Hypertension is a major public health concern and a risk factor for several diseases 
such as myocardial infarction, stroke, coronary heart disease and renal disease (Li et 
al., 2012a). Lowering blood pressure through the inactivation of angiotensin-I-
converting enzyme (ACE) in the renin–angiotensin system is the most effective 
therapeutic approach for the treatment and regulation of hypertension and related 
diseases (Bougatef et al., 2009). In patients with high blood pressure, dipeptidyl 
carboxypeptidase (ACE or kinase II, EC 3.4.15.1), which belongs to the class of zinc 
metalloproteases, efficiently regulates blood pressure by cleaving the C-terminal of 
angiotensin I (Asp–Arg–Val–Tyr–Ile–His–Pro–Phe–His–Leu) to release the dipeptide 
(His–Leu) and produce a vasopressor octapeptide, angiotensin II (Asp–Arg–Val–Tyr–
Ile–His–Pro–Phe); in addition, ACE degrades the vasodilator bradykinin (Wijesekara 
and Kim, 2010; Clarke and Turner, 2011). Antihypertensive agents such as captopril 
are likely to have side effects and cause health problems, generating tremendous 
interest in the study of natural ACE inhibitors such as peptides derived from food 
proteins (Ghassem et al., 2012b). 
Nitric oxide (NO) radical is a highly reactive free radical and exerts significant 
vasodilatory effects on the blood vessels, thereby increasing blood flow and 
preventing platelet aggregation and leukocyte adhesion (de la Rosa et al., 2010). In 
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mammals, this molecule is endogenously generated from L-arginine, oxygen and 
NADPH by the action of the enzyme endothelial NO synthase. In hypertensive 
patients, the endothelium is unable to produce sufficient quantities of bioactive NO 
because of the association between cardiovascular diseases and a high rate of reactive 
oxygen species (ROS) synthesis, thereby leading to endothelial dysfunction (Russo et 
al., 2002; Coletta et al., 2012). The walls of blood vessels contain several enzyme 
systems that are responsible for ROS production, including NADPH oxidases, 
xanthine oxidase and enzymes of the mitochondrial respiratory chain (Mueller et al., 
2005). Bioactive NO has been shown to exert protective effects against endothelial 
dysfunction and functions against oxidative stress (Schächinger and Zeiher, 2000; 
Davignon and Ganz, 2004). 
The intracellular production of radical and non-radical ROS such as superoxide anion 
(O2−·), hydrogen peroxide (H2O2), hydroxyl radical (OH·) and hypochlorous acid is 
an inevitable outcome of aerobic metabolism (Veal and Day, 2011; Ray et al., 2012). 
In endothelial cells, enzyme systems such as NADPH oxidase and xanthine oxidase 
are accountable for ROS production. Excessive production of these reactive species 
results in the alteration of various biological components such as lipids, proteins, 
enzymes and nucleic acids, which leads to cell death and promotes the development 
of numerous degenerative diseases such as chronic inflammation, cardiovascular 
complications, cancer and Alzheimer’s disease (Shieh et al., 2010; Bae et al., 2011; 
Yongvanit et al., 2012; Carocho and Ferreira, 2013). 
 
Living cells contain endogenous antioxidant systems comprising enzymes such as 
superoxide dismutase, glutathione peroxidases and catalase that convert ROS to less 
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harmful species (de Moraes Mourão et al., 2009). In cellular systems, the stimulation 
of such enzymatic antioxidants by agents that exert cytoprotective effects is a major 
defence strategy against oxidative damage. Several epidemiological studies have 
provided considerable evidence for the existence of positive association between diets 
rich in proteins and reduced risk of several dangerous diseases, including chronic 
diseases (Alfaro-Moreno et al., 2007). Therefore, significant attention has been paid 
to compounds derived from natural sources that exhibit the capacity for modulating 
ROS levels (Cantin et al., 2009). 
 
It has recently been shown that bioactive peptides derived from food proteins exhibit 
antioxidative and antihypertensive activities by stimulating NO-mediated vasodilation 
(Udenigwe and Aluko, 2012). Several studies on the functional properties of natural 
antioxidant peptides and proteins have shown that they reduce ROS generation and 
inhibit lipid oxidation in the human umbilical vein endothelial cell lines (HUVECs), 
chiefly EA.hy926 HUVEC (Huang et al., 2004; Beretta et al., 2007; Yu et al., 2013). 
The human EA.hy926 endothelial cell line displays similar characteristics as the 
vascular endothelial cells (Bouis et al., 2001). 
 
The present study aims to evaluate the protective effects of the bovine serum albumin 
(BSA)-derived peptide fraction gel-filtration (GF) fraction 22 (GF22) against tert-
butyl hydroperoxide (t-BHP)-induced oxidative damage in the human endothelial cell 
line EA.hy926. Changes in cellular morphology induced by the peptide fraction in the 
presence and absence of t-BHP were observed using a phase-contrast microscope. 
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Intracellular ROS were measured by chemiluminescence as well as a fluorometric 
method, and NO production was evaluated. The inhibitory effect of the BSA-derived 
peptide fraction on ACE activity in EA.hy926 cells was also evaluated. 
 
6.2   Materials and methods 
6.2.1   Materials 
The human endothelial cell line EA.hy926 was generously donated by the nutrition 
group (Faculty of Health and Medical Sciences, University of Surrey, UK). BSA, 
pepsin (from gastric mucosa, ≥2,500 units/mg protein), 3-[4,5-dimethylthiazol-2-yl]-
2,5 diphenyl tetrazolium bromide (MTT), 6-hydroxy-2,5,7,8-tetramethylchromane-2-
carboxylic acid (Trolox), ascorbic acid, dimethyl sulfoxide (DMSO), 
penicillin/streptomycin antibiotic solution (50 U/ml), trypan blue, captopril, t-BHP, 
N,N′-dimethyl-9,9′-biacridinium dinitrate (Lucigenin) and hippuryl–L-histidyl–L-
leucine (HHL) were purchased from Sigma–Aldrich Co. Ltd. (Poole, Dorset, UK). 
Dulbecco’s Modified Eagle’s Medium (DMEM) high glucose (containing phenol red 
and GlutaMAX™ I but not pyruvate), purified trypsin-ethylenediaminetetraaceticacid 
solution (0.05%), heat-inactivated foetal bovine serum (FBS), the Griess reagent kit 
for nitrite determination, Hanks-buffered saline solution (HBSS; without calcium, 
magnesium and phenol red) and dihydroethidium (DHE) dye were procured from 
Invitrogen (Paisley, UK). Phosphate-buffered saline (PBS) was purchased from Fisher 
Scientific Holding UK Ltd. (Loughborough, UK), and ultrafiltration membrane with 
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10-kDa molecular weight cut-off was purchased from Vivaspin (Epsom, UK). The 
remaining chemicals and reagents employed in experiments were of analytical grade. 
 
6.2.2   Methods 
6.2.2.1   Isolation and purification of BSA peptides-derived peptide 
fraction 
6.2.2.1.1   Enzymatic hydrolysis of BSA 
Enzymatic hydrolysis of BSA was performed as described in Section 2.2.2.1 
6.2.2.1.2   Ultrafiltration 
Ultrafiltration of the BSA hydrolysate was performed as described in Section 
2.2.2.2.1. 
6.2.2.1.3   Gel filtration chromatography 
Gel filtration chromatography of the BSA-derived peptide fraction (<10 kDa) was 
performed as described in Section 2.2.2.2.2. 
 
6.2.2.2   Determination of EA.hy926 endothelial cell viability 
6.2.2.2.1   Cell culture conditions 
The endothelial cell line EA.hy926 stored in liquid nitrogen (−196°C) was thawed in 
a water bath at 37C and centrifuged at 500 g for 3 min, followed by resuspension in 
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cell culture medium and plating; cells were used between passages 8 and 9. The cells 
were transferred to a 25-cm2 flask and cultured in DMEM high glucose supplemented 
with 10% heat-inactivated FBS and 5% penicillin/streptomycin antibiotic solution. 
The cells were cultured in an incubator at 37C under atmospheric conditions of 95% 
air and 5% CO2, and culture medium was replaced with fresh medium every 2 or 3 
days. Once the desired confluence (80%) was attained, the medium was aspirated, and 
cells were washed with HBSS (2 ml) and detached by adding trypsin (1 ml), followed 
by incubation for 30 sec; trypsin was subsequently removed 1 min following its 
addition, and the trypsinised cells incubated at 37C for 2 or 3 min for dissociating 
them. Fresh DMEM high glucose medium (6 ml) was added for inactivating trypsin, 
and the cells were subsequently employed for splitting, counting and freezing. 
 
6.2.2.2.2   Cell viability 
Cell viability was assessed by the MTT colorimetric assay, as elucidated in Roehm et 
al. (1991), by incorporating slight modifications to the method detailed in Lu et al. 
(2014). The principle underlying the MTT assay has previously been described in 
Section 5.2.2.3.2. The assay was initiated by trypsinising EA.hy926 cells at 80% 
confluence, followed by cell counting using a hemocytometer and coating of cells in a 
96-well cell culture plate at a density of 2 × 104 cells (200 µl per well); cells were 
allowed to adhere for 24 h at 37C. The cells were then washed with PBS (2 ml), 
followed by the addition of MTT solution (10 mg/ml in PBS; 20 µl) and incubation at 
37C for 3 h. The culture medium was aspirated, and the insoluble product formazan 
was solubilised in DMSO (200 µl) under constant agitation for 3 min at room 
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temperature; the intensity of the purple colour was spectrophotometrically measured 
at a wavelength of 492 nm using a multiwell scanning spectrophotometer [enzyme-
linked immunosorbent assay (ELISA) plate reader]. In this assay, higher absorbance 
reflects greater cell viability. The percentage of viable cells with respect to the control 
was measured using the following equation: 
Cell viability (%) = (mean absorbance of treated cells/mean absorbance of control 
cells) × 100 
The DMEM high glucose medium was employed as the negative control (untreated 
cells), while trolox (0.01%) and ascorbic acid (0.01%) solutions, also prepared in 
DMEM high glucose media were employed as positive controls. Triplicate samples 
were employed for each experimental condition, and the experiment was 
independently repeated three times to ensure reproducibility. 
 
6.2.2.2.3   Viability of EA.hy926 cells treated with the BSA-derived peptide 
The endothelial cell line EA.hy926 was cultured in a 96-well cell culture plate at a 
density of 2 × 104 cells (200 µl per well), as described in Section 6.2.2.2.1. After 
incubation for 24 h at 37C, the culture medium was removed and replaced with fresh 
DMEM high glucose medium (200 µl) containing different concentrations of the 
BSA-derived peptide fraction (using a stock solution of 1 mg/ml) and incubated for 
24 h. Cell viability was subsequently determined by the MTT assay, as described in 
Section 6.2.2.2.2 (Kim et al., 2014b). 
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6.2.2.2.4   Viability of tert-butyl hydroperoxide-treated EA.hy926 cells 
The lipophilic alkyl hydroperoxide t-BHP is known to induce oxidative stress and 
cellular damage in cell/tissue cultures in a dose-dependent manner (Adams et al., 
1994; Sardão et al., 2007; Tiwari and Kakkar, 2009); t-BHP could therefore be 
employed for artificially inducing oxidative stress to assess the protective effects of 
various antioxidant proteins and polyphenol products (Chen et al., 2012b; Tobwala et 
al., 2014). Prior to the actual experiment, the effective concentration of t-BHP capable 
of inhibiting the viability of 50% of cells was determined. EA.hy926 cells were 
seeded in a 96-well cell culture plate at a density of 2 × 104 cells (200 µl per well) and 
incubated at 37C for 24 h. The culture medium was then aspirated, and fresh DMEM 
high glucose medium (200 µl) containing different concentrations of t-BHP [0.1, 0.3, 
0.5, 1, 3, 5 and 10 mM; prepared from a 70% (w/v) stock solution] was added, 
followed by further incubation for 2.5 h to induce oxidative stress. The viability of t-
BHP-treated cells was measured by the MTT assay, as described in Section 6.2.2.2.2 
(Kim et al., 2014b). 
 
6.2.2.2.5   Protective effects of the BSA-derived peptide fraction against tert-butyl 
hydroperoxide-induced oxidative stress in EA.hy926 cells 
Following cell counting, EA.hy926 cells were seeded in a 96-well cell culture plate at 
a density of 2 × 104 cells (200 µl per well) and incubated in a humidified incubator at 
37°C for 24 h. The culture medium was then aspirated, followed by the addition of 
fresh DMEM high glucose medium (200 µl) containing 0.02 mg/ml of the BSA-
derived peptide fraction and incubated for 24 h at 37C. The culture medium was then 
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aspirated, and cells were treated with 3 mM t-BHP (200 µl per well), followed by 
incubation for 2.5 h. The viability of cells was then determined by the MTT assay, as 
described in Section 6.2.2.2.2 (Kim et al., 2014b). 
 
6.2.2.3   Morphological alterations in EA.hy926 cell line 
The morphology of EA.hy926 cells was observed using a phase-contrast microscope. 
In brief, a suspension of EA.hy926 cells was seeded in 25-cm2 cell culture flasks at a 
density of 1 × 106 cells per flask and incubated for 24 h in a humidified incubator at 
37°C. The culture medium was then aspirated, and cells were washed with PBS (2 
ml), followed by the addition of fresh DMEM high glucose medium containing the 
BSA-derived peptide fraction at a concentration determined by the MTT assay (0.02 
mg/ml; prepared from a stock solution of 1 mg/ml) and allowed to adhere for 24 h. 
The culture medium was then removed, and cells were washed with PBS (2 ml), 
followed by treatment with 3 mM t-BHP for 2.5 h. The cells were subsequently 
examined under a phase-contrast microscope (Zeiss Telaval microscope) fitted with a 
camera (Nikon, Japan). 
 
6.2.2.4   Measurement of ROS by chemiluminescence 
Chemiluminescence is a widely employed technique for measuring the production of 
biologically relevant oxidative species, particularly free radicals (Wardman, 2007). 
The interaction of chemiluminescent probes with radicals results in the release of 
energy as photons, which is in turn detectable by a luminometer. Lucigenin is a 
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selective probe for measuring the production of O2−· (Faulkner and Fridovich, 1993; 
Afanas’ev, 2001). 
 
The assay was initiated by seeding EA.hy926 cells in a 25-cm2 cell culture flask at a 
density of 1 × 106 cells per flask and incubated in a humidified incubator at 37C until 
the desired confluence (80%) was attained. The cells were washed once with HBSS 
buffer, followed by the addition of fresh DMEM high glucose medium containing 
0.02 mg/ml of the BSA-derived peptide fraction and incubation for 24 h at 37C. The 
EA.hy926 cells were then treated with 10 nM angiotensin II enzyme (prepared in 
Milli-Q water) for 1 h at 37C. The cells were then washed twice with HBSS buffer 
and detached by trypsinisation. The cells were immediately resuspended in DMEM 
high glucose medium (6 ml) and sonicated for 10 min. The cells were then transferred 
to a 96-well white-bottomed plate, followed by the immediate addition of 200 µM 
lucigenin (prepared in Milli-Q water). The luminescence intensity of the lucigenin-
treated cells was read for 90 s using a Single Probe Luminometer (GloMax® 96 
Microplate Luminometer, Promega). DMEM high glucose medium was employed as 
a negative control (untreated cells). Six replicate samples were employed for each 
experimental condition, and the experiment was independently repeated three times to 
ensure reproducibility (Sukumar et al., 2013). 
 
6.2.2.5   Measurement of ROS using dihydroethidium 
DHE is a cell-permeable lipophilic probe that has been employed for the fluorometric 
detection of O2−·. Following entry into the cell, this probe reacts with O2−· to form a 
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red fluorescent compound (2-hydroxyethidium; (Sudheesh and Vijayalakshmi, 2005), 
which in turn intercalates with DNA to increase the intracellular fluorescence of 
ethidium (Li et al., 2003). 
 
The measurement of ROS using DHE was performed as described in Biancardi and 
Stern (2014), with minor modifications. In brief, EA.hy926 cells were seeded in 25-
cm2 cell culture flasks at a density of 1 × 106 cells per flask and incubated in a 
humidified incubator at 37C until the desired confluence (80%) was attained. The 
cells were then washed once with HBSS buffer, followed by the addition of fresh 
DMEM high glucose medium containing 0.02 mg/ml of the BSA-derived peptide and 
incubation for 24 h at 37C. The EA.hy926 cells were then treated with 10 nM 
angiotensin II enzyme (prepared in Milli-Q water) and incubated for 1 h at 37C. The 
cells were then washed twice with HBSS buffer, followed by the addition of HBSS 
buffer (3 ml) and DHE (at a final concentration of 25 µM; prepared in DMSO) and 
incubation for 30 min at 37C. The cells were then rinsed once with HBSS (2 ml), 
followed by the addition of HBSS buffer (3 ml) and incubation at 37°C for 1 h. The 
buffer was then removed, and the treated cells were scraped from the culture flask 
following the addition of cold methanol (1 ml). The cell suspension was homogenised 
and filtered through 0.22-µm membrane filters to dissociate the cells. The cells were 
then transferred to a 96-well black-bottomed plate, and the fluorescence was detected 
using a fluorometric microplate reader (Varian, USA) using excitation and emission 
wavelengths of 480 and 580 nm, respectively. DMEM high glucose medium was 
employed as the negative control (untreated cells). Eight replicate samples were 
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employed for each experimental condition, and the experiment was independently 
repeated for a minimum of three times. 
 
6.2.2.6   Measurement of NO production 
Nitrite production was quantified using the Griess Reaction Kit (Invitrogen, Paisley, 
UK), according to the manufacturer’s instructions. In biological samples, sulfanilic 
acid reacts with nitrite under acidic conditions to form a diazonium salt, which in turn 
reacts with N-(1-naphthyl) ethylenediamine dihydrochloride (NED) to yield a yellow 
water-soluble azo dye that is detectable at a wavelength of 550 nm using a microplate 
reader (Boehring CO, Marburg, Germany). 
 
In brief, the EA.hy926 cells were seeded in a 96-well cell culture plate at a density of 
2 × 104 cells (200 µl per well) until the desired confluence was attained. Following 24 
h of incubation at 37C, the culture medium was removed and fresh DMEM high 
glucose medium (200 µl) containing various concentrations of the BSA-derived 
peptide (using a stock solution of 1 mg/ml) was added and incubated overnight. The 
culture medium (100 µl) thereby removed was added to a fresh 96-well plate and 
mixed with Griess reagent (20 µl) containing equal proportions of components A and 
B (0.1% NED and 1% sulfanilic acid in 5% phosphoric acid, respectively) and Milli-
Q water (150 µl), followed by incubation for 10 min at room temperature. The yellow 
colour thereby attained was measured at 548 nm. The intensity of the yellow colour is 
proportional to nitrite concentration. The nitrite concentration in the experimental 
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samples was calculated on the basis of the nitrite standard curve, in turn generated 
using the nitrite standard solution provided with the kit. 
 
 6.2.2.7  Determination of ACE inhibitory activity of the BSA-derived 
peptide in EA.hy926 cells 
The ACE inhibitory activity of the BSA-derived peptide in EA.hy926 cells was 
determined using the fluorometric method detailed in Sentandreu and Toldrá (2006) 
and Samaranayaka et al. (2010), with slight modifications. EA.hy926 cells were 
seeded in 25-cm2 cell culture flasks at a density of 1 × 106 cells per flask and 
incubated in a humidified incubator at 37°C until the desired confluence (80%) was 
attained. The cells were then washed once with HBSS buffer, followed by the 
addition of fresh DMEM high glucose medium containing 0.02 mg/ml of the BSA-
derived peptide and overnight incubation. The cells were then rinsed twice with 
HBSS buffer and harvested with HBSS (1 ml). The harvested cells (20 µl) were added 
to 5 mM HHL (80 µl; prepared in HBSS buffer) to allow the hydrolysis of HHL to 
HA by ACE and incubated for 3 h in a humidified incubator at 37C. The reaction 
was then inactivated by the addition of 0.5 M NaOH (1.4 ml), followed by the 
addition of o-phthaldialdehyde dye (10 mg/ml prepared in methanol; 100 µl) to allow 
the detection of HHL and incubation at room temperature for 5 min. The enzymatic 
reaction was subsequently terminated by the addition of 6 M HCl (250 µl). The cells 
were then transferred to a 96-well black-bottomed plate, and the activity of ACE was 
measured using a fluorometric microplate reader (Varian, USA) using excitation and 
emission wavelengths of 365 and 495 nm, respectively. DMEM high glucose medium 
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was employed as the negative control (untreated cells), and captopril (1 µM) was used 
as the positive control. Twelve replicate samples were employed for each 
experimental condition, and the experiment was independently repeated for a 
minimum of three times. 
 
6.2.3   Statistical analysis 
Each experiment was independently repeated three times to ensure reproducibility, 
and all assays were run at least in triplicate. Data are presented as mean ± SD and 
were analysed using statistical package for the social sciences (SPSS). One-way 
analysis of variance (ANOVA) in conjunction with Dunnett’s multiple comparison 
test was employed for determining the significance of differences between the mean 
values of control and test treatments. Differences were considered to be significant at 
P < 0.05 (95% confidence interval). 
 
6.3   Results and discussion 
Endothelial cells present a good in vitro tool for studying various physiological and 
pathological cellular processes. The morphological characteristics and functional 
properties of EA.hy926 cells are similar to those of human macrovascular endothelial 
cells (Bouïs et al., 2001). The EA.hy926 cells are relatively easy to handle and have 
therefore been extensively employed in several cell culture-based studies, including 
studies on oxidative stress, protein expression, leukocyte adhesion and cardiovascular 
studies (Song et al., 2000; Dichtl et al., 2003; Yu et al., 2007; Piqueras et al., 2007). 
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The present study employs EA.hy926 cells as a model system for studying the effect 
of BSA-derived peptide on ROS accumulation in human endothelial cells and in ACE 
inhibition.  
 
6.3.1 Viability of EA.hy926 cells treated with the BSA-derived 
peptide fraction GF22 
The viability of the endothelial cell line EA.hy926 was examined in the presence of 
the BSA-derived peptide fraction by the MTT assay, which is dependent on 
mitochondrial metabolism in viable cells. Viability of the cells treated with the 
peptides was detected 24 h post-addition of the peptide. 
 
Figure 6.1  Viability of EA.hy926 cells treated with various concentrations of the bovine 
serum albumin-derived peptide fraction gel-filtration fraction 22. Cell viability was 
determined at a wavelength of 492 nm by the 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tetrazolium bromide assay. Untreated cells were employed as the negative control. Triplicate 
samples were employed for each experimental condition (n = 3), and the experiment was 
independently repeated three times to ensure reproducibility. The different columns represent 
means with significant differences (P < 0.05). Data are presented as mean ± SD. 
 
100 98.6
92.3 90.2
81.1 80.3
76.3 76.4
70
0
20
40
60
80
100
120
control 0.02 0.04 0.06 0.08 0.2 0.4 0.6 0.8
C
el
l v
ia
b
ili
ty
 (%
)
Concentrations (mg/ml)
 187 
 
Figure 6.1 shows the viability of EA.hy926 cells (plated at a density of 20,000 
cells/well) treated with various concentrations (0.02–0.8 mg/ml) of the BSA-derived 
peptide fraction GF22 for 24 h; a slight decrease in growth rate was observed with an 
increase in peptide concentration. Treatment with the peptide at the indicated 
concentrations did not cause any significant toxicity during the 24-h incubation 
period, and the results were statistically significant (P ≤ 0.05). Compared with the 
control (100% viability), treatment with 0.02 mg/ml peptide yielded the highest cell 
viability (98.6%; P ≥ 0.05) among the various peptide concentrations tested. This 
peptide concentration (0.02 mg/ml) was therefore selected for use in subsequent 
experiments in EA.hy926 cells because of the high rate of cell growth and lack of 
cytotoxicity associated with this concentration. 
 
 
Figure 6.2  Viability of EA-hy926 cells treated with the bovine serum albumin-derived 
peptide fraction gel-filtration fraction 22 at a concentration of 0.02 mg/ml. Cell viability was 
determined at a wavelength of 492 nm by the 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tetrazolium bromide assay. Untreated cells were employed as the negative control, and trolox 
(0.01%) and ascorbic acid (0.01%) were used as positive controls. Data are presented as mean 
± SD of triplicate measurements (n = 3). 
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The viability of the cell line EA.hy926 was determined upon treatments with the 
BSA-derived peptide (0.02 mg/ml) and the commercial antioxidative agents ascorbic 
acid (0.01%) and trolox (0.01%) by the MTT assay, as shown in Figure 6.2. A higher 
percentage of cell viability (98.6%) was observed upon treatment of EA.hy926 cells 
with the peptide (0.02 mg/ml) in comparison with ascorbic acid (94.5%; P < 0.01); 
however, the highest percentage of viability was observed in EA.hy926 cells treated 
with trolox (101.5%), which was higher than that in the untreated cells (100%; P ≥ 
0.05). Statistically significant differences in the viability of EA.hy926 cells treated 
with the BSA-derived peptide and trolox (P ≤ 0.05) were obtained using ANOVA. 
This result strongly suggests that the bioactive peptide derived from the dairy protein 
exhibits good cellular antioxidant activity at the selected concentration. 
 
6.3.2    Viability of tert-butyl hydroperoxide-treated EA.hy926 cells 
The membrane-permeable oxidative agent t-BHP has been widely employed for 
studying the mechanism of cell injury resulting from oxidative stress (Williams and 
Jeffrey, 2000). This toxic compound affects cell integrity and triggers lipid 
peroxidation as a result of its metabolic conversion to free radicals by the action of 
cytochrome P-450 in cultures of various types of cells (Martı́n et al., 2001). Figure 6.3 
shows the viability of EA.hy926 cells treated with various concentrations of t-BHP 
relative to the negative control (untreated cells), as determined by the MTT assay. 
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Figure 6.3  Viability of EA.hy926 cells treated with various concentrations of tert-butyl 
hydroperoxide for 2.5 h. Cell viability was assessed at 492 nm by the 3-[4,5-dimethylthiazol-
2-yl]-2,5 diphenyl tetrazolium bromide assay. Untreated cells were employed as negative 
control. Data are presented as mean ± SD of triplicate measurements (n = 3). 
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These results indicate that t-BHP exerted cytotoxic effects in endothelial cells in a 
dose-dependent manner. Several studies have reported cytotoxic effects of t-BHP in 
endothelial cells through the generation of highly reactive hydroxyl radicals (Chapple 
et al., 2013). Significantly, these highly reactive radicals react with cellular 
macronutrients such as proteins and lipids in a relatively uncontrolled manner, 
generating a series of free radicals, thereby leading to oxidative cell death (Lemire et 
al., 2013). The generation of reactive radicals by t-BHP is higher at high 
concentrations, as witnessed by the increased cytotoxic effects in endothelial cells at 
higher concentrations such as 20 mM (Fig. 6.3) (Prasad et al., 2007; Chapple et al., 
2013). 
 
6.3.3   Protective effects of the BSA-derived peptide fraction against 
tert-butyl hydroperoxide-induced oxidative stress 
The protective effects exerted by the BSA-derived peptide fraction GF22 on the 
viability of the endothelial cell line EA.hy926 treated with t-BHP were assessed by 
the MTT assay. As depicted in Figure 6.4, increased cell viability was observed upon 
treatment of endothelial cells with the peptide (0.02 mg/ml; 97.4% viability). As 
expected, compared with the treatment with t-BHP alone (53.6%), preincubation of 
cells with the peptide conferred significant protection against the cytotoxicity 
generated by treatment with 3 mM t-BHP for 2.5 h, as evidenced by enhanced 
viability (70.4%) at the selected concentration and in a time-dependent manner. 
Statistical analysis using ANOVA revealed significant differences between the 
various test treatments (P ≤ 0.01). 
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Figure 6.4  Protective effects of the bovine serum albumin-derived peptide fraction GF22 
(0.02 mg/ml) against oxidative stress induced by tert-butyl hydroperoxide (3 mM) in the 
endothelial cell line EA.hy926. Untreated cells were employed as the negative control. The 
different columns represent means with significant differences (P < 0.05). Data are presented 
as mean ± SD of triplicate measurements (n = 3). 
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6.3.4   Morphological alterations in EA.hy926 cells 
Changes in the morphological features of the endothelial cells EA.hy926 treated with 
t-BHP in the presence or absence of the BSA-derived peptide fraction were 
investigated using a phase-contrast microscope. The untreated endothelial cells 
(negative control) exhibited regular morphology forming a confluent monolayer on 
the flask surface (Fig. 6.5A). Similarly, EA.hy926 cells treated with the peptide (0.02 
mg/ml), trolox (0.01%) and ascorbic acid (0.01%) also exhibited normal morphology, 
with healthy-appearing cells resembling the negative control, suggesting the lack of 
effect of the treatments on the morphology of endothelial cells (Fig. 6.5, panels B, C, 
and D, respectively). In contrast, treatment with 3 mM t-BHP resulted in marked 
morphological changes because of the cytotoxic effects of t-BHP (Fig. 6.5F). 
However, pretreatment of cells with the BSA-derived peptide exerted remarkable 
protective effects in endothelial cells at 48 h post-treatment with 3 mM t-BHP for 2.5 
h; this protective effect is attributable to the antioxidant and radical-scavenging 
activities of the peptide (Fig. 6.5E). 
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 (A) Control (untreated cells)                                                (B) Peptide (0.02 mg/ml)                              
               
(C) Trolox (0.01%)                                                                   (D) Ascorbic acid (0.01%)  
                     
            
  (E) Peptide (0.02 mg/ml) and t-BHP (3mM)                        (F) t-BHP (3mM) 
 
Figure 6.5  Changes in morphological features of the endothelial cell line EA.hy926 upon 
treatment with the bovine serum albumin-derived peptide fraction (0.02 mg/ml) and tert-butyl 
hydroperoxide (3 mM). Cells were observed under a phase-contrast microscope (Zeiss 
Telaval microscope) fitted with a camera (Nikon, Japan). 
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6.3.5   Measurement of ROS by chemiluminescence 
Lucigenin-enhanced chemiluminescence is a widely employed technique for the 
detection of ROS in endothelial as well as other cell types (Caldiz et al., 2007). This 
technique involves the release of a photon from the chemiluminescent probe lucigenin 
following exposure to O2−·, which in turn is detectable using a luminometer. O2−· 
reacts with the probe lucigenin and reduces the lucigenin cation (LC2+) to cation 
radical (LC·+), which subsequently reacts with a second radical to form the energy-
rich dioxetane (LCO2), which emits a photon (Li et al., 1998; Kuribayashi et al., 
2008). 
 
Mitochondrial ROS (mROS) are known to be essential for cellular signalling 
pathways that regulate normal physiological processes; however, excessive 
production of mROS results in oxidative stress and thereby induces mitochondrial 
dysfunction in endothelial and vascular smooth muscle cells (Dikalov and 
Nazarewicz, 2013). Angiotensin II (Ang II) hormone has been shown to promote the 
synthesis of intracellular mROS, particularly O2−· and hydrogen peroxide (H2O2), in 
endothelial cells by stimulating NADPH oxidase in mitochondria (Sachse and Wolf, 
2007; Thakur et al., 2010). Consequently, Ang II mediates endothelial dysfunction 
resulting in alterations in cardiovascular and renal cells, suggesting that antioxidant 
activities that inhibit Ang II confer protection to EA.hy926 cells against mROS-
induced oxidative stress (Dikalov and Nazarewicz, 2013). 
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Figure 6.6   Effect of the bovine serum albumin (BSA)-derived peptide fraction GF18 on the 
generation of mitochondrial ROS (mROS). The endothelial cell line EA.hy926 was treated 
with Ang II for 1 h in the presence or absence of the BSA-derived peptide fraction, and 
mROS production was detected by chemiluminescence using lucigenin as a probe. Untreated 
cells were employed as the negative control. The different columns represent means with 
significant differences (P ≤ 0.05). Data are presented as mean ± SD of triplicate 
measurements (n = 3). 
 
In the present study, mROS production was assessed by chemiluminescence using 
lucigenin as a probe to establish that the BSA-derived peptide fraction could inhibit 
Ang II-mediated oxidative stress in EA.hy926 cells. Figure 6.6 shows the marked 
increase in chemiluminescence units in EA.hy926 cells treated with Ang II alone 
(30.8%), attributable to high oxidant levels resulting from mROS overproduction. 
However, compared with treatment with Ang II alone, mROS production was 
significantly decreased upon treatment of EA.hy926 cells with the peptide, both in the 
presence and absence of Ang II (24.2% and 15.3%, respectively; P ≤ 0.01). Compared 
with untreated cells, treatment with the peptide alone resulted in a slight decrease in 
mROS levels because of the scavenging activity of the peptide; however, the 
difference was not statistically significant (P ≥ 0.05). 
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These results suggest that the purified peptide exerts protective effects against Ang II-
mediated oxidative damage in endothelial cells and has the ability to reduce mROS 
production through its action as an ROS scavenger (Wiriyaphan et al., 2012). 
 
6.3.6   Measurement of ROS using dihydroethidium 
The cellular production of ROS is also detectable by a fluorescent technique involving 
the use of a nonfluorescent hydrophobic compound DHE. The diffusion of DHE into 
cells is followed by its oxidisation to the positively charged ethidium (EB) in the 
presence of intracellular ROS, resulting in red fluorescence (Zielonka et al., 2009). 
 
The treatment of EA.hy926 cells with Ang II alone resulted in marked increase in 
intracellular mROS production (fluorescence intensity of 2.45), as assessed by the 
detection of 2-hydroxyethidium (Fig. 6.7); this is attributable to the activation of Ang 
II, which leads to excessive production of mROS in endothelial cells, thereby 
resulting in endothelial dysfunction (Thakur et al., 2010). However, compared with 
cells treated with Ang II alone, a statistically significant decrease in ROS production 
was observed upon treatment of EA.hy926 cells with the peptide, both in the absence 
and presence of Ang II (fluorescence intensity of 1.62 and 0.77, respectively; P < 
0.001). Compared with untreated cells, treatment with the peptide alone resulted in a 
slight decrease in the mROS levels because of the scavenging activity of the peptide, 
and the difference was statistically significant (P ≤ 0.05). 
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Figure 6.7   Effect of the bovine serum albumin (BSA)-derived peptide fraction GF18 on the 
generation of reactive oygen species (ROS). The endothelial cell line EA.hy926 was treated 
with angiotensin II for 1 h in the presence and absence of the BSA-derived peptide fraction. 
ROS production was detected by a fluorescent technique involving the use of a 
nonfluorescent hydrophobic compound dihydroethidium. Untreated cells were employed as 
the negative control. The different columns represent means with significant differences (P ≤ 
0.05). Data are presented as mean ± SD of triplicate measurements (n = 3). 
 
These results highlight the protective effects exerted by the BSA-derived peptide 
fraction against Ang II-mediated oxidative damage in endothelial cells and its ability 
to inhibit mROS production through its action as an ROS scavenger (Jung et al., 
2007; Bougatef et al., 2009). The antioxidant activity of the purified peptide is 
attributable to its amino acid sequence and the presence of amino acid residues with 
radical scavenging activities, as discussed previously (Section 4.3.3). Of the two 
techniques employed for the in vitro detection of mROS, lucigenin-enhanced 
chemiluminescence appears to be more sensitive than DHE-mediated fluorescence in 
endothelial cells (Susanto et al., 2006). 
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6.3.7   Determination of NO production 
The production of NO was detected in EA.hy926 cells at 24 h post-treatment with 
various concentrations of the BSA-derived peptide fraction by detecting the 
accumulation of nitrite (NO2·), the stable conversion product of NO in culture 
supernatants. NO detection was accomplished using the Griess reagent kit (Lauer et 
al., 2001), which allows colorimetric detection of NO products, particularly nitrites 
and nitrates. In fact, this kit has been widely employed for determining NO 
production in the presence of several food proteins and peptides (Jia et al., 2012; Ngo 
et al., 2014). 
 
 
Figure 6.8  Production of nitric oxide following the treatment of EA.hy926 cells with 
different concentrations of the bovine serum albumin-derived peptide fraction gel-filtration 
fraction 22 for 24 h. Untreated cells were employed as the negative control. The different 
columns represent means with significant differences (P ≤ 0.05). Data are presented as mean 
± SD of triplicate measurements (n = 3). 
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The effect of the BSA-derived peptide fraction on NO production was assessed using 
different concentrations of the peptide (0.02–0.8 mg/ml), as shown in Figure 6.8. 
Treatment with the purified peptide resulted in decreased NO formation in the culture 
supernatant in a concentration-dependent manner (P ≤ 0.05). NO production in 
EA.hy926 cells was inhibited at all tested concentrations of the peptide (P ≤ 0.05); 
however, compared with the negative control, significant inhibition of NO production 
(0.02 µM nitrite concentration) was observed at a peptide concentration of 0.08 
mg/ml (P < 0.001). 
 
Reactive nitrogen species play various functional roles when produced in limited 
concentrations, including as a vasodilator, immune regulator and neurotransmitter. 
However, excessive production of NO allows its reaction with O2−·, leading to the 
formation of harmful peroxynitrite radicals. In biological systems, these radicals cause 
damage to several macromolecules, resulting in protein nitration, DNA strand 
breakage and guanine nitration, which leads to cytotoxicity and mutagenesis 
(Napolitano et al., 2005). In the present study, different concentrations of the BSA-
derived peptide fraction were found to exert protective effects against the damaging 
effects of excessive NO production by reducing nitrite concentration. 
 
The amino acid composition of peptides is known to play an important role in the 
inhibition of NO production, as described previously (Section 4.3.3); the BSA-derived 
GF peptide fraction GF22 contains amino acid residues such as lysine, which has been 
reported to reduce cellular NO production by inhibiting cationic amino acid 
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transporters, which in turn inhibits the uptake of cationic amino acids, particularly L-
arginine (Luiking and Deutz, 2007; Cui et al., 2011). The decreased uptake of L-
arginine in turn decreases the intracellular production of NO (Cui et al., 2011). 
 
 6.3.8   Determination of ACE inhibitory activity of the BSA-derived 
peptide fraction in EA.hy 926 cells 
In this study, cellular inhibition of ACE activity was assessed using a fluorescence-
based method, as detailed in Sentandreu and Toldrá (2006) and Samaranayaka et al. 
(2010), with slight modifications. The ACE inhibitory activity of different 
concentrations of the BSA-derived peptide fraction GF22 in the endothelial cell line 
EA.hy926 is shown in Figure 6.9. 
 
Figure 6.9  The angiotensin-I-converting enzyme inhibitory activity resulting from 24-h 
treatment with different concentrations (0.02–0.8 mg/ml) of the bovine serum albumin-
derived peptide fraction in the endothelial cell line EA.hy926. The activity was measured 
using a fluorescence-based method. Captopril (1 µM) was employed as the positive control. 
The different columns represent means with significant differences (P ≤ 0.05). Data are 
presented as mean ± SD of triplicate measurements (n = 3). 
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Figure 6.9 shows that the BSA-derived peptide fraction GF22 causes a significant 
increase in the ACE inhibitory activity in a dose-dependent manner (P ≤ 0.05) in 
EA.hy926 cells, with ACE inhibition achieved at all tested concentrations of the 
peptide (P ≤ 0.05). However, compared with the positive control captopril, marked 
inhibition of ACE activity was attained at a peptide concentration of 0.8 mg/ml 
(88.6% vs. 70.7%; P < 0.001). 
 
In the cardiovascular system, ACE inhibitory activity reduces the production of Ang 
II and increases vasodilation by interrupting the conversion of Ang I to Ang II. 
Reduced production of Ang II is known to lower blood pressure, decrease O2−· 
production and reduce smooth muscle cell proliferation. Therefore, the inhibition of 
ACE activity is important for decreasing cardiovascular morbidity and mortality 
(Bougatef et al., 2009). In the present study, the BSA-derived peptide fraction proved 
effective in inhibiting the activity of ACE in a dose-dependent manner, suggesting 
that the BSA-derived peptide could decrease the rate of Ang II formation in cells. 
 
The presence of hydrophobic amino acid (aromatic or branched chain) residues such 
as phenylalanine, tryptophan and tyrosine within the peptide sequence is likely to 
significantly contribute to the ACE inhibitory activity of the peptide, as described 
previously (Section 4.3.3). Several studies have reported ACE inhibitory activities of 
various proteins and polyphenols in endothelial cells (Aviram and Dornfeld, 2001; 
Person et al., 2009; Rousseau-Ralliard et al., 2010). 
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6.4   Conclusion 
The present study shows that the BSA-derived peptide fraction GF22, obtained upon 
the hydrolysis of BSA with pepsin, exhibited good antioxidant activity and exerted a 
protective effect in the endothelial cell line EA.hy926 against t-BHP-induced 
oxidative stress. A slight decrease in the growth rate was observed upon increasing 
peptide concentrations; however, significant toxicity was not observed during the 24-
h assay period. The characterisation of morphological features revealed the protective 
effects of the BSA-derived peptide in endothelial cells after 48 h after treatment with 
3 mM t-BHP, attributable to the antioxidant effects of the peptide and its radical 
scavenging activity. The use of fluorescence-based techniques (lucigenin-enhanced 
chemiluminescence and DHE-based fluorescence techniques) also revealed the 
protective effects of the BSA-derived peptide against Ang II-mediated oxidative 
damage in endothelial cells and its ability to reduce mROS production through its 
activity as a ROS scavenger. In addition, different concentrations of the BSA-derived 
peptide fraction showed the ability to protect cells from the damaging effect of 
excessive NO production by reducing the nitrite concentration. Thus, the study 
revealed that the BSA-derived peptide exhibited the capacity to inhibit ACE activity 
in a dose-dependent manner. Moreover, the antioxidant and ACE inhibitory activities 
of the BSA-derived peptide were associated with the presence of specific amino acid 
residues in the peptide sequence. These results suggest that the BSA-derived peptide 
fraction GF22 exhibits both antioxidant and ACE inhibitory activities in the 
endothelial cell line EA.hy926. 
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7  General discussion and conclusions  
7.1  General discussion  
7.1.1  Bovine serum albumen protein and peptides 
Bioactive peptides represent an important source of health-promoting food. They have 
shown several useful properties for human health, including antimicrobial, 
antioxidant, antihypertensive, antiviral and antitumor activities. These peptides 
remain inactive when present as part of the primary structure of the parent proteins; 
however, they can be released during gastrointestinal digestion or food processing 
from many plant or animal proteins. As a result, researchers have tried to produce 
bioactive peptides from food, to study their properties and applications in various 
areas.  
 
Serum albumin, which has been extensively studied over several years (Carter and 
Ho, 1994b), is a highly abundant protein in the blood plasma. Bovine serum albumin 
(BSA) is among the most commonly studied proteins and the chief serum albumin 
protein derived from cows, including meat and dairy products. BSA is one of the main 
components of blood plasma, accounting for approximately 60% of its total protein 
content (Moriyama et al., 1996). It is also present in milk accounting for 1.2% of its 
total protein content. 
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This study aimed to examine the biological functions and the nutritional value of 
bovine serum albumin. Therefore, the main objective of this study was the 
identification of the in vitro antioxidant and angiotensin-I-converting enzyme 
inhibitory peptides derived from bovine serum albumin and the characterization after 
further purification. To achieve this, the crude BSA was hydrolysed using digestive 
enzyme pepsin. Then, the bioactive peptides generated from BSA hydrolysates were 
fractionated by UF using membranes with MWCO of < 10 kDa followed by 
purification using gel-filtration chromatography (Martínez-Maqueda et al., 2013); the 
peptides were then tested for their antioxidant and ACE-inhibitory activities. The 
amino acid composition of their purified peptide was analysed by HPLC. 
 
7.1.2  Antioxidant activities of peptides derived from bovine serum 
albumen protein hydrolysate 
Lipid oxidation is a complex process in biological systems that proceeds via radical-
mediated elimination of hydrogen atoms from the methylene group of polyunsaturated 
fatty acids, initiating a sequence of reactions that produce potentially toxic substances 
such as aldehydes and ketones (Niki, 2010; Winczura et al., 2012). Thus, inhibition of 
lipid oxidation is an important parameter for evaluating the total antioxidant potential 
of food proteins and peptides. 
 
BSA hydrolysates obtained upon incubation with pepsin for different time periods (2, 
3, 4, and 6 h) were assayed in the linoleic acid model system over a period of 7 days 
and then subject to FTC assay to assess optimum conditions for the enzymatic activity 
 206 
 
of pepsin. Hydrolysates generated following a 6-h incubation with pepsin 
demonstrated the highest lipid peroxidation inhibitory activity (40.7%), followed by 
incubations for 4, 3, and 2 h (25.7%, 19.4%, and 14.7% activity, respectively); 
statistically significant differences were obtained between the test samples (P ≤ 0.05). 
 
BSA hydrolysate and its peptide fraction (< 10 kDa) were used in the linoleic acid 
emulsion as a potential antioxidant and the results showed that they can inhibit the 
formation of peroxides and MDA. Based on FTC assay, BSA hydrolysate, its peptide 
fraction (< 10 kDa), trolox, and BHA, presented a considerably higher percentage 
inhibition of lipid oxidation with 34.9%, 44.8%, 73.7% and 79.9% respectively. 
Likewise, TBARS inhibition was 42.8%, 54.8%, 76.7% and 84.4% for BSA 
hydrolysate, <10 kDa, BHA and trolox respectively. It is clear that the antioxidant 
activity determined using the TBARS assay was slightly higher (significant) 
compared with the FTC assay, suggesting that the BSA hydrolysate and its peptide 
fraction (< 10 kDa) displayed slightly higher efficiency in inhibiting the production of 
MDA compared with peroxide. 
       
Further purification of the < 10 kDa peptide fraction by gel filtration chromatography 
yielded 14 peptide fractions (numbered 13–26), the separation of peptides was 
detected at 250 nm. Based on the FTC assay, fraction number 18 (GF18) exhibited the 
highest antioxidant activity (65.93%) among the GF fractions. The antioxidant 
activity of GF18 was slightly decreased compared with the known antioxidants BHA 
and trolox (69.5% and 78.5%, respectively). The lipid oxidation inhibitory activity of 
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the BSA-derived peptide fraction GF18 was found to be dose dependent with strong 
positive linear correlation between peptide concentration and lipid oxidation 
inhibitory activity (R2 ≥ 0.963). The effective peptide concentration capable of 
inhibiting 50% of lipid oxidation in the linoleic acid model system, (IC50) was found 
to be 0.467 mg/ml. The presence of hydrophobic amino acids such as phenylalanine, 
valine, leucine, alanine, and tryptophan in the peptide fraction GF18 is likely to 
significantly contribute to its free-radical scavenging activity (Rajapakse et al., 2005; 
Udenigwe and Aluko, 2011). Moreover, the hydrophobicity of peptides facilitates its 
antioxidant activity by enhancing solubility within lipids and providing better access 
to the free radicals generated during lipid oxidation (Sarmadi et al., 2011). 
 
7.1.3  Mechanism of antioxidant activity of the ultrafiltration peptide 
fraction (< 10 kDa) of bovine serum albumin hydrolysates 
 
Five distinct experiments were carried out for characterizing the antioxidant activity 
of the BSA-derived UF peptide fraction (< 10 kDa) on the basis of its amino acid 
content, including the 1, 1-diphenyl-2-picrylhydrazyl (DPPH•), hydroxyl (OH•) and 
superoxide anion (O2
-•) radical scavenging; ferric (Fe3+) reducing and ferrous (Fe2+) 
ion chelating activities. 
 
The reducing power of the BSA-derived peptide fraction (< 10 kDa) was found to be 
dose-dependent with increasing reducing power observed upon increasing peptide 
concentration over the range 0.5–20 mg/ml (P ≤0.05). BSA-derived UF peptide 
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fractions have been shown to possess the ability to reduce Fe3+/ferricyanide complex 
to Fe2+ stable forms ((Beyhan and Gedikli, 2010). However, the reducing activity of 
the BSA-derived peptide fraction (< 10 kDa) at 10 mg/ml concentration was 
significantly lower (0.1) compared with the known antioxidants BHA and trolox 
(absorbance of 0.14 and 0.16, respectively, P ≤ 0.05), These results suggest that the 
BSA hydrolysate generated in the present study through proteolytic digestion with the 
enzyme pepsin contains peptides or amino acids capable of functioning as an electron 
donor and reacting with free radicals to form stable products.  
 
The presence of BSA-derived UF peptide fraction in the reaction mixture as 
antioxidant agents with chelating activity decreased the intensity of the (Fe2+–Fz3) 
complex. The chelating activity of the peptide fraction increased with increasing 
concentrations of the peptide, suggesting a dose-dependent Fe2+-chelating activity of 
the peptide fraction over the concentration range 0.5–20 mg/ml. The BSA-derived 
peptide fraction was observed to exhibit lower Fe2+-chelating activity (33.5%) 
compared with the synthetic chelator EDTA (64.7%, P≤0.05) (Torres-Fuentes et al., 
2011). The Fe2+-chelating activity observed in the present study may be attributed to 
the presence of histidine residues in the peptide. Moreover, the chelation of pro-
oxidant metal ions such as iron and copper by histidine-containing peptides may lead 
to subsequent reduction in lipid peroxidation in both biological and food systems. 
 
The radical scavenging activity of BSA-derived UF peptide fraction (< 10 kDa) was 
examined based on the radical scavenging assays of DPPH. The treatment of DPPH 
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radical with a proton (H+)-donor such as antioxidants results in quenching of the 
radical and change in color of the DPPH solution from dark purple to pale yellow, 
accompanying the transfer of an electron from the antioxidant scavengers to the 
DPPH radical and the formation of a stable non-radical compound DPPH-H (Xie et 
al., 2008; Liu et al., 2010). The scavenging activity of the BSA-derived peptide 
fraction (< 10 kDa) was found to be dose dependent with an IC50 15.2 mg/ml (Sun et 
al., 2013). The DPPH scavenging activity of the BSA-derived peptide (< 10 kDa) was 
found to be higher (42.5%) than that of BHA (33.7%). Statistically significant 
differences in DPPH scavenging activity were observed between the antioxidant 
peptide and trolox (56.8%, P≤ 0.05). These results indicate that the BSA-derived 
peptide fraction (< 10 kDa) contains a higher proportion of amino acid groups capable 
of donating electrons to the DPPH radical compared with larger peptides.  
 
The superoxide scavenging activity of the peptide fraction increased with an increase 
in sample concentration over the range 0.5–20 mg/ml, corresponding to 25.5%–89.7% 
activity (Moure et al., 2006). The IC50 was calculated as 13.2 mg/ml from linear 
regression analysis of superoxide scavenging activity and various concentrations of 
the BSA-derived peptide fraction (< 10 kDa); the activity was also found to be dose- 
dependent (Udenigwe et al., 2009). The scavenging activity of the peptide at 10 
mg/ml was significantly higher (52.5%) compared with the well-known antioxidants 
BHA and trolox (20.9% and 35.2%, respectively; P ≤ 0.05). These results clearly 
show that the BSA-derived peptide fraction (< 10 kDa) has the ability to successfully 
inhibit superoxide-induced damage to vital cellular components (Sannigrahi et al., 
2010). 
 210 
 
The hydroxyl radical scavenging activity increased from 8.5% to 65.8% with increase 
in peptide concentrations (5-20 mg/ml), with the highest scavenging activity observed 
at 20 mg/ml peptide concentration (65.8%). The BSA-derived peptide exhibited dose-
dependent hydroxyl radical scavenging activity due to the presence of amino acids 
that function as hydrogen donors, thereby stabilizing the hydroxyl radical (Jung et al., 
1995). The hydroxyl radical scavenging activity of the BSA-derived peptide at 10 
mg/ml was lower (38.8%) compared with BHA (52.9%) and trolox (66.2%; P ≤ 0.05) 
(Zhuang et al., 2013). 
 
7.1.4 Angiotensin-I-converting enzyme inhibitory peptides derived 
from bovine serum albumin 
Hypertension is a significant global public health issue in the developed world and a 
rapidly emerging problem in developing countries (Zhang et al., 2006; Lin et al., 
2012c). Several therapeutic approaches have been employed for the treatment of 
hypertension, including the use of medicines containing synthetic ACE inhibitors, 
which are known to cause undesirable side effects (Antonios and MacGregor, 1995; 
Coleman and Cox, 2011). Naturally occurring peptides capable of inhibiting ACE 
activity have been isolated from hydrolysates of several food proteins (Ariyoshi, 
1993). In the present study, BSA hydrolysis was carried out for 6 h using the protease 
pepsin, which allows investigation of the gastric degradation of the BSA-derived ACE 
inhibitory peptide. BSA hydrolysates at 10 mg/ml were found to exhibit ACE 
inhibitory activity of 30.2% and a low IC50 of 0.75 mg/ml. Following enrichment by 
ultrafiltration, the peptide fraction of molecular weight < 10 kDa at 10 mg/ml 
exhibited significantly increased ACE inhibitory activity (44.7%) at a concentration 
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of 10 mg/ml and a corresponding IC50 of 0.56 mg/ml. However, the positive control 
captopril, a strong ACE inhibitor, exhibited highest ACE inhibitory activity (88.5%) 
and a lower IC50 of 0.022 µM among the test samples (P ≤ 0.001) (Li et al., 2012).  
 
Further purification of the ultrafiltration peptide fraction (<10 kDa) using GF 
chromatography yielded 14 fractions (numbered 13–26), possessing ACE inhibitory 
activity; of these, GF22 was the most potent and exhibited the highest ACE inhibitory 
activity (79.5%) and a low IC50 (0.32 mg/ml). The percentage inhibition of ACE 
activity exhibited by GF22 was significantly lower than that of the synthetic ACE 
inhibitor captopril (79.5% and 88.5%, respectively; P ≤ 0.05). The three-dimensional 
structure of ACE reveals that its somatic isoform is composed of two active sites 
termed the N- and C-domains. ACE inhibitors could act on both active sites; however, 
the C-domain active site appears to play a more important role in regulating blood 
pressure (Wei et al., 1992; Johnston, 1994). Moreover, bioactive peptides with 
hydrophobic and aromatic amino acids in the C-domain also contribute to binding 
with angiotensin II receptors, thereby blocking the activity of ACE (Ryan et al., 
2011). In this study, the amino acid profile of GF22 exhibited variations and included 
a high proportion of phenylalanine, tryptophan, and tyrosine, suggesting that these 
amino acids could be responsible for the activity that was observed by this fraction. 
The ACE inhibitory activity of the peptide derived from BSA hydrolysate may be 
attributed to the presence of hydrophobic amino acids (Ghassem et al., 2011). 
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The mechanism of ACE inhibition by fraction GF22 was determined using the 
Lineweaver-Burk plot. The kinetics of ACE inhibition was examined at two different 
concentrations (4 and 10 mg/ml) of the peptide. The rate of ACE activity was found to 
be significantly higher in the control (uninhibited ACE in the absence of peptide) as 
opposed to the test samples (in the presence of peptide), suggesting that the ACE-
inhibitory peptide derived from BSA decreased the rate of ACE activity, which 
catalyzes the release of HA from Hip–His–Leu substrate. The Michaelis–Menten 
constant (Km) and maximum velocity (Vmax) were analyzed using the Lineweaver–
Burk plot. The Km values for the negative control and the peptide concentrations 4 and 
10 mg/ml were 0.61mM, 0.66 and 0.69 mM respectively, while the corresponding 
Vmax values were 0.46, 1.7 and 2.5 mM/min, respectively. These results confirm that 
the BSA-derived GF peptide fraction GF22 is a competitive inhibitor of ACE, which 
gains access to and competes with the Hip–His–Leu substrate for binding to the active 
site of ACE (Rao et al., 2012). To conclude, the present study shows that BSA is a 
potential source of ACE inhibitory peptides and could be employed as a component of 
functional foods and nutraceuticals. 
 
7.1.5 Antioxidant activity of the bovine serum albumin-derived 
peptide against tert-butyl hydroperoxide-induced oxidative stress in 
the human intestinal Caco-2 cell line 
The partial reduction of oxygen to various reactive oxygen species (ROS) such as 
superoxide ion biradical (O2−·), hydroxyl radical (OH.), and oxidants such as 
hydrogen peroxide (H2O2) accompanies various metabolic processes (Jaiswal, 2004; 
 213 
 
Perjés et al., 2012). Extreme production of ROS results in oxidative damage to several 
cellular components, particularly membrane proteins, lipids, enzymes and DNA. 
Therefore, the aim of the present study was to use Caco-2 cells as a valid cell culture 
model to assess the protective effect of bovine serum albumin (BSA)-derived gel-
filtration (GF) peptide fraction GF18 (see Chapter 2) against tert-butyl hydroperoxide 
(t-BHP)-induced oxidative damage in cultures of Caco-2 epithelial cell line. 
 
The treatment of Caco-2 cells (20,000 cells/well) with the BSA-derived peptide 
fraction GF18 for 24 h resulted in excellent cell viability (≥80%), indicating that the 
range of peptide concentration employed (0.002–0.8 mg/ml) did not cause cellular 
damage or exert cytotoxic effects during the 24-h incubation period. Similar cell 
viability was observed upon treatments with the peptide at 0.008 mg/ml and the two 
well-known antioxidants ascorbic acid and trolox (99.7%, 95.2%, and 92.8% viability, 
respectively; P ≥ 0.05). This result strongly supports previous observations that the 
bioactive peptide derived from dairy proteins exhibits good cellular antioxidant 
activity comparable with that of the positive controls (antioxidants) at the 
concentrations selected (Serafini et al., 2002; Vinson et al., 2002). Pre-incubation of 
the peptide for 2.5 hours with 3mM t-BHP, showed significant protection against the 
toxic effect of t-BHP, produced approximately (77.9%) improve in cell viability 
(P<0.01), this protection may be attributed to the presence of His-containing peptide 
and the hydrophobic amino acids (Val, Ile, Leu and Phe) which have the ability to 
scavenge radicals generated by t-BHP through the Fenton reaction (Kim et al., 2007). 
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Morphological characteristics of Caco-2 cells treated with 3 mM t-BHP for 2.5 h 
resulted in marked morphological alterations indicative of cell death due to the 
cytotoxic effects of t-BHP. However, pretreatment with the BSA-derived peptide 
fraction GF18 exerted protective effects 48 h post-treatment with 3 mM t-BHP. 
 
The protective effect of the peptide resulted in markedly decreased formation of MDA 
(27.7 µg/ml) compared with cells subjected to oxidative stress (30.3 µg/ml, P<0.001). 
These results indicated that the BSA-derived peptide fraction possessed the capacity 
to increase the resistance of Caco-2 cells to t-BHP-induced oxidative stress and 
scavenged lipid-derived free radicals that oxidize polyunsaturated fatty acids in the 
cell membrane (Chapple et al., 2013). Moreover, the side chains of the constituent 
amino acid residues in the antioxidant BSA-derived peptide are likely to function as 
hydrogen donors, with the ability to quench/decrease the load of oxidizing free 
radicals (Udenigwe and Aluko, 2011; Wiriyaphan et al., 2012). 
 
Moreover, significantly lower activation of caspases 3 and 7 was observed in Caco-2 
cells treated with t-BHP in the presence of prior treatment with the BSA-derived 
peptide (25.4%). These results suggest that the antioxidant activity of the BSA-
derived peptide fraction allowed reduction in cellular apoptosis by decreasing the 
activation of caspases 3 and 7 in response to t-BHP-induced free-radical chain 
reaction. These results are similar to those observed by Giovannelli et al. (2000), 
where the antioxidant activity of phenolic compounds was found to exert protective 
effects against H2O2-induced oxidative damage. 
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The BSA-derived peptide therefore exhibited antioxidant effects against t-BHP-
induced oxidative stress in Caco-2 cells by inhibiting intracellular ROS production. 
Statistically significant decrease in ROS generation was observed upon treatment of 
Caco-2 cells with the BSA-derived peptide, both in the presence and absence of t-
BHP (33.7% and 40.3%, respectively) compared with t-BHP-treated cells (80.5%, P 
< 0.001). These observations suggest that the rapid increase in ROS production and 
the oxidative damage triggered by the action of t-BHP is likely to be associated with 
its higher stability in aqueous solution (Alía et al., 2005). Moreover, the present study 
also highlights the protective effects of the BSA-derived peptide against oxidative 
damage in colon cancer cells and its ability to reduce ROS production; this activity is 
likely to be related to its action as a ROS scavenger (García-Nebot et al., 2011; 
García-Nebot et al., 2014; Kim et al., 2014a). 
 
The total concentration of glutathione in Caco-2 cells significantly increased in cells 
pre-treated with 0.008 mg/ml of the BSA peptide by approximately 0.15 µM. 
Treatment with 3 mM of t-BHP alone significantly decreased the total glutathione 
level in Caco-2 cells by 0.06 µM; however, in the presence of the BSA peptide there 
was a slight increase by 0.09 µM (P < 0.01). The above results indicate that the BSA 
peptide is useful for measuring the total glutathione content and protects Caco-2 cells 
against t-BHP induced oxidative damage (Tiawari and Kakkar, 2009). 
 
There was no significant difference in CAT activity in Caco-2 cells under oxidative 
stress induced by t-BHP compared to untreated cells (P > 0.05). CAT activity in 
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untreated cells was 9.9 U/mg protein; furthermore, when cells were treated with 
peptide alone, the CAT activity was 7.6 U/mg protein, and when cells were treated 
with and without t-BHP, CAT activity was 10.4 and 9.1 U/mg protein, respectively 
(Figure 5.11). CAT is induced by low concentrations of endogenous or exogenous t-
BHP or H2O2 (Masaki et al., 1998). Therefore, the concentration of t-BHP (i.e. 3 mM) 
used in this study may have been too low to induce CAT. This may explain why no 
significant differences were observed between cells treated with or without t-BHP. In 
addition, our study showed that the BSA peptide had no effect on CAT activity, which 
is in agreement with several previous results of peptides obtained from food proteins 
(Sullivan et al., 2012; Yaning Shi et al., 2014; Carla Souse et al., 2015). 
 
In the current study, SOD activity was highest in Caco-2 cells treated with the BSA 
peptide alone compared to untreated cells (i.e. 66.4% of the SOD activity in control 
cells; P < 0.05). After the cells were placed under oxidative stress with 3 mM t-BHP, 
the SOD activity was markedly reduced to 50.6%, observed in the control cells (P < 
0.01) (Figure 5.13). However, the lowest SOD activity was observed when Caco-2 
cells were treated with 3 mM of t-BHP alone (42.2% of the SOD activity in control 
cells; P < 0.05). The above result supports the fact that the BSA peptide (GF18), 
which acts as an antioxidant, helps to protect Caco-2 cells against t-BHP induced 
toxicity by enhancing SOD activity (Sullivan et al., 2011; Sullivan et al., 2012; Carla 
Souse et al., 2015). 
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7.1.6   Effects of the bovine serum albumin-derived peptides on the 
inhibition of angiotensin-I-converting enzyme and reactive oxygen 
species in the endothelial cancer cell line EA.hy926   
In endothelial cells, enzyme systems such as NADPH oxidase and xanthine oxidase 
are accountable for ROS production. Excessive production of these reactive species 
results in the alteration of various biological components such as lipids, proteins, 
enzymes, and nucleic acids, which lead to cell death and also promote the 
development of numerous degenerative diseases such as chronic inflammation, 
cardiovascular complications, cancer, and Alzheimer’s disease (Shieh et al., 2010; 
Bae et al., 2011; Yongvanit et al., 2012; Carocho and Ferreira, 2013). Hypertension is 
a major public health concern and a risk factor for several diseases such as myocardial 
infarction, stroke, coronary heart disease, and renal disease (Li et al., 2012a). 
Therefore, the use of ACE inhibitory and antioxidant peptides derived from food 
products for maintaining population health by lowering high blood pressure and 
scavenging radicals is of enormous interest (Cian et al., 2014). The present study 
employs EA.hy926 cells as a model system for studying the effect of bovine serum 
albumin (BSA)-derived gel-filtration (GF) peptide fraction GF22 (referred to in 
Chapter 4) on ROS accumulation in human endothelial cells and in the inhibition of 
ACE. 
 
Cell viability by MTT assay showed a slight decrease in growth rate upon increasing 
peptide concentrations; however, significant toxicity was not observed during the 24-
h assay period, and the results were statistically significant (P ≤ 0.05). Compared with 
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the control (100% viability), treatment with 0.02 mg/ml peptide yielded the highest 
cell viability (98.6%; P ≥ 0.05) and was not significantly different. However, the 
treatment with 0.02 mg/ml peptide was the highest among the various peptide 
concentrations tested (0.02-0.8 mg/ml). Higher percentage cell viability (98.6%) was 
observed upon treatment of EA.hy926 cells with the peptide (0.02 mg/ml) compared 
with ascorbic acid (94.5%; P < 0.01). In addition, there was no significant difference 
in viability  observed in EA.hy926 cells treated with trolox (101.5%) compared with 
untreated cells or the cells treated with 0.02 mg/ml peptide (100%; P ≥ 0.05). This 
result strongly suggests that the bioactive peptide derived from the dairy or meat 
protein exhibits good cellular antioxidant activity at the selected concentration.  
 
Pre-incubation of cells with the peptide conferred significant protection against the 
cytotoxicity generated by treatment with 3 mM t-BHP for 2.5 h, as evidenced by 
enhanced viability (70.4%) compared with the treatment with t-BHP alone (53.6%) at 
the selected concentration and in a time-dependent manner. The radical-scavenging 
activity of protein hydrolysates depends on the amino acid composition and sequence 
of the constituent oligopeptides (Wiriyaphan et al., 2012). The results obtained in the 
present study show that the BSA-derived peptide exhibited antioxidant and radical-
scavenging activities and thereby could potentially protect endothelial cells from 
oxidative stress. 
 
Characterization of morphological features revealed the protective effects of the BSA-
derived peptide in endothelial cells 48-h post-treatment with 3 mM t-BHP, 
 219 
 
attributable to the antioxidant effects of the peptide and its radical scavenging activity. 
The use of fluorescence-based techniques (lucigenin-enhanced chemiluminescence 
and DHE-based fluorescence techniques) also revealed the protective effects of the 
BSA-derived peptide against Ang II-mediated oxidative damage in endothelial cells 
and its ability to reduce mROS production through its activity as a ROS scavenger.  
 
NO production in EA.hy926 cells was inhibited at all tested concentrations of the 
peptide (P ≤ 0.05); however, significant inhibition of NO production (0.02 µM nitrite 
concentration) was observed at a peptide concentration of 0.08 mg/ml compared with 
the negative control (P < 0.001). In the present study, different concentrations of the 
BSA-derived peptide fraction were found to exert protection against the damaging 
effects of excessive NO production by reducing nitrite concentration. The amino acid 
composition of peptides is known to play an important role in the inhibition of NO 
production, the BSA-derived GF peptide fraction GF22 contains amino acid residues 
such as lysine, which has been reported to reduce cellular NO production by 
inhibiting cationic amino acid transporters, which in turn inhibits the uptake of 
cationic amino acids, particularly L-arginine (Luiking and Deutz, 2007; Cui et al., 
2011). The decreased uptake of L-arginine in turn decreases the intracellular 
production of NO (Cui et al., 2011). 
 
The study revealed that the BSA-derived peptide exhibited the capacity to inhibit 
ACE activity at all tested concentrations of the peptide (P ≤ 0.05), in a dose-
dependent manner. However, marked inhibition of ACE activity (by 70.7%) was 
 220 
 
attained at a peptide concentration of 0.8 mg/ml compared with the positive control 
captopril (88.6%; P < 0.001). ACE inhibitory activity is known to reduce the 
production of Ang II and increase vasodilation in the cardiovascular system by 
interrupting the conversion of Ang I to Ang II. Reduced production of Ang II lowers 
blood pressure, decreases superoxide anion production, and reduces smooth muscle 
cell proliferation. Therefore, inhibition of ACE activity is important for decreasing 
cardiovascular morbidity and mortality (Bougatef et al., 2009). In the current study, 
the BSA-derived peptide fraction proved effective in inhibiting the activity of ACE in 
a dose-dependent manner, suggesting that the BSA-derived peptide could decrease the 
rate of Ang II formation in cells. 
 
Thus, the antioxidant and ACE inhibitory activities of the BSA-derived peptide are 
associated with the presence of specific amino acid residues in the peptide sequence. 
These results suggest that the BSA-derived peptide fraction GF22 exhibits both 
antioxidant and ACE inhibitory activities in the endothelial cell line EA.hy926. 
 
7.2  General conclusions  
 The crude BSA hydrolysate and its peptide fractions (< 10 kDa fraction 
generated by UF and GF18 gel-filtration fraction) exhibited good antioxidant 
activity and inhibited lipid oxidation in the linoleic acid model system that was 
comparable to trolox and BHA.  
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 The antioxidant activity may be attributed to the presence of specific amino 
acids in the peptide fraction, notably, the hydrophobic amino acids that facilitate 
hydrogen bonding or donate electrons to the free-radical species. 
 
 
 The in vitro antioxidant activity of the BSA derived peptide fraction (< 10 kDa) 
exhibited strong free radical scavenging, metal-ion chelating and reducing 
activities in a peptide dose-dependent manner; the antioxidant activity of (< 10 
kDa)  was comparable with that of the synthetic antioxidants BHA and trolox 
(0.01%) , that are currently used in food and pharmaceutical products.  
 
 The in vitro digestion of bovine serum albumin using pepsin produced peptides 
with ACE inhibitory activity;  the gel filtration fraction GF22 exhibited the 
highest ACE inhibitory activity (79.56%) and a low IC50 (0.32 mg/ml). 
 
 The amino acid profile of GF22 exhibited variations and included a high 
proportion of tryptophan, lysine, leucine and tryptophan residues, and limited 
amounts of histidine, isoleucine, methionine and cysteine residues. The ACE- 
inhibitory activity of the peptide derived from BSA hydrolysate is likely to be 
due to the presence of hydrophobic amino acids. 
 
 The ACE inhibitory peptide in BSA-derived peptide fraction GF22 is a 
competitive inhibitor of ACE and therefore competes with the substrate Hip–
His–Leu for active site binding, suggesting that it may be potentially useful for 
nutraceutical antihypertensive application. 
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 The BSA-derived peptide fraction GF18 obtained following hydrolysis of BSA 
with pepsin exhibited good antioxidant activity and exerted a protective effect 
against t-BHP-induced oxidative stress in Caco-2 cells by increasing cell 
viability. 
 
 Under stress conditions, the BSA-derived peptide fraction GF18 decreased 
formation of MDA, inhibited caspases 3/7 activity and reduced intracellular 
ROS production. 
 
 The GF18 peptide treated Caco-2 cells possessed good cellular glutathione level 
and protected cells against t-BHP induced reduction in SOD activity without 
affecting catalase levels.  
 
 The BSA-derived peptide fraction GF22, obtained upon the hydrolysis of BSA 
with pepsin, exhibited good antioxidant activity and exerted a protective effect in 
the endothelial cell line EA.hy926 against t-BHP-induced oxidative stress. 
 
 
 The BSA-derived peptide fraction GF22 exhibits both antioxidant and ACE 
inhibitory activities in the endothelial cell line EA.hy926. 
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7.3  Future work  
 To investigate the antihypertensive effect of the BSA-derived peptides fraction 
using an in vivo model system, particularly spontaneously hypertensive rats 
(SHR). 
 
 To investigate the in vivo antioxidant effect of the BSA-derived peptides 
fraction on cancer reduction or progression in mice with induced colon cancer. 
 
 
 To investigate the effect of BSA-derived peptides fraction on liver and breast 
cancer cell lines. 
 
 To identify the amino acid sequence of the purified gel-filtered antioxidant 
(GF18) and ACE-inhibitory (GF22) peptides. 
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